YUTREPIA™ surpasses 900 unique patient prescriptions and 550 patient starts within 11 weeks after approval to treat PAH and PH-ILD Positive interim data from ASCENT trial reinforces YUTREPIA’s tolerability and efficacy profile in PH-ILD with median improvement in six-minute walk distance of 31.5 meters at Week 16 Company to host webcast today at 8:30 a.m. ET MORRISVILLE, N.C., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, today announced its financial results for the second quarter ended June 30, 2025. The company will also host a webcast at 8:30 a.m. Eastern Time on August 12, 2025, to review financial performance and provide a corporate update. Dr. Roger Jeffs, Liquidia’s Chief Executive Officer, said: “The second quarter was a defining period for Liquidia with the FDA approval and rapid commercial launch of YUTREPIA™ (treprostinil) inhalation powder. More than 350 physicians across the country have already prescribed YUTREPIA to treat patients with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), including those new to prostacyclin treatment or transitioning from Tyvaso®, Tyvaso DPI®, and even from oral prostacyclins. In the 11 weeks since approval, we’ve recorded over 900 unique patient prescriptions leading to more than 550 patient starts. This initial demand has exceeded my own high expectations. The robust and increasing uptake reflects a clear need for more flexible and better-tolerated prostacyclin therapies. We’ve already seen broad demand across both indications from both cardiologists and pulmonologists. Notably, this early momentum has been achieved ahead of full payor adoption, highlighting the potential for accelerating growth as we continue to expand market access during the third and fourth quarters. In addition, we have continued to build differentiated clinical evidence of YUTREPIA’s safety and efficacy to treat PH-ILD through the ongoing, open-label ASCENT study, which fully enrolled last March (n=54). Interim analyses of eligible patients at Week 8 and Week 16 reinforced YUTREPIA’s tolerability profile at higher doses and showed sustained median improvements in six-minute walk distance (6MWD) of 21.5 meters at Week 8 and 31.5 meters at Week 16. Importantly, patients titrated to a median dose of 132.5mcg at Week 8 and 159mcg at Week 16 with no change in mean cough score. There were no discontinuations stemming from drug-related adverse events, such as cough or throat irritation. More detailed clinical findings will be presented at medical conferences in September and October of 2025. With this strong early commercial execution, compelling clinical evidence, and financial flexibility through our recent funding under our financing agreement (HCR Agreement) with Healthcare Royalty (HCRx), we are well positioned to scale access to YUTREPIA, expand our clinical programs, and deliver durable value for patients and shareholders.” Second Quarter and Recent Corporate Highlights On May 23, 2025, the U.S. Food and Drug Administration (FDA) approved YUTREPIA™ (treprostinil) inhalation powder to treat adults diagnosed with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD) to improve exercise ability. In the first week of June 2025, Liquidia commercially launched YUTREPIA and initiated shipments to U.S. customers. Unique patient prescriptions and starts have accelerated month-over-month since launch. As of August 8, specialty pharmacies reported more than 900 unique patient prescriptions leading to more than 550 patient starts. During the first six weeks post-launch, 75% of prescriptions converted to treatment starts. On June 16, 2025, Liquidia signed a lease for approximately 70,000 square feet of additional manufacturing space to support continued growth. Targeted for occupancy in 2026, this state-of-the-art facility will include production space to house additional PRINT manufacturing lines, analytical labs, and cleanrooms. On June 23, 2025, Liquidia received $50.0 million under its sixth amendment to the HCR Agreement following the first commercial sale of YUTREPIA. In July and August of 2025, the company analyzed interim data from the 52-week, prospective, open-label ASCENT study which fully enrolled 54 patients with PHILD. Safety data and observed exploratory efficacy data was summarized for Week 8 and Week 16 timepoints. The tolerability profile of YUTREPIA in PH-ILD was consistent with initial observations in the first 20 patients at Week 8. Most patients continued on treatment to Week 16 with 10 of 54 (18.5%) discontinuing the study. There were no discontinuations stemming from drug-related adverse events, such as cough or throat irritation. Of those patients who reported a treatment related cough, 24 of 26 patients reported a mild cough and 2 patients reported a moderate cough. The mean daytime simplified cough scores remained essentially unchanged from baseline through Week 16, suggesting the cough tended to be transient nature. Dose titration remains steady, with a median dose of 132.5 mcg QID at Week 8, and 159 mcg QID at Week 16. The highest exposure at Week 16 was 318 mcg QID. The median improvements in six-minute walk distance were 21.5 meters at Week 8 and 31.5 meters at Week 16. Release of detailed clinical data is targeted for medical conferences in September and October of 2025. Second Quarter 2025 Financial Results Cash and cash equivalents totaled $173.4 million as of June 30, 2025, compared to $176.5 million as of December 31, 2024. Product revenue, net, was $6.5 million for the three months ended June 30, 2025. Following receipt of full FDA approval for YUTREPIA on May 23, 2025, we began shipping YUTREPIA to our customers in the United States in June 2025. We did not recognize any product revenue during the three months ended June 30, 2024. Service revenue, net, was $2.3 million for the three months ended June 30, 2025, compared to $3.7 million for the three months ended June 30, 2024. Service revenue, net related primarily to the promotion agreement with Sandoz, Inc. pursuant to which we share profits from the sale of Treprostinil Injection in the United States (Promotion Agreement). The decrease of $1.4 million was primarily due to the impact of unfavorable gross-to-net returns and managed care adjustments recorded in the current year. Cost of product sales was $0.2 million for the three months ended June 30, 2025 and related to sales of YUTREPIA. We did not record any cost of product sales for the three months ended June 30, 2024. Cost of service revenue was $1.3 million for the three months ended June 30, 2025, compared to $1.5 million for the three months ended June 30, 2024. Cost of service revenue related to the Promotion Agreement as noted above. Research and development expenses were $6.0 million for the three months ended June 30, 2025, compared to $9.4 million for the three months ended June 30, 2024. The decrease of $3.4 million or 36% was primarily due to a $2.7 million decrease in personnel expenses (including stock-based compensation) due to a shift from activities related to research and development to the commercialization of YUTREPIA, a $1.0 million decrease in expenses related to our YUTREPIA research and development activities, and a $0.4 million decrease in facilities and infrastructure expenses. These decreases were offset by a $1.1 million increase in clinical expenses for our L606 program, primarily related to our planned global pivotal study for the treatment of PH-ILD. Selling, general and administrative expenses were $38.8 million for the three months ended June 30, 2025, compared to $19.9 million for the three months ended June 30, 2024. The increase of $18.9 million or 95% was primarily due to a $8.8 million increase in personnel expenses (including stock-based compensation) driven by higher headcount and a shift from activities related to research and development to the commercialization of YUTREPIA, a $5.8 million increase in legal fees related to our ongoing YUTREPIA-related litigation, a $2.3 million increase in commercial and consulting expenses to support the commercialization of YUTREPIA, and a $1.3 million increase in facilities and infrastructure expenses. Total other expense, net was $4.1 million for the three months ended June 30, 2025, compared with $1.5 million for the three months ended June 30, 2024. The increase of $2.6 million was primarily attributable to the higher borrowings under the HCR Agreement. Net loss for the three months ended June 30, 2025, was $41.6 million or $0.49 per basic and diluted share, compared to a net loss of $28.7 million, or $0.38 per basic and diluted share, for the three months ended June 30, 2024. Webcast Information Liquidia will host a live webcast at 8:30 a.m. Eastern Time on August 12, 2025, to discuss the second quarter financial results and corporate update. The webcast will be available on Liquidia's website at https://liquidia.com/investors/events-and-presentations. A rebroadcast of the event will be available and archived for a period of one year at the same location. About YUTREPIA™ (treprostinil) Inhalation PowderYUTREPIA is an inhaled dry-powder formulation of treprostinil delivered through a convenient, low-effort, palm-sized device. YUTREPIA is indicated for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD) to improve exercise ability. YUTREPIA was designed using Liquidia’s PRINT® technology, which enables the development of drug particles that are precise and uniform in size, shape and composition, and that are engineered for enhanced deposition in the lung following oral inhalation. YUTREPIA was previously referred to as LIQ861 in investigational studies. About L606 (liposomal treprostinil) Inhalation SuspensionL606 is an investigational, sustained-release formulation of treprostinil administered twice-daily with a next-generation nebulizer. The L606 suspension uses Pharmosa Biopharm’s proprietary liposomal formulation to encapsulate treprostinil which can be released slowly at a controlled rate into the lung, enhancing drug exposure over an extended period of time. L606 is currently being evaluated in an open-label study in the United States for treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD) with a planned global pivotal placebo-controlled efficacy study for the treatment of PH-ILD. About Treprostinil InjectionTreprostinil Injection is the first-to-file, fully substitutable generic treprostinil for parenteral administration. Treprostinil Injection contains the same active ingredient, same strengths, same dosage form and same inactive ingredients as Remodulin® (treprostinil) and is offered to patients and physicians with the same level of service and support, but at a lower price than the branded drug. Liquidia PAH promotes the appropriate use of Treprostinil Injection for the treatment of PAH in the United States in partnership with its commercial partner, Sandoz, who holds the Abbreviated New Drug Application (ANDA) with the FDA. About Pulmonary Arterial Hypertension (PAH)Pulmonary arterial hypertension (PAH) is a rare, chronic, progressive disease caused by hardening and narrowing of the pulmonary arteries that can lead to right heart failure and eventually death. Currently, an estimated 45,000 patients are diagnosed and treated in the United States. There is currently no cure for PAH, so the goals of existing treatments are to alleviate symptoms, maintain or improve functional class, delay disease progression and improve quality of life. About Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)Pulmonary hypertension (PH) associated with interstitial lung disease (ILD) includes a diverse collection of up to 150 different pulmonary diseases, including interstitial pulmonary fibrosis, chronic hypersensitivity pneumonitis, connective tissue disease-related ILD, and chronic pulmonary fibrosis with emphysema (CPFE) among others. Any level of PH in ILD patients is associated with poor 3-year survival. A current estimate of PH-ILD prevalence in the United States is greater than 60,000 patients, though actual prevalence in many of these underlying ILD diseases is not yet known due to factors including underdiagnosis and lack of approved treatments until March 2021 when inhaled treprostinil was first approved for this indication. About Liquidia CorporationLiquidia Corporation is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company’s current focus spans the development and commercialization of products in pulmonary hypertension and other applications of its proprietary PRINT® Technology. PRINT enabled the creation of Liquidia’s first approved product, YUTREPIA™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).  The company is also developing L606, an investigational sustained-release formulation of treprostinil administered twice-daily with a next-generation nebulizer, and currently markets generic Treprostinil Injection for the treatment of PAH. To learn more about Liquidia, please visit www.liquidia.com. Remodulin®, Tyvaso® and Tyvaso DPI® are registered trademarks of United Therapeutics Corporation. Cautionary Statements Regarding Forward-Looking StatementsThis press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release other than statements of historical facts, including statements regarding our future results of operations and financial position, our strategic and financial initiatives, our business strategy and plans and our objectives for future operations, are forward-looking statements. Such forward-looking statements, including statements regarding clinical trials, clinical studies and other clinical work (including the funding therefor, anticipated patient enrollment, safety data, study data, trial outcomes, timing or associated costs), regulatory applications and related submission contents and timelines, the timelines or outcomes related to patent litigation with United Therapeutics in the U.S. District Court for the District of Delaware and U.S. District Court for the Middle District of North Carolina, or other litigation between Liquidia and United Therapeutics or others, including rehearings or appeals of decisions in any such proceedings, the issuance of patents by the USPTO and our ability to execute on our strategic or financial initiatives, the potential for additional funding under the HCR Agreement, our anticipated use of net proceeds funded under the HCR Agreement, our estimates regarding future expenses, capital requirements and needs for additional financing, and potential revenue and profitability of YUTREPIA involve significant risks and uncertainties and actual results could differ materially from those expressed or implied herein. YUTREPIA’s approval and our launch of YUTREPIA remain subject to ongoing litigation in which United Therapeutics is seeking injunctive relief, which could block our ability to continue to sell YUTREPIA for one or both of PAH and PH-ILD. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “would,” and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives and financial needs. These forward-looking statements are subject to a number of risks discussed in our filings with the SEC, as well as a number of uncertainties and assumptions. Moreover, we operate in a very competitive and rapidly changing environment and our industry has inherent risks. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events discussed in this press release may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Nothing in this press release should be regarded as a representation by any person that these goals will be achieved, and we undertake no duty to update our goals or to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise. Financial Statement RevisionDuring the three months ended March 31, 2025, we identified immaterial errors in our accounting treatment of the fourth and fifth amendments to the HCR Agreement. We voluntarily revised our previously issued 2024 annual consolidated financial statements to correct the immaterial errors and disclosed the impacts to our quarterly financial statements for the respective 2024 interim periods in our Current Report on Form 8-K filed on May 8, 2025. As a result of the revision, the loss on extinguishment has been eliminated and an adjustment to interest expense resulting from the modifications has been recorded, with corresponding adjustments to the long-term debt and accumulated deficit accounts. The financial statement line items as of and for the three months ended June 30, 2024 in the financial statements presented in this press release reflect such revisions. Contact InformationInvestors:Jason AdairChief Business Officer919.328.4350Jason.adair@liquidia.com Media:Patrick WallaceDirector, Corporate Communications919.328.4383patrick.wallace@liquidia.com Liquidia CorporationSelect Condensed Consolidated Balance Sheet Data (unaudited)(in thousands)       June 30,     December 31,       2025     2024   Cash and cash equivalents   $ 173,422     $ 176,479   Total assets   $ 257,410     $ 230,313   Total liabilities   $ 242,221     $ 150,935   Accumulated deficit   $ (637,335 )   $ (557,389 ) Total stockholders’ equity   $ 15,189     $ 79,378                 Liquidia CorporationCondensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)(in thousands, except share and per share amounts)       Three Months Ended June 30,       2025     2024   Revenues:                 Product sales, net   $ 6,517       -   Service revenue, net     2,320       3,659   Total revenue     8,837       3,659   Costs and expenses:                 Cost of product sales     205       -   Cost of service revenue     1,292       1,493   Research and development     6,021       9,420   Selling, general and administrative     38,824       19,943   Total costs and expenses     46,342       30,856   Loss from operations     (37,505 )     (27,197 ) Other income (expense):                 Interest income     1,584       1,855   Interest expense     (5,658 )     (3,326 ) Total other expense, net     (4,074 )     (1,471 ) Net loss and comprehensive loss   $ (41,579 )   $ (28,668 ) Net loss per common share, basic and diluted   $ (0.49 )   $ (0.38 ) Weighted average common shares outstanding, basic and diluted     85,588,108       76,435,831   The post Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update appeared first on ForexTV.

--Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal side effects compared to semaglutide alone-- --Company reported positive efficacy and safety data from Phase 2b QUALITY Maintenance Extension study showing enobosarm significantly reduced body weight regain, prevented fat regain, and preserved lean mass after semaglutide discontinuation-- --Company has selected a novel modified release oral enobosarm formulation following pharmacokinetic clinical study-- --Company anticipates FDA feedback to clarify the regulatory pathway for enobosarm to preserve lean mass during chronic weight loss management-- --Company to host conference call and webcast today at 8:00 a.m. ET-- MIAMI, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced financial results for its fiscal 2025 third quarter and provided an update on progress of its clinical development programs. “We have now reported all the positive efficacy and safety topline results from our Phase 2b QUALITY and Maintenance Extension study, and are looking forward to FDA feedback on the regulatory pathway for enobosarm to be used as an adjunctive therapy with GLP-1 RA to preserve lean mass while burning more fat for chronic weight loss management,” said Mitchell Steiner, M.D., Chairman, President, and Chief Executive Officer of Veru. “The efficacy and safety of Veru’s oral agent enobosarm looks better than any of the injectable myostatin inhibitors now under development by our competitors. Unlike our competitors, enobosarm has positive physical function data measured by stair climb power. Furthermore, we have strengthened our intellectual property position with the selection of a novel modified release oral enobosarm formulation confirmed in a clinical pharmacokinetic study.” Enobosarm for Chronic Weight Loss Management Program Phase 2b QUALITY study- enobosarm is a next generation drug that makes GLP-1 RA weight loss more selective for fat loss while preserving lean mass and physical function In January 2025, the Company announced positive topline efficacy results from the Phase 2b QUALITY clinical study, which is a multicenter, double-blind, placebo-controlled, randomized, dose-finding clinical trial designed to evaluate the safety and efficacy of enobosarm 3mg, enobosarm 6mg, or placebo as a treatment to augment fat loss and to prevent muscle loss in 168 older patients (≥60 years of age) receiving semaglutide for chronic weight management. The 3mg enobosarm dose had the best profile to advance into Phase 3 program. Enobosarm 3mg + semaglutide group met the primary endpoint of study with a statistically significant 100% average preservation of total lean mass compared to placebo + semaglutide at 16 weeks (p<0.001).  Enobosarm + semaglutide treatment resulted in dose dependent greater loss of fat mass compared to placebo + semaglutide with the enobosarm 6mg dose having a 42% greater relative loss of fat mass compared to placebo + semaglutide group at 16 weeks (p=0.017) and the enobosarm 3mg having a 12% greater fat loss.  Even with having preserved lean mass, enobosarm + semaglutide treatment resulted in a similar mean body weight loss as semaglutide alone at 16 weeks. The tissue composition of the total body weight lost was 34% lean mass and 66% fat mass for the placebo + semaglutide group whereas it was 0% lean mass and 100% fat mass for the enobosarm 3mg + semaglutide group. Physical function was measured by the Stair Climb Test. A responder analysis was conducted using a greater than 10% decline in stair climb power as the cut off at 16 weeks which represents an approximate 7 to 8 year loss of stair climb power that naturally occurs with aging. Phase 2b QUALITY clinical trial is the first human study to demonstrate that older patients who are overweight or have obesity receiving semaglutide are at higher risk for accelerated loss of physical function as 44.8% of the placebo + semaglutide group had at least a 10% decline in stair climb power physical function at 16 weeks. Enobosarm treatment preserved lean mass which translated into a reduction in the proportion of patients that had a clinically significant stair climb physical function decline with 17% of the enobosarm 3mg + semaglutide group having at least a 10% decline in stair climb power physical function at 16 weeks which is a 59.8% relative reduction in the proportion of subjects that lost at least 10% stair climb power compared to placebo + semaglutide group (p=0.006). In May 2025, the Company announced that the enobosarm and semaglutide GLP-1 RA combination had a positive safety profile in the Phase 2b QUALITY clinical trial After trial participants completed the efficacy dose-finding portion of the Phase 2b QUALITY clinical trial, 148 participants continued to the Phase 2b Maintenance Extension study, a double-blind study, where all patients discontinued semaglutide treatment, but continued receiving placebo, enobosarm 3mg, or enobosarm 6mg as monotherapy for 12 weeks. In June 2025, the Company announced positive topline efficacy and safety results from the maintenance extension portion of the Phase 2b QUALITY clinical study that showed that enobosarm significantly reduced body weight regain, prevented fat regain, and preserved Lean mass after semaglutide discontinuation The 3mg enobosarm monotherapy significantly reduced the body weight regained by 46% after discontinuation of semaglutide. At the end of the Phase 2b QUALITY study active weight loss period of 16 weeks, body weight loss was similar across treatment groups with the semaglutide plus placebo group losing an average of 11.88 lbs. After the 12-week Maintenance Extension study period (Day 112 to Day 196) where all treatment groups discontinued semaglutide, the placebo monotherapy group regained 43% of body weight that was previously lost during the Phase 2b QUALITY for a mean percent change of 2.57% (5.06 lbs) in body weight, compared to 1.41% (2.73 lbs) for the 3mg enobosarm group (p=0.038) and 2.87% (5.29lbs) for the 6mg enobosarm group. The mean tissue composition of body weight regained was 28% fat and 72% lean mass in the placebo group, versus 0% fat and 100% lean mass in both the 3mg and the 6mg enobosarm groups. Enobosarm plus semaglutide followed by enobosarm monotherapy regimen was more effective in preserving lean mass and causing and maintaining greater loss of fat by the end of the study. Placebo plus semaglutide followed by placebo monotherapy group experienced a loss of lean mass, while both enobosarm plus semaglutide followed by enobosarm monotherapy groups (3 mg and 6 mg doses) significantly preserved more than 100% of lean mass (enobosarm 3mg p<0.001 and enobosarm 6mg p=0.004). The enobosarm plus semaglutide followed by enobosarm monotherapy patients had a 58% greater loss of fat with enobosarm 3mg (p=0.085) and a 93% greater loss of fat with enobosarm 6mg (p=0.008) compared to placebo plus semaglutide followed by placebo monotherapy. Adverse events (AEs) and adverse events of special Interest In the double-blind Phase 2b QUALITY Maintenance Extension clinical trial (Day 112-196), enobosarm monotherapy had a positive safety profile. After discontinuation of semaglutide, there were essentially no gastrointestinal side effects, no evidence of drug induced liver injury (by Hy’s law), and no increases in obstructive sleep apnea observed at any dose of enobosarm compared to placebo monotherapy. There were no AEs of increases in prostate specific antigen in men. There were no AEs related to masculinization in women. There were no reports of suicidal ideation observed (Columbia-Suicide Severity Rating Scale). The Phase 2b QUALITY and Maintenance Extension clinical trial confirms that preserving lean mass with enobosarm plus semaglutide led to greater fat loss during the active weight loss period, and after semaglutide was discontinued, enobosarm monotherapy significantly prevented the regain of both weight and fat mass during the maintenance period such that by end of study there was greater loss of fat mass while preserving lean mass for a higher quality weight reduction compared to the placebo group. Novel Modified Release Oral Enobosarm Formulation On August 11, 2025, the Company announced the selection of a novel modified release oral enobosarm formulation following a pharmacokinetic clinical study for chronic weight loss management. The single-dose, open label pilot study evaluated the plasma concentration versus time profile of a proprietary, patentable modified release formulation of enobosarm 3mg. The new formulation demonstrated the intended distinct target product release profile, which includes a reduction in maximum plasma concentration (Cmax), a delayed time to maximum plasma concentration (Tmax), a distinct secondary peak concentration, and similar extent of absorption (AUC) compared to historical values for enobosarm immediate-release capsules. The novel modified release oral enobosarm formulation is planned to be available for further clinical studies and for commercialization. The novel enobosarm oral formulation’s unique manufacturing process is protected by issued global patents with protection through 2037 and the new patents on the novel modified release oral enobosarm formulation have been filed and if issued, expiry is expected to be 2046. Third Quarter Financial Summary: Fiscal 2025 vs Fiscal 2024 Research and development expenses decreased to $3.0 million from $4.8 million Selling, general and administrative expenses decreased to $5.0 million from $5.8 million Operating loss from continuing operations decreased to $7.5 million from $10.5 million Net loss from continuing operations decreased to $7.3 million, or $0.50 per share, compared to $10.3 million, or $0.71 per share Net loss decreased to $7.3 million, or $0.50 per share, compared to $11.0 million, or $0.75 per share Year-to-Date Financial Summary: Fiscal 2025 vs Fiscal 2024 Research and development expenses increased to $12.7 million from $9.5 million Selling, general and administrative expenses decreased to $15.4 million from $18.4 million Operating loss from continuing operations decreased to $25.9 million from $26.8 million Net loss from continuing operations decreased to $17.0 million, or $1.16 per share, compared to $26.7 million, or $2.04 per share Net loss decreased to $24.2 million, or $1.65 per share, compared to $29.3 million, or $2.23 per share Balance Sheet InformationCash, cash equivalents, and restricted cash were $15.0 million as of June 30, 2025 versus $24.9 million as of September 30, 2024 Event DetailsThe audio webcast will be accessible under the Home page and Investors page of the Company’s website at www.verupharma.com. To join the conference call via telephone, please dial 1-800-341-1602 (domestic) or 1-412-902-6706 (international) and ask to join the Veru Inc. call. An archived version of the audio webcast will be available for replay on the Company’s website for approximately three months. A telephonic replay will be available at approximately 12:00 p.m. ET by dialing 1-877-344-7529 (domestic) or 1-412-317-0088 (international), passcode 2184944, for one week. About Veru Inc.Veru is a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases. The Company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin. Enobosarm, a selective androgen receptor modulator (SARM), is being developed as a next generation drug that makes weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass thereby improving body composition and physical function. Sabizabulin, a microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease. Forward-Looking StatementsThis press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995, including, without limitation, express or implied statements related to whether and when the full data set, including safety data, from the Phase 2b QUALITY study and Maintenance Extension study of enobosarm discussed above will be made available and whether that data will align with disclosed topline results or change any of the conclusions drawn from the topline data; whether and when the Company will present the full data from the Phase 2b QUALITY study and Maintenance Extension study and in what forum; whether and when the Company will have an end-of-Phase-2 meeting with FDA and the results of any such meeting; whether the results of the Phase 2b QUALITY study and Maintenance Extension study of enobosarm will be replicated to the same or any degree in any future Phase 3 studies; the expected costs, timing, patient population, design, endpoints and results of the planned Phase 3 studies of enobosarm as a body composition drug or any other Phase 3 studies; whether the Company and FDA will align on the Phase 3 program for enobosarm as a body composition drug and whether any such program will be able to be funded by the Company; whether the modified-released formation of enobosarm will be developed successfully and whether such formulation will have the same effectiveness as the current formulation, and whether and when such modified-release formulation will be available for any planned or future clinical studies; whether and when any patents will actually issue regarding such modified-release formulation and what any expiration dates of any such patents might be; whether the Company will be able to obtain sufficient GLP-1 RA drugs in a timely or cost-effective manner in the planned Phase 3 study or other Phase 3 studies; whether FDA will require more than one Phase 3 study for enobosarm as a body composition drug; whether enobosarm will enhance weight loss or preserve muscle in, or meet any unmet need for, obesity patients and whether it will enhance weight loss in any planned or other Phase 3 studies or if approved, in clinical practice; whether patients treated with enobosarm for a longer period of time than in the Phase 2b QUALITY study and Maintenance Extension study will have a greater loss of adiposity or greater weight loss than with semaglutide alone; and whether and when enobosarm will be approved by the FDA as a body composition drug. The words "anticipate," "believe," "could," "expect," "intend," "may," "opportunity," "plan," "predict," "potential," "estimate," "should," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release are based upon current plans and strategies of the Company and reflect the Company's current assessment of the risks and uncertainties related to its business and are made as of the date of this press release. The Company assumes no obligation to update any forward-looking statements contained in this press release because of new information or future events, developments or circumstances. Such forward-looking statements are subject to known and unknown risks, uncertainties and assumptions, and if any such risks or uncertainties materialize or if any of the assumptions prove incorrect, our actual results could differ materially from those expressed or implied by such statements. Factors that may cause actual results to differ materially from those contemplated by such forward-looking statements include, but are not limited to: the development of the Company’s product portfolio and the results of clinical studies possibly being unsuccessful or insufficient to meet applicable regulatory standards or warrant continued development; the Company’s ability to reach agreement with FDA on study design requirements for the Company’s planned clinical studies, including for the Phase 3 program for enobosarm as a body composition drug and the number of Phase 3 studies to be required and the cost thereof; potential delays in the timing of and results from clinical trials and studies, including as a result of an inability to enroll sufficient numbers of subjects in clinical studies or an inability to enroll subjects in accordance with planned schedules; the ability to fund planned clinical development as well as other operations of the Company; the timing of any submission to the FDA or any other regulatory authority and any determinations made by the FDA or any other regulatory authority; the potential for disruptions at the FDA or other government agencies to negatively affect our business; any products of the Company, if approved, possibly not being commercially successful; the ability of the Company to obtain sufficient financing on acceptable terms when needed to fund development and operations and to enable us to continue as a going concern; demand for, market acceptance of, and competition against any of the Company’s products or product candidates; new or existing competitors with greater resources and capabilities and new competitive product approvals and/or introductions; changes in regulatory practices or policies or government-driven healthcare reform efforts, including pricing pressures and insurance coverage and reimbursement changes; the Company’s ability to protect and enforce its intellectual property; costs and other effects of litigation, including product liability claims, securities litigation, and litigation and other disputes with the purchaser of the Company’s FC2 business; our ability to maintain compliance with the continued listing requirements of the Nasdaq Stock Market, including our ability to regain and subsequently maintain compliance with the Nasdaq minimum bid price requirement after our recently completed reverse stock split; the Company’s ability to identify, successfully negotiate and complete suitable acquisitions or other strategic initiatives; the Company’s ability to successfully integrate acquired businesses, technologies or products; and other risks detailed from time to time in the Company’s press releases, shareholder communications and Securities and Exchange Commission filings, including the Company's Form 10-K for the year ended September 30, 2024, and subsequent quarterly reports on Form 10-Q. These documents are available on the “SEC Filings” section of our website at www.verupharma.com/investors.   FINANCIAL SCHEDULES FOLLOW     Veru Inc.Condensed Consolidated Balance Sheets(unaudited)                   June 30,   September 30,     2025   2024                   Cash, cash equivalents, and restricted cash   $ 15,010,154     $ 24,916,285   Prepaid expenses and other current assets     1,183,023       1,547,928   Current assets of discontinued operations     —       8,759,011   Total current assets     16,193,177       35,223,224                     Property and equipment, net     393,381       481,372   Operating lease right-of-use assets     2,875,672       3,250,623   Goodwill     6,878,932       6,878,932   Other assets     989,596       989,596   Long-term assets of discontinued operations     —       13,595,025   Total assets   $ 27,330,758     $ 60,418,772                     Accounts payable   $ 2,538,724     $ 2,259,668   Accrued compensation     2,780,570       4,494,278   Accrued expenses and other current liabilities     1,362,721       1,406,655   Residual royalty agreement liability, short-term portion     —       1,025,837   Current liabilities of discontinued operations     —       2,681,530   Total current liabilities     6,682,015       11,867,968                     Residual royalty agreement liability, long-term portion     —       8,850,792   Operating lease liability, long-term portion     2,500,736       2,905,309   Other liabilities     2,803,374       4,477,991   Total liabilities     11,986,125       28,102,060                     Total stockholders' equity     15,344,633       32,316,712   Total liabilities and stockholders' equity   $ 27,330,758     $ 60,418,772                       Veru Inc.Condensed Consolidated Statements of Operations(unaudited)                   Three Months Ended   Nine Months Ended     June 30,   June 30,     2025   2024   2025   2024                                   Operating expenses:                                 Research and development   $ 3,020,563     $ 4,846,156     $ 12,669,495     $ 9,489,848   Selling, general and administrative     5,010,528       5,809,325       15,402,074       18,364,622   Total operating expenses     8,031,091       10,655,481       28,071,569       27,854,470                                     Gain on sale of ENTADFI® assets     484,615       110,000       2,154,134       1,028,372                                     Operating loss     (7,546,476 )     (10,545,481 )     (25,917,435 )     (26,826,098 )                                   Non-operating income:                                 Gain on extinguishment of debt     —       —       8,624,778       —   Other non-operating income, net     223,375       205,425       307,260       115,561   Total non-operating income     223,375       205,425       8,932,038       115,561                                     Net loss from continuing operations     (7,323,101 )     (10,340,056 )     (16,985,397 )     (26,710,537 ) Net loss from discontinued operations, net of taxes     (9,719 )     (628,818 )     (7,194,389 )     (2,560,266 ) Net loss   $ (7,332,820 )   $ (10,968,874 )   $ (24,179,786 )   $ (29,270,803 )                                   Net loss from continuing operations per basic and diluted common shares outstanding   $ (0.50 )   $ (0.71 )   $ (1.16 )   $ (2.04 ) Net loss from discontinued operations per basic and diluted common shares outstanding   $ (0.00 )   $ (0.04 )   $ (0.49 )   $ (0.20 ) Net loss per basic and diluted common shares outstanding   $ (0.50 )   $ (0.75 )   $ (1.65 )   $ (2.23 )                                   Basic and diluted weighted average common shares outstanding     14,657,777       14,638,317       14,644,927       13,101,071                                       Veru Inc.Condensed Consolidated Statements of Cash Flows(unaudited)             Nine Months Ended     June 30,     2025   2024                   Net loss   $ (24,179,786 )   $ (29,270,803 )                   Adjustments to reconcile net loss to net cash used in operating activities     3,920,100       12,177,598                     Changes in operating assets and liabilities     (4,292,066 )     (223,034 )                   Net cash used in operating activities     (24,551,752 )     (17,316,239 )                   Net cash provided by investing activities     18,867,232       14,714                     Net cash (used in) provided by financing activities     (4,221,611 )     36,826,910                     Net (decrease) increase in cash, cash equivalents, and restricted cash     (9,906,131 )     19,525,385                     Cash, cash equivalents and restricted cash at beginning of period     24,916,285       9,625,494                     Cash, cash equivalents and restricted cash at end of period   $ 15,010,154     $ 29,150,879                     Investor and Media Contact:Samuel FischExecutive Director, Investor Relations and Corporate CommunicationsEmail: veruinvestor@verupharma.com The post Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress appeared first on ForexTV.

GOUVERNEUR, N.Y. and VANCOUVER, British Columbia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Titan Mining Corporation (TSX: TI; OTCQB: TIMCF) ("Titan" or the "Company") today announced its financial and operating results for the quarter ended June 30, 2025. The Company met quarterly production guidance at its Empire State Mines LLC (“ESM”) and is on track to be the first end to end producer of natural flake graphite in the United States by Q4 2025. Q2 25 HIGHLIGHTS:(1) Payable zinc production of 15.5 million pounds, up 7% from Q2 2024 Revenues of $16.3 million, C1 cash costs and AISC of $0.90/lb Cash flow from operations of $2.4 million Reduction in net debt by 21% from Q2 2024 Cash balance of $8.1 million at quarter end EXIM Bank financing secured for $15.8 million, the first direct mining loan under its Make More in America Initiative (2) Strong safety performance, with an injury frequency rate well below the U.S. national average Over 40,000 acres of mineral rights added through lease and option to lease agreements with St. Lawrence County in May 2025. This expands the Company’s mineral tenure to over 120,000 acres in upstate New York and increases the discovery opportunities for additional zinc and graphite resources as well as iron-oxide copper gold deposits Graphite processing facility construction underway at ESM site; over 50% of major equipment delivered Expected commissioning in Q4 2025, making Titan the first integrated producer of natural flake graphite in the U.S. in over 70 years. (1) All amounts disclosed in this news release are in U.S. dollars unless otherwise stated.(2) The EXIM Bank Financing was completed on July 21, 2025, subsequent to end of Q2 2025. Don Taylor, Chief Executive Officer of Titan, commented, “Our Q2 performance reflects consistent execution at ESM, with strong production, start-up of the N2D zone and continued cost control. Importantly, our graphite project has moved from concept to construction, supported by public and private sector backing. Titan is building the foundation to become a multi-commodity, integrated supplier of critical minerals to the U.S. economy”. Rita Adiani, President of Titan commented: “Titan is executing a unique dual-commodity strategy. Our zinc operations continue to generate cash flow, while the Kilbourne graphite first phase processing facility is rapidly progressing toward commissioning. With strong government support and tangible progress on-site, we’re positioning Titan as a future-facing, U.S.-based supplier of both industrial and critical minerals”. TABLE 1 Financial and Operating Highlights     2025     Q2  Q1  YTD  Operating         Payable zinc produced mlbs  15.51  15.37  30.88  Payable zinc sold mlbs  16.04  15.57  31.61  Average Realized Zinc Price $/lb  1.20  1.29  1.24  C1 Cost(1) $/lb  0.90  0.91  0.91  AISC(1) $/lb  0.90  0.96  0.93  Financial         Revenue $m  16.34  16.02  32.36  Net Income (loss) after tax $m  0.54  0.35  0.89  Earnings (loss) per share- basic $/sh  0.00  0.00  0.01  Cash Flow from Operating Activities before changes in non-cash working capital $m  2.36  2.69  5.05  Financial Position         Cash & Cash Equivalents $m  8.1  12.2  8.1  Net Debt(1) $m  24.2  23.1  24.2  Note: The sum of the quarters in the table above may not equal the year-to-date amounts disclosed elsewhere due to rounding. 1 C1 Cash Cost, All-In Sustaining Cost (“AISC”) and Net Debt are non-GAAP measures. Accordingly, these financial measures are not standardized financial measures under IFRS and might not be comparable to similar financial measures disclosed by other issuers. These financial measures have been calculated on a basis consistent with historical periods. Information explaining these non-GAAP measures is provided below under “Non-GAAP Performance Measures”. ZINC OPERATIONS REVIEW Mining during the quarter continued in the Mahler, New Fold, and Mud Pond zones at the #4 mine, with additional production initiated from the N2D zone for the first time since May 2023. High-grade ore from the Lower Mahler zone supported above-budget output. N2D production is ramping from 250 to 500 tons per day in Q3. GRAPHITE UPDATE Construction of the Kilbourne graphite demonstration plant is advancing, with over half of major equipment being delivered and site installation underway. Commissioning is on track for Q4 2025. Once operational, the facility will be the first to produce natural flake graphite end-to-end in the U.S. in over 70 years. Technical studies for the project are underway. EXPLORATION UPDATE The Company added additional 43,942 acres of mineral rights added through lease and option to lease agreements with St. Lawrence County in May of 2025 (See press release dated May 8th, 2025 “Titan Mining Signs Cooperative Agreements with St. Lawrence County, Expands Mineral Tenure to Greater Than 120,000 acres in Upstate New York”). Titan continues to evaluate the potential of the district for base, industrial, and precious metals. Multiple areas with historically documented graphite mineralization have been identified, with confirmed graphite mineralization within the ESM mineral tenure. The St. Lawrence County agreement has added the Parish Magnetite prospect to the Company’s target list, a possible Iron Oxide Copper Gold (IOCG) occurrence in the historic Adirondack Magnetite Belt. Underground drill programs in the second quarter of 2025 targeted Mahler, New Fold, N2D and Mud Pond. Underground drilling totaled 21 drill holes and 8,894ft (2,710 m). All underground drilling was completed with Company-owned underground drills by Company employees. Drilling continues to hit mineralization at anticipated grades outside of the existing life of mine model signifying mine life expansion potential. Surface drilling continued with Company drills in the second quarter with drilling at Pleasant Valley and Pork Creek for a total of 3,154ft (961.3m). Drilling for 2025 is expected to continue at previously outlined targets including Parish. Quality Assurance and Quality Control Core drilling was completed using ESM owned and operated drills which produced AWJ (1.374 in) size drill core. All core was logged by ESM employees. The core was washed, logged, photographed, and sampled. All core samples were cut in half, lengthwise, using a diamond saw with a diamond-impregnated blade and sampled on 5 ft intervals with adjustments made to match geological contacts. After a sample is cut, one half of the core was returned to the original core box for reference and long-term storage. The second half was placed in a plastic or cloth sample bag, labeled with the corresponding sample identification number, along with a sample tag. All sample bags were secured with staples or a draw string, weighed and packed in shipping boxes. Shipping boxes are placed on pallets and shipped by freight to ALS Geochemistry (“ALS”), an independent ISO/IEC accredited lab located in Sudbury, Ontario, Canada. ALS prepares a pulp of all samples and sends the pulps to their analytical laboratory in Vancouver, B.C., Canada, for analysis. ALS analyzes the pulp sample by an aqua regia digestion (ME-ICP41 for 35 elements) with an ICP – AES finish including Cu (copper), Pb (lead), and Zn (zinc). All samples in which Cu (copper), Pb (lead), or Zn (zinc) are greater than 10,000 ppm are re-run using aqua regia digestion (Cu-OG46; Pb-OG46; and Zn-OG46) with the elements reported in percentage (%). Silver values are determined by an aqua regia digestion with an ICP-AES finish (ME-ICP41) with all samples with silver values greater than 100 ppm repeated using an aqua regia digestion overlimit method (Ag-OG46) calibrated for higher levels of silver contained. Gold values are determined by a 30 g fire assay with an ICP-AES finish (Au-ICP21). Mr. Taylor has a fulsome staff of experts on-site that thoroughly review and verify ESM technical data on a regular basis, as described above. For this reason, Mr. Taylor has relied entirely on such verification procedures for verifying the scientific and technical data in this news release. Mr. Taylor has not identified any legal, political, environmental, or other risks that could materially affect the potential development of the mineral resources disclosed herein. Qualified Person The scientific and technical information contained in this news release has been reviewed and approved by Donald R. Taylor, MSc., PG, Chief Executive Officer of the Company. Mr. Taylor is a qualified person for the purposes of NI 43-101. Mr. Taylor has more than 25 years of mineral exploration and mining experience and is a Registered Professional Geologist through the SME (Registered Member #4029597). Non-GAAP Performance Measures This document includes non-GAAP performance measures, discussed below, that do not have a standardized meaning prescribed by IFRS. The performance measures may not be comparable to similar measures reported by other issuers. The Company believes that these performance measures are commonly used by certain investors, in conjunction with conventional GAAP measures, to enhance their understanding of the Company's performance. The Company uses these performance measures extensively in internal decision-making processes, including to assess how well the Empire State Mine is performing and to assist in the assessment of the overall efficiency and effectiveness of the mine site management team. The tables below provide a reconciliation of these non-GAAP measures to the most directly comparable IFRS measures as contained within the Company's issued financial statements. C1 Cash Cost Per Payable Pound Sold C1 cash cost is a non-GAAP measure. C1 cash cost represents the cash cost incurred at each processing stage, from mining through to recoverable metal delivered to customers, including mine site operating and general and administrative costs, freight, treatment and refining charges. The C1 cash cost per payable pound sold is calculated by dividing the total C1 cash costs by payable pounds of metal sold. All-in Sustaining Costs AISC measures the estimated cash costs to produce a pound of payable zinc plus the estimated capital sustaining costs to maintain the mine and mill. This measure includes the C1 cash cost and capital sustaining costs divided by pounds of payable zinc sold. AISC does not include depreciation, depletion, amortization, reclamation and exploration expenses.         Q2 2025   Q2 2024                     $ $/lb $ $/lb Pounds of payable zinc sold (millions)         16.0     14.7 Operating expenses and selling costs     $ 12,750 $ 0.80 $ 9,652 $ 0.66 Concentrate smelting and refining costs       1,671   0.10   1,913   0.13 Total C1 cash cost     $ 14,421 $ 0.90 $ 11,565 $ 0.79 Sustaining capital expenditures       27   0.00   -   0.00 AISC     $ 14,448 $ 0.90 $ 11,565 $ 0.79               Net Debt Net debt is calculated as the sum of the current and non-current portions of long-term debt, net of the cash and cash equivalent balance as at the balance sheet date. A reconciliation of net debt is provided below.         Q2 2025     Q2 2024                 Current portion of debt       $ 29,135     $ 36,177   Non-current portion of debt         3,254       -   Total debt       $ 32,389     $ 36,177   Less: Cash and cash equivalents         (8,142 )     (5,547 ) Net debt       $ 24,247     $ 30,630                 On July 21, 2025, subsequent to the end of Q2 2025, the Company restructured a $16.5 million dollar loan due to a related party. The loan has an approximate three-year term at 8% per annum. Approximately $9 million of the loan has been reclassified as non-current debt, thereby improving the Company’s working capital position significantly. About Titan Mining Corporation Titan is an Augusta Group company which produces zinc concentrate at its 100%-owned Empire State Mine located in New York state. Titan’s goal is to deliver shareholder value through operational excellence, development and exploration. We have a strong commitment towards developing critical minerals assets which enhance the security of the domestic supply chain.  For more information on the Company, please visit our website at www.titanminingcorp.com Contact For further information, please contact: Investor Relations: Email: info@titanminingcorp.com Cautionary Note Regarding Forward-Looking Information Certain statements and information contained in this new release constitute "forward-looking statements", and "forward-looking information" within the meaning of applicable securities laws (collectively, "forward-looking statements"). These statements appear in a number of places in this news release and include statements regarding our intent, or the beliefs or current expectations of our officers and directors, including that Titan is on track to commission the first integrated US graphite facility in 2025; expected commissioning in Q4 2025, making Titan the first integrated producer of natural flake graphite in the U.S. in over 70 years; Titan is building the foundation to become a multi-commodity, integrated supplier of critical minerals to the U.S. economy; the Kilbourne graphite first phase processing facility is rapidly progressing toward commissioning; we’re positioning Titan as a future-facing, U.S.-based supplier of both industrial and critical minerals; high-grade ore from the Lower Mahler zone supported above-budget output; N2D production is ramping from 250 to 500 tons per day in Q3; drilling continues to hit mineralization at anticipated grades outside of the existing life of mine model signifying mine life expansion potential; drilling for 2025 is expected to continue at previously outlined targets including Parish. When used in this news release words such as “to be”, "will", "planned", "expected", "potential", and similar expressions are intended to identify these forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements and/or information are reasonable, undue reliance should not be placed on forward-looking statements since the Company can give no assurance that such expectations will prove to be correct. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to vary materially from those anticipated in such forward-looking statements, including risks related to general business, economic, competitive, political, regulatory and social uncertainties; actual results of exploration activities and economic evaluations being different than modelled; fluctuations in currency exchange rates; changes in project parameters; changes in costs, including labor, infrastructure, operating and production costs in respect of both the Company’s zinc and graphite operations; future prices of zinc, graphite and other minerals; variations of mineral grade or recovery rates; operating or technical difficulties in connection with exploration, development or mining activities, including the failure of plant, equipment or processes to operate as anticipated in respect of both the Company’s zinc and graphite operations; delays in completion of exploration, development or construction activities in respect of both the Company’s zinc and graphite operations; changes in government legislation and regulation; the ability to maintain and renew existing licenses and permits or obtain required licenses and permits in a timely manner; the ability to obtain financing on acceptable terms in a timely manner; contests over title to properties; employee relations and shortages of skilled personnel and contractors; the speculative nature of, and the risks involved in, the exploration, development and mining business; and the factors discussed in the section entitled "Risks Factors" in the Company’s most recent annual information form filed on SEDAR+. Such forward-looking statements are based on various assumptions, including assumptions made with regard to our forecasts and expected cash flows; our projected capital and operating costs in respect of both the Company’s zinc and graphite operations; our expectations regarding mining and metallurgical recoveries in respect of both the Company’s zinc and graphite operations; mine life and production rates in respect of both the Company’s zinc and graphite operations; that laws or regulations impacting mining activities will remain consistent; our approved business plans; our mineral resource estimates and results of the PEA; our experience with regulators; political and social support of the mining industry in New York State; our experience and knowledge of the New York State mining industry and our expectations of economic conditions and the price of zinc and graphite; demand for graphite; exploration results; the ability to secure adequate financing (as needed); the Company maintaining its current strategy and objectives; and the Company’s ability to achieve its growth objectives. While the Company considers these assumptions to be reasonable, based on information currently available, they may prove to be incorrect. While the Company considers these assumptions to be reasonable, based on information currently available, they may prove to be incorrect. Except as required by applicable law, we assume no obligation to update or to publicly announce the results of any change to any forward-looking statement contained herein to reflect actual results, future events or developments, changes in assumptions or changes in other factors affecting the forward-looking statements. All forward-looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement. The post Titan Mining Delivers Strong Q2 Results; On Track to Commission First Integrated U.S. Graphite Facility in 2025 appeared first on ForexTV.

Solaris Estates launches direct-to-investor offering, giving accredited investors access to institutional-grade real estate while supporting affordable housing in underserved U.S. communities. Miami, Florida, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Solaris Estates LLC, a national multifamily housing firm specializing in the revitalization of underserved communities, is proud to announce the launch of its new direct-to-investor capital raise. This offering gives accredited investors the opportunity to participate directly in the company's mission—without traditional intermediaries targeting recurring cash flow from stabilized assets. Just as Solaris transforms underperforming real estate into safe, affordable homes for working families, the company is also transforming how those projects are funded. Its direct investment platform eliminates broker layers and allows accredited investors to access institutional-quality opportunities with increased transparency and alignment. A Mission-Driven Approach to Real Estate With over 4,500 units and a $500M+ portfolio under management, Solaris Estates has a proven track record of converting distressed housing into thriving, resilient neighborhoods. Their vertically integrated operations ensure control over every stage—from acquisition to property management—delivering consistent performance and measurable community impact. Investment With Immediate Purpose This offering enables accredited investors to get involved in institutional-grade real estate typically reserved for large funds. Solaris’s structure is designed to deliver cash flow and longterm value while supporting its mission to build safer, stronger communities. About Solaris Estates LLC Solaris Estates LLC is a national multifamily real estate company focused on revitalizing America’s underserved communities. Family-run for the last 25 years, Solaris operates with a long-term commitment to integrity, accountability, and community transformation. Through its vertically integrated platform, Solaris acquires, renovates, and manages multifamily housing with a commitment to long-term value and impact. Learn more at https://www.solarisestates.com/ Media Contact Lola Iparraguirre  Email: admin@solarisestates.com Phone: 786-673-0461 Website: https://www.solarisestates.com/ Disclaimer: Statements in this release that are not historical facts are forward-looking and involve risks and uncertainties that could cause actual results to differ. This release is for informational purposes only and does not constitute investment advice. The post Solaris Estates Launches Direct-to-Investor Offering, Empowering Investors to Build Stronger Communities Nationwide appeared first on ForexTV.

Leading Macau’s Non-Gaming Diversification Through MICE, Entertainment And Sporting Events Q2 2025 Group Adjusted EBITDA of $3.6 Billion, Up 12% Year-on-Year & Up 8% Quarter-on-Quarter Announced Interim Dividend of $0.70 Per Share Capella at Galaxy Macau Exclusive Private Preview Well Received by Its High Value Customers HONG KONG, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Galaxy Entertainment Group (“GEG”, “Company” or the “Group”) (HKEx stock code: 27) today reported results for the three-month and six-month periods ended 30 June 2025. (All amounts are expressed in Hong Kong dollars unless otherwise stated) Mr. Francis Lui, Chairman of GEG said: “Today I am pleased to report solid performance for the Macau market and GEG in Q2 and the first half of 2025. Despite global tariff disruptions, continued economic slowdown and regional competition, Macau remained resilient in Q2 2025 with Gross Gaming Revenue (‘GGR’) growing 8% year-on-year and 6% quarter-on-quarter to $59.3 billion. GEG delivered solid results and growth in market share under competitive market conditions. We managed to drive every segment of the business, particularly the premium mass. For the first half of 2025, the Group reported Net Revenue of $23.2 billion, up 8% year-on-year. Adjusted EBITDA was $6.9 billion, up 14% year-on-year. For Q2, the Group’s Net Revenue was $12.0 billion, up 10% year-on-year and up 8% quarter-on-quarter. Adjusted EBITDA was $3.6 billion, up 12% year-on-year and up 8% quarter-on-quarter. The ultra-luxury Capella at Galaxy Macau, our latest addition to GEG’s hotel portfolio, offered exclusive previews in May and contributed to our strong performance over the Golden Week. In June we hosted K-pop star G-Dragon and Hong Kong acclaimed singer Jacky Cheung at our Galaxy Arena, which led to a record high number of a single-day visitation of over 123,000 to Galaxy Macau™. The Group’s balance sheet remains healthy and liquid, with cash and liquid investments of $30.7 billion as of 30 June 2025 with minimal debt. This financial strength allows us to fund our development pipeline, explore overseas opportunities and return capital to shareholders via dividends. The previously announced final dividend of $0.50 per share was paid in June and today the Board announced an interim dividend of $0.70 per share, payable in October 2025. This again demonstrates our confidence in the medium to longer term outlook for Macau in general and GEG specifically. We continue to compete through our exceptional products and service and ongoing property enhancements, including our retail, food & beverage, multiple hotels and the Grand Resort Deck. More importantly, we continue to leverage the competitive edge of our MICE facilities and Galaxy Arena. Over the past two years it was proven that entertainment shows and events played a key role in driving new and repeat customers to Macau. During the first half of 2025, we have held a total of approximately 190 entertainment, sports and MICE events, and experienced a 65% year-on-year increase in the foot traffic at Galaxy Macau™. In Q2, we hosted multiple mega entertainment events such as in April the ITTF World Cup Macao 2025, one of the world’s most prestigious table tennis events. In May we hosted the Wakin Chau World Tour and K-pop star BTS’s j-hope. In June we had K-pop group BIGBANG’s G-Dragon and the acclaimed Hong Kong singer Jacky Cheung’s concerts, all experienced overwhelming customer demand. Post Q2 in July we hosted one of America’s hottest comedy stars Jimmy O. Yang’s first live performance in Macau, and in August we hosted ‘King of Asian Pop’ Eason Chan’s Concert. These entertainment events contributed significantly to our business. In November we will support the National Games and host its Table Tennis Competition in Galaxy Arena. We remain optimistic about mega events tourism in the second half of the year. We previously advised that we had completed the full rollout of smart tables. We are now commencing to experience the benefits of this technology and are leveraging the knowledge gained from the data to provide a better customer experience. In June, GEG announced that the Waldo Casino will cease operation by the end of this year due to commercial considerations. GEG’s employees working at the Waldo Casino will be reallocated to its other properties and casinos. Related departments will discuss the best options with the team members and provide them with a series of vocational training programs to assist them in adapting to their new working environment. GEG would like to thank the Macau residents, patrons and the community for their support to the Waldo Casino over the years. GEG recently won two prestigious awards at the Global Gaming Awards Asia-Pacific 2025, including the ‘Integrated Resort of the Year’ for Galaxy Macau™ and the ‘Casino Operator of the Year’ for the Group for the second consecutive year. Additionally, in The MICHELIN Guide Hong Kong Macau 2025 List, four of our restaurants collectively earned five MICHELIN stars. In the Forbes Travel Guide 2025 List, Galaxy Macau™ proved its unrivalled position as an integrated resort with the most Five-Star hotels under one roof of any luxury resort company worldwide for the third consecutive year. These recognitions from the international community are testaments to GEG’s outstanding achievements in promoting the sustainable development of integrated tourism, leisure and the gaming industry. Recently the all-suite Capella at Galaxy Macau offered exclusive previews in May to our most distinguished VIPs, offering stays by invitation only and we expect its full opening in the coming months. The exclusive preview of Capella at Galaxy Macau has been well received by the market and has been helping us to attract ultra-high value customers. On the development front we are progressing well with the construction of Phase 4. Construction of the Super Structure and the external facade has been completed and we are progressing to the next stage of development which is fitting out the building. We have entered into a new contract for the internal fitting out works of the approximately 600,000 sqm Phase 4 development which includes multiple high-end hotel brands that are new to Macau, together with an approximately 5,000-seat theater, extensive F&B, retail, non-gaming amenities, landscaping, a water resort deck and a casino. Phase 4 is targeted to complete in 2027. We also continue to evaluate development opportunities in the Greater Bay Area and overseas markets on a case-by-case basis, including Thailand. After examining the economic situation and the actual operations of the gaming industry, the Macau Government announced in June that it has lowered its GGR estimate for 2025 from MOP240 billion to MOP228 billion. We acknowledge that there are shorter term challenges including the slowing global economy and potential tariffs impact, however we remain confident in the medium to longer term outlook for Macau. As always, GEG remains fully committed to making a positive contribution to the Macau’s leisure and tourism industry. Finally, I would like to thank all our team members who deliver ‘World Class, Asian Heart’ service each and every day and contribute to the success of the Group.” Q2 & INTERIM 2025 RESULTS HIGHLIGHTS GEG: Well Positioned for Future Growth 1H Group Net Revenue of $23.2 billion, up 8% year-on-year 1H Group Adjusted EBITDA of $6.9 billion, up 14% year-on-year 1H Net Profit Attributable to Shareholders (“NPAS”) of $5.2 billion, up 19% year-on-year Q2 Group Net Revenue of $12.0 billion, up 10% year-on-year and up 8% quarter-on-quarter Q2 Group Adjusted EBITDA of $3.6 billion, up 12% year-on-year and up 8% quarter-on-quarter Normalized Q2 Adjusted EBITDA was $3.2 billion after adjusting for good luck of $407 million Latest twelve months Adjusted EBITDA of $13.0 billion, up 13% year-on-year and up 3% quarter-on-quarter Galaxy Macau™: Primary Driver to Group Earnings 1H Net Revenue of $19.1 billion, up 13% year-on-year 1H Adjusted EBITDA of $6.3 billion, up 18% year-on-year Q2 Net Revenue of $10.0 billion, up 16% year-on-year and up 9% quarter-on-quarter Q2 Adjusted EBITDA of $3.3 billion, up 20% year-on-year and up 10% quarter-on-quarter Normalized Q2 Adjusted EBITDA was $2.9 billion after adjusting for good luck of $410 million Hotel occupancy for Q2 across the nine hotels was 98% StarWorld Macau: Continuing with Major Property Upgrades 1H Net Revenue of $2.4 billion, down 10% year-on-year 1H Adjusted EBITDA of $653 million, down 21% year-on-year Q2 Net Revenue of $1.2 billion, down 11% year-on-year and down 6% quarter-on-quarter Q2 Adjusted EBITDA of $303 million, down 22% year-on-year and down 13% quarter-on-quarter Normalized Q2 Adjusted EBITDA was $306 million after adjusting for bad luck of $3 million Hotel occupancy for Q2 was 100% Broadway Macau™, City Clubs and Construction Materials Division (“CMD”) Broadway Macau™: Q2 Adjusted EBITDA was $4 million, versus $8 million in Q2 2024 and $2 million in Q1 2025 City Clubs: Q2 Adjusted EBITDA was $2 million, versus $5 million in Q2 2024 and $1 million in Q1 2025 CMD: Q2 Adjusted EBITDA was $238 million, down 7% year-on-year and up 29% quarter-on-quarter Balance Sheet: Remained Healthy and Liquid As at 30 June 2025, cash and liquid investments were $30.7 billion and the net position was $30.3 billion after debt of $0.4 billion Paid the previously announced final dividend of $0.50 per share in June 2025 Announced an interim dividend of $0.70 per share payable on or about 31 October 2025 Development Update: Capella at Galaxy Macau offered exclusive private previews in May; Continue ramping up GICC, Galaxy Arena, Raffles at Galaxy Macau and Andaz Macau; Progressing with Phase 4 Capella at Galaxy Macau offered exclusive private previews in May Cotai Phase 3 – Ramping up GICC, Galaxy Arena, Raffles at Galaxy Macau and Andaz Macau Cotai Phase 4 – Our efforts are firmly focused on the development of Phase 4 which has a strong focus on non-gaming, primarily targeting entertainment, family facilities and also includes a casino International – Continuously exploring opportunities in overseas markets, including Thailand Macau Market Overview Based on DICJ reporting, Macau’s GGR for the first half of 2025 was up 4% year-on-year to $115.3 billion. Q2 2025 GGR was up 8% year-on-year and up 6% quarter-on-quarter to $59.3 billion, representing 83% of 2019 level. In the first half of 2025, visitor arrivals to Macau were 19.2 million, up 15% year-on-year, of which overnight visitors and same-day visitors grew by 3% and 26% year-on-year respectively. Mainland visitor arrivals were 13.8 million, up 19% year-on-year. Among the Mainland visitors, 867,492 travelled under the “one trip per week measure”, 241,257 under the “multiple-entry measure” and 72,149 under the “tourist group multi-entry measure”. Visitors from the nine Pearl River Delta cities in the Greater Bay Area rose by 26% year-on-year to 7 million, driven by an upsurge of 57% in the number of visitors from Zhuhai. International visitors totaled 1.3 million, up 15% year-on-year. GEG has continued to work with Macao Government Tourism Office (“MGTO”) to actively promote Macau as a tourism destination. We have marketing offices in Tokyo, Seoul and Bangkok. Group Financial Results 1H 2025 In 1H 2025, Group Net Revenue was $23.2 billion, up 8% year-on-year. Adjusted EBITDA was $6.9 billion, up 14% year-on-year. NPAS was $5.2 billion, up 19% year-on-year. Galaxy Macau™’s Adjusted EBITDA was $6.3 billion, up 18% year-on-year. StarWorld Macau’s Adjusted EBITDA was $653 million, down 21% year-on-year. Broadway Macau™’s Adjusted EBITDA was $6 million, versus $12 million in 1H 2024. In 1H 2025, GEG experienced good luck in its gaming operation, which increased its Adjusted EBITDA by approximately $737 million. Normalized 1H 2025 Adjusted EBITDA was $6.1 billion, up 3% year-on-year. The Group’s total GGR in 1H 2025 was $22.9 billion, up 15% year-on-year. Mass GGR was $17.0 billion, up 6% year-on-year. VIP GGR was $4.4 billion, up 63% year-on-year. Electronic GGR was $1.5 billion, up 20% year-on-year. Group Key Financial Data           (HK$'m) 1H 2024 1H 2025 Revenues:     Net Gaming 16,776 18,578 Non-gaming 3,089 3,165 Construction Materials 1,605 1,503 Total Net Revenue 21,470 23,246       Adjusted EBITDA 6,011 6,865       Gaming Statistics1     (HK$'m) 1H 2024 1H 2025 Rolling Chip Volume2 84,612 102,139 Win Rate % 3.2% 4.3% Win 2,690 4,391       Mass Table Drop3 63,841 67,266 Win Rate % 25.1% 25.3% Win 16,019 17,041       Electronic Gaming Volume 41,413 54,171 Win Rate % 3.0% 2.8% Win 1,258 1,514       Total GGR Win4 19,967 22,946 Q2 2025 In Q2 2025, Group Net Revenue was $12.0 billion, up 10% year-on-year and up 8% quarter-on-quarter. Adjusted EBITDA was $3.6 billion, up 12% year-on-year and up 8% quarter-on-quarter. Galaxy Macau™’s Adjusted EBITDA was $3.3 billion, up 20% year-on-year and up 10% quarter-on-quarter. StarWorld Macau’s Adjusted EBITDA was $303 million, down 22% year-on-year and down 13% quarter-on-quarter. Broadway Macau™’s Adjusted EBITDA was $4 million, versus $8 million in Q2 2024 and $2 million in Q1 2025. Latest twelve months Group Adjusted EBITDA was $13.0 billion, up 13% year-on-year and up 3% quarter-on-quarter. In Q2 2025, GEG experienced good luck in its gaming operations which increased its Adjusted EBITDA by approximately $407 million. Normalized Q2 2025 Adjusted EBITDA was $3.2 billion, down 1% year-on-year and up 7% quarter-on-quarter. Summary Table of GEG Q2 & 1H 2025 Adjusted EBITDA and Adjustments: in HK$'m Q22024 Q12025 Q22025 YoY QoQ   1H2024 1H2025 Adjusted EBITDA 3,176 3,296 3,569 12% 8%   6,011 6,865 Luck5 (20) 330 407 - -   43 737 Normalized Adjusted EBITDA 3,196 2,966 3,162 (1)% 7%   5,968 6,128 The Group’s total GGR in Q2 2025 was $12.0 billion, up 16% year-on-year and up 10% quarter-on-quarter. Mass GGR was $8.8 billion, up 6% year-on-year and up 7% quarter-on-quarter. VIP GGR was $2.4 billion, up 73% year-on-year and up 22% quarter-on-quarter. Electronic GGR was $785 million, up 19% year-on-year and up 8% quarter-on-quarter. Group Key Financial Data                       (HK$'m)             Q2 2024 Q1 2025 Q2 2025 1H 2024 1H 2025 Revenues:           Net Gaming 8,595 8,922 9,656 16,776 18,578 Non-gaming 1,483 1,557 1,608 3,089 3,165 Construction Materials 840 723 780 1,605 1,503 Total Net Revenue 10,918 11,202 12,044 21,470 23,246             Adjusted EBITDA 3,176 3,296 3,569 6,011 6,865             Gaming Statistics6           (HK$'m)             Q2 2024 Q1 2025 Q2 2025 1H 2024 1H 2025 Rolling Chip Volume7 46,155 46,375 55,764 84,612 102,139 Win Rate % 3.0% 4.3% 4.3% 3.2% 4.3% Win 1,391 1,978 2,413 2,690 4,391             Mass Table Drop8 32,370 32,190 35,076 63,841 67,266 Win Rate % 25.6% 25.6% 25.1% 25.1% 25.3% Win 8,291 8,230 8,811 16,019 17,041             Electronic Gaming Volume 22,370 25,562 28,609 41,413 54,171 Win Rate % 2.9% 2.9% 2.7% 3.0% 2.8% Win 658 729 785 1,258 1,514             Total GGR Win9 10,340 10,937 12,009 19,967 22,946 Balance Sheet and Dividend The Group’s balance sheet remains healthy and liquid. As of 30 June 2025, cash and liquid investments were $30.7 billion and the net position was $30.3 billion after debt of $0.4 billion. Our strong balance sheet combined with substantial cash flow from operations allows us to return capital to shareholders via dividends and to fund our development pipeline. The Group paid the previously announced final dividend of $0.50 per share in June 2025. Subsequently the GEG Board announced an interim dividend of $0.70 per share to be paid on or about 31 October 2025. Galaxy Macau™ Galaxy Macau™ is the primary contributor to the Group’s revenue and earnings. Net Revenue in 1H 2025 was $19.1 billion, up 13% year-on-year. Adjusted EBITDA was $6.3 billion, up 18% year-on-year. In 1H 2025, Galaxy Macau™ experienced good luck in its gaming operations which increased its Adjusted EBITDA by approximately $755 million. Normalized 1H 2025 Adjusted EBITDA was $5.6 billion, up 3% year-on-year. In Q2 2025, Galaxy Macau™’s Adjusted EBITDA was $3.3 billion, up 20% year-on-year and up 10% quarter-on-quarter. In Q2 2025, Galaxy Macau™ experienced good luck in its gaming operations which increased its Adjusted EBITDA by approximately $410 million. Normalized Q2 2025 Adjusted EBITDA was $2.9 billion, up 3% year-on-year and up 9% quarter-on-quarter. The combined nine hotels occupancy was 98% for 1H and Q2 2025. Galaxy Macau™ Key Financial Data   (HK$'m) Q2 2024 Q1 2025 Q2 2025 1H 2024 1H 2025 Revenues:           Net Gaming 7,347 7,762 8,567 14,234 16,329 Hotel / F&B / Others 971 1,052 1,105 2,027 2,157 Mall 326 335 328 697 663 Total Net Revenue 8,644 9,149 10,000 16,958 19,149 Adjusted EBITDA 2,782 3,016 3,325 5,395 6,341 Adjusted EBITDA Margin 32% 33% 33% 32% 33%             Gaming Statistics10           (HK$'m) Q2 2024 Q1 2025 Q2 2025 1H 2024 1H 2025 Rolling Chip Volume11 44,577 44,371 54,859 82,010 99,230 Win Rate % 2.9% 4.4% 4.4% 3.1% 4.4% Win 1,287 1,941 2,391 2,530 4,332             Mass Table Drop12 24,647 25,270 27,416 49,119 52,686 Win Rate % 28.6% 27.8% 28.0% 27.4% 27.9% Win 7,047 7,027 7,669 13,453 14,696             Electronic Gaming Volume 14,772 16,333 18,435 27,551 34,768 Win Rate % 3.5% 3.5% 3.3% 3.7% 3.4% Win 524 570 611 1,011 1,181             Total GGR Win 8,858 9,538 10,671 16,994 20,209 StarWorld Macau StarWorld Macau’s Net Revenue was $2.4 billion in 1H 2025, down 10% year-on-year. Adjusted EBITDA was $653 million, down 21% year-on-year. In 1H 2025, StarWorld Macau experienced bad luck in its gaming operations which decreased its Adjusted EBITDA by approximately $18 million. Normalized 1H 2025 Adjusted EBITDA was $671 million, down 14% year-on-year. In Q2 2025, StarWorld Macau’s Adjusted EBITDA was $303 million, down 22% year-on-year and down 13% quarter-on-quarter. In Q2 2025, StarWorld Macau experienced bad luck in its gaming operations which decreased its Adjusted EBITDA by approximately $3 million. Normalized Q2 2025 Adjusted EBITDA was $306 million, down 14% year-on-year and down 16% quarter-on-quarter. Hotel occupancy was 100% for 1H 2025 and Q2 2025. StarWorld Macau Key Financial Data   (HK$’m) Q2 2024 Q1 2025 Q2 2025 1H 2024 1H 2025 Revenues:           Net Gaming 1,190 1,118 1,047 2,425 2,165 Hotel / F&B / Others 128 119 119 256 238 Mall 5 5 5 11 10 Total Net Revenue 1,323 1,242 1,171 2,692 2,413 Adjusted EBITDA 390 350 303 825 653 Adjusted EBITDA Margin 29% 28% 26% 31% 27%             Gaming Statistics13           (HK$'m) Q2 2024 Q1 2025 Q2 2025 1H 2024 1H 2025 Rolling Chip Volume14 1,578 2,004 905 2,602 2,909 Win Rate % 6.5% 1.8% 2.4% 6.1% 2.0% Win 104 37 22 160 59             Mass Table Drop15 7,467 6,734 7,501 14,223 14,235 Win Rate % 16.2% 17.4% 14.8% 17.5% 16.1% Win 1,207 1,174 1,112 2,490 2,286             Electronic Gaming Volume 6,325 8,351 9,284 11,370 17,635 Win Rate % 1.8% 1.8% 1.7% 1.8% 1.7% Win 113 146 162 206 308             Total GGR Win 1,424 1,357 1,296 2,856 2,653 Broadway Macau™ Broadway Macau™ is a unique family friendly, street entertainment and food resort supported by Macau SMEs. Broadway Macau™’s Net Revenue was $97 million for 1H 2025, down 3% year-on-year. Adjusted EBITDA was $6 million for 1H 2025 versus $12 million in 1H 2024. In Q2 2025, Broadway Macau™’s Adjusted EBITDA was $4 million, versus $8 million in Q2 2024 and $2 million in Q1 2025. City Clubs City Clubs contributed $3 million of Adjusted EBITDA to the Group’s earnings for 1H 2025, versus $9 million in 1H 2024. Q2 2025 Adjusted EBITDA was $2 million, versus $5 million in Q2 2024 and $1 million in Q1 2025. GEG announced that the Waldo Casino will cease operation by the end of this year due to commercial considerations. GEG’s employees working at the Waldo Casino will be reallocated to its other properties and casinos. Related departments will discuss the best options with the team members and provide them with a series of vocational training programs to assist them in adapting to their new working environment. GEG would like to thank the Macau residents, patrons and the community for their support to the Waldo Casino over the years. As always, GEG remains fully committed to making a positive contribution to the Macau’s leisure and tourism industry. Construction Materials Division (“CMD”) CMD continued to deliver solid results and contributed Adjusted EBITDA of $423 million in 1H 2025, up 16% year-on-year. In Q2 2025, CMD’s Adjusted EBITDA was $238 million, down 7% year-on-year and up 29% quarter-on-quarter. Development Update Galaxy Macau™ and StarWorld Macau We continue to make ongoing progressive enhancements to our resorts to ensure that they remain competitive and appealing to our guests including adding new F&B and retail offerings at Galaxy Macau™. We are also ramping up GICC, Galaxy Arena, Raffles at Galaxy Macau and Andaz Macau. At StarWorld Macau we have commenced implementing a range of major upgrades, that includes the main gaming floor, the lobby arrival experience and increasing the F&B options. We have completed the upgrade of Level 3 and StarWorld Macau now hosts one of the largest scale LTG terminals in Macau. Cotai – The Next Chapter Capella at Galaxy Macau is the 10th hotel brand in GEG’s portfolio. We offered exclusive previews commencing in May 2025 and we anticipate to have the property fully opened to the public in the coming months. Capella at Galaxy Macau is an all-suite gilded residence, located within Asia’s most luxurious and award-winning resort. Showcasing new standards of bespoke, accentuated luxury, Capella at Galaxy Macau sets the scene for the most discerning of guests to forge authentic connections with Macau – Asia’s entertainment hub with a rich history of culture, UNESCO-world heritage gastronomy and a gateway to the vibrant Greater Bay Area. This 17-storey property offers 95 ultra-luxury signature suites and Capella Penthouses. Each of the Capella Penthouses includes a light-filled balcony with a private infinity-edge pool, outdoor lounge and sunroom, entertainment lounge and hidden Winter Garden, among a series of unique features. Capella at Galaxy Macau is the ultimate expression of elegance, bespoke luxury and refined hospitality. It promises to bring a new level of elegance and ultra-luxury to Macau. On the development front we are progressing well with the construction of Phase 4. Construction of the Super Structure and the external facade has been completed and we are progressing to the next stage of development which is fitting out the building. We have entered into a new contract for the internal fitting out works of the approximately 600,000 sqm Phase 4 development which includes multiple high-end hotel brands that are new to Macau, together with an approximately 5,000-seat theater, extensive F&B, retail, non-gaming amenities, landscaping, a water resort deck and a casino. Phase 4 is targeted to complete in 2027. We remain highly confident about the future of Macau where Phases 3 & 4 will support Macau’s vision of becoming a World Centre of Tourism and Leisure. Selected Major Awards in 1H 2025 AWARD PRESENTER GEG   Casino Operator of the Year Global Gaming Awards Asia-Pacific 2025 11th Outstanding Corporate Social Responsibility Award Ceremony - Outstanding Corporate Social Responsibility Award Mirror Post of Hong Kong 2025 Macao International Environmental Co-operation Forum & Exhibition - Green Booth Award Macau Fair & Trade Association and Macao Low Carbon Development Association Best Cohesive Partnership Award Trip.com GALAXY MACAU™ Integrated Resort of the Year Global Gaming Awards Asia-Pacific 2025 MICHELIN One-Star Restaurant 8½ Otto e Mezzo BOMBANA Lai Heen Sushi Kissho by Miyakawa MICHELIN Selected Restaurants Saffron Terrazza Italian Restaurant The Ritz-Carlton Café The MICHELIN Guide Hong Kong Macau 2025 Five-Star Hotel Banyan Tree Macau Galaxy Hotel™ Hotel Okura Macau Raffles at Galaxy Macau The Ritz-Carlton, Macau Five-Star Restaurant 8½ Otto e Mezzo BOMBANA Yamazato Five-Star Spa Banyan Tree Spa Macau The Ritz-Carlton Spa, Macau 2025 Forbes Travel Guide 2025 Black Pearl Restaurant Guide One Diamond 8½ Otto e Mezzo BOMBANA Hotel Awards Appreciation Event Influential Hotel Group - Galaxy Macau™ Popular Resort Hotel - Galaxy Hotel™ Hotel of Excellent Service - Andaz Macau Mei Tuan SCMP 100 Top Tables 2025 8½ Otto e Mezzo BOMBANA Lai Heen Sushi Kissho by Miyakawa Teppanyaki Shou Yamazato South China Morning Post Macau Green Hotel Awards – Gold Award – Hotel Okura Macau Environmental Protection Bureau of the Macao SAR Government STARWORLD MACAU MICHELIN Two-Star Restaurant – Feng Wei Ju The MICHELIN Guide Hong Kong Macau 2025 2025 Black Pearl Restaurant Guide One Diamond – Feng Wei Ju Mei Tuan SCMP 100 Top Tables 2025 – Feng Wei Ju South China Morning Post Broadway Macau™ Hotel Awards Appreciation Event - Popular Hotel - Broadway Macau™ Mei Tuan Macau Green Hotel Awards – Silver Award – Broadway Hotel Environmental Protection Bureau of the Macao SAR Government Overseas Popularity Award - Broadway Macau™ Trip.com Traveller Review Awards 2025 Winner - Broadway Macau™ Booking.com Construction Materials Division Carbon Reduction Action - Participation as Collaborating Partner of Carbon Reduction Action – Certificate Environmental Campaign Committee Outlook Looking forward we continue to remain laser focused on our customer service standards. Our target is to ensure that each customer interaction is memorable and exceptional. We continue to progressively upgrade our resort facilities to ensure that they remain world-class amenities and highly competitive. We continue to yield all our existing assets including hotels, food and beverage, retail, resort and cinema facilities. Costs are being carefully managed to deliver operating leverage as we continue to grow the top line. We previously advised that we had completed the full rollout of smart tables. We are now commencing to experience the benefits of this technology and are leveraging the knowledge gained from the data to provide a better customer experience. Large scale entertainment is providing a significant boost to foot traffic across our resorts. Mega entertainment events have resulted in a substantial increase in gaming, retail, food and beverage and hotel revenues. We are working hard to continue to build the Galaxy Arena brand as a world-class entertainment arena and to attract even more large scale mega entertainment events into the future. In November we will support the National Games and host its Table Tennis Competition in Galaxy Arena. We remain optimistic about mega events tourism in the second half of the year. The recent exclusive preview of Capella at Galaxy Macau has been exceptionally well received by its high value customers, and we will progressively open all the remaining facilities over the coming months. On the development front we are progressing well with the construction of Phase 4. Construction of the Super Structure and the external facade has been completed and we are progressing to the next stage of development which is fitting out the building. We have entered into a new contract for the internal fitting out works of the approximately 600,000 sqm Phase 4 development which includes multiple high-end hotel brands that are new to Macau, together with an approximately 5,000-seat theater, extensive F&B, retail, non-gaming amenities, landscaping, a water resort deck and a casino. Phase 4 is targeted to complete in 2027. Originally Thailand’s Parliament was scheduled to debate the Entertainment Complex Bill on 9 July 2025. However, the Parliament decided to withdraw the Bill from discussion. We await further updates on the potential progress of the Entertainment Complex Bill. We believe that an integrated resort in Bangkok would be highly accretive to our resort portfolio. We continue to remain very interested in Thailand. The state of the world economy and ongoing discussions on tariffs, whilst gaining significant media coverage has to date not impacted gaming revenue as much as some analysts had previously predicted. Macau still rates in the top three destinations of choice by Chinese travelers. International customer development continues to be a priority and we are leveraging our marketing offices in Tokyo, Seoul and Bangkok. In the first half of 2025 international visitor arrivals to Macau grew 15% year-on-year to 1.3 million. We remain confident in the outlook for Macau. The reasons for this confidence include the ongoing improvement in transportation infrastructure making it easier to travel to and from Macau, as well as within Macau. That includes the recent extension of Macau LRT’s new line connecting the Hengqin Port and the commencement of Macau International Airport expansion and reclamation project, among others. The opening of the fourth Macau-Taipa bridge in late-2024 further improved travel within Macau. We remain confident in the medium to longer term outlook for Macau. In the interim we will continue to leverage our resorts assets and staff to grow the business, and to support Macau’s development into the World Centre of tourism and leisure. About Galaxy Entertainment Group (HKEx stock code: 27) Galaxy Entertainment Group Limited (“GEG” or the “Company”) and its subsidiaries (“GEG” or the “Group”) is one of the world’s leading resorts, hospitality and gaming companies. The Group primarily develops and operates a large portfolio of integrated resort, retail, dining, hotel and gaming facilities in Macau. GEG is listed on the Hong Kong Stock Exchange and is a constituent stock of the Hang Seng Index. GEG through its subsidiary, Galaxy Casino S.A., is one of the three original concessionaires in Macau when the gaming industry was liberalized in 2002. In 2022, GEG was awarded a new gaming concession valid from January 1, 2023, to December 31, 2032. GEG has a successful track record of delivering innovative, spectacular and award-winning properties, products and services, underpinned by a “World Class, Asian Heart” service philosophy, that has enabled it to consistently outperform the market in Macau. The Group operates three flagship destinations in Macau: on Cotai, Galaxy Macau™, one of the world’s largest integrated destination resorts, and the adjoining Broadway Macau™, a unique landmark entertainment and food street destination; and on the Peninsula, StarWorld Macau, an award-winning premium property. The Group has the largest development pipeline of any concessionaire in Macau. When The Next Chapter of its Cotai development is completed, GEG’s resorts footprint on Cotai will be more than 2 million square meters, making the resorts, entertainment and MICE precinct one of the largest and most diverse integrated destinations in the world. GEG also considers opportunities in the Greater Bay Area and internationally. These projects will help GEG develop and support Macau in its vision of becoming a World Centre of Tourism and Leisure. In July 2015, GEG made a strategic investment in Société Anonyme des Bains de Mer et du Cercle des Étrangers à Monaco (“Monte-Carlo SBM”), a world renowned owner and operator of iconic luxury hotels and resorts in the Principality of Monaco. GEG continues to explore a range of international development opportunities with Monte-Carlo SBM. GEG is committed to delivering world class unique experiences to its guests and building a sustainable future for the communities in which it operates. For more information about the Group, please visit www.galaxyentertainment.com ____________________________________ 1 Gaming statistics are presented before deducting commission and incentives. 2 Reflects sum of promoter and inhouse premium direct.3 Mass table drop includes the amount of table drop plus cash chips purchased at the cage.4 Total GGR win includes gaming win from City Clubs.5 Reflects luck adjustments associated with our rolling chip program.6 Gaming statistics are presented before deducting commission and incentives.7 Reflects sum of promoter and inhouse premium direct.8 Mass table drop includes the amount of table drop plus cash chips purchased at the cage.9 Total GGR win includes gaming win from City Clubs.10 Gaming statistics are presented before deducting commission and incentives.11 Reflects sum of promoter and inhouse premium direct.12 Mass table drop includes the amount of table drop plus cash chips purchased at the cage.13 Gaming statistics are presented before deducting commission and incentives.14 Reflects sum of promoter and inhouse premium direct.15 Mass table drop includes the amount of table drop plus cash chips purchased at the cage. Photos accompanying this announcement are available athttps://www.globenewswire.com/NewsRoom/AttachmentNg/630f381e-20ef-484b-9511-f4aa42746a5ahttps://www.globenewswire.com/NewsRoom/AttachmentNg/6868d789-ac9a-4801-a459-7c6dcc8721d0 CONTACT: For Media Enquiries: Galaxy Entertainment Group - Investor Relations Mr. Peter J. Caveny / Ms. Yoko Ku / Ms. Crystal Chan Tel: +852 3150 1111 Email: ir@galaxyentertainment.com The post Galaxy Entertainment Group Q2 & Interim Results 2025 appeared first on ForexTV.

Leading National Presence — Launched fully-driverless commercial operations in Shanghai; the ONLY Company commercially operating fully-driverless Robotaxi services across all four tier-one cities in China. Strong Revenues Momentum — Total revenues up 76% year-over-year, with Robotaxi fare-charging revenues surging by over 300%. NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Pony AI Inc. (“Pony.ai” or the “Company”) (Nasdaq: PONY), a global leader in achieving large-scale commercialization of autonomous mobility, today announced its unaudited financial results for the second quarter ended June 30, 2025. Dr. James Peng, Chairman and Chief Executive Officer of Pony.ai, commented, “This quarter marked a significant milestone in our journey toward large-scale production and deployment, further solidifying our leadership in the Robotaxi industry. Since mass production started two months ago, over 2001 Gen-7 Robotaxi vehicles have rolled off the production line, putting us firmly on track to hit the year-end 1,000-vehicle target. Our robust Robotaxi revenues more than doubled, with fare-charging revenues surging by over 300% year-over-year. The path toward positive unit economics is also clear, as we made substantial improvements in key cost items such as remote assistance and vehicle insurance. These achievements are underpinned by our rapid scaling and operational breakthroughs in all four tier-one cities in China, coupled with expanded presence in Dubai, South Korea and Luxembourg. As we enter the second half of this pivotal year of mass production, we are driving strongly toward positive unit economics and accelerating our multi-year growth trajectory.” Dr. Tiancheng Lou, Chief Technology Officer of Pony.ai, commented, “Our leading position in the Robotaxi industry is built on two key pillars, fully-driverless and scale, both of which we have already achieved. With extensive real-world testing and operations across diverse conditions, we have demonstrated our commitment to rigorous engineering practices, the reliability of the autonomous driving stack and the strong generalization capabilities powered by our proprietary PonyWorld. With mass production underway, we are not just on track to reach 1,000 vehicles but building the foundation for sustained future growth.” Dr. Leo Wang, Chief Financial Officer of Pony.ai, commented, “We delivered strong results in the second quarter, with total revenues growing 76% year-over-year, reflecting the effectiveness of our go-to-market execution. Our robust Robotaxi fare-charging revenues growth once again underscores our progress in building a scalable and recurring monetization model and enhancing long-term business visibility. As Gen-7 mass production gains momentum and we maintain disciplined investment, we are well positioned to accelerate the large-scale commercialization.” Kicking off Robotaxi Scaling-up, a Strong Validation of our Scalable Fully-Driverless Advantage Mass production and operations of multiple Gen-7 Robotaxi models. 1) We kicked off mass production of the Guangzhou Automobile Group (“GAC”) and Beijing Automotive Industry Corporation (“BAIC”) Gen-7 Robotaxi models in June and July, respectively. With over 200 already produced, we’re accelerating toward our 1,000-vehicle target by the end of 2025. 2) We initiated operations in all four tier-one cities, collectively accumulating over 2 million kilometers of on-road autonomous driving mileage. This showcases the safety and stability of our entire autonomous driving stack in complex real-world scenarios. 3) We have made significant progress in cost efficiency, driven by an improving remote assistant-to-vehicle ratio and lower vehicle insurance. We are confident of achieving a 1:30 ratio by the end of 2025, enabling one remote assistant to monitor 30 vehicles. Two key pillars for technological advancement: fully-driverless and scale. 1) By achieving fully-driverless operations on a large scale, we have already established ourselves as one of the leading Robotaxi companies worldwide. 2) Among all participants in the World Artificial Intelligence Conference (“WAIC”) 2025 in Shanghai, we were the only provider offering fully-driverless and on-demand ride-hailing services to the public. In addition, we were the only one to remain fully-operational during extreme weather conditions, including typhoons and heavy rainstorms. Accelerating Commercial Deployment with Extending Service and User Coverage Accelerating commercial deployment and expanding ecosystem at scale. 1) Growing user adoption, increasing fleet of deployed Robotaxi vehicles and optimizing operational strategy collectively propelled our fare-charging revenues growth, establishing a sustainable monetization model. 2) We entered into a strategic partnership with Shenzhen Xihu Corporation Limited (“Xihu Group”), Shenzhen’s largest taxi operator, to jointly deploy a fleet of over 1,000 Gen-7 Robotaxis in Shenzhen over the coming years. Scaling up service availability to a wider user group. 1) Registered users on our platform surged by 136% year-over-year in the second quarter. 2) We secured testing permits for Gen-7 Robotaxis in all four tier-one cities, laying out a solid foundation for public-facing commercial deployment. 3) In July, we started fully-driverless commercial Robotaxi services to the public in Shanghai’s Pudong New Area, the heart of Shanghai’s financial district and luxury retails. 4) We extended Robotaxi services from 15 hours per day to full 24/7 coverage in certain areas of Guangzhou and Shenzhen to better fulfill rising user demand. Expanding Global Presence by Entering New Markets and Deepening Our Existing Footprint Strategic collaboration with local partners. We have reached a strategic collaboration with Dubai’s Roads and Transport Authority (“RTA”) to integrate our autonomous driving technology into the city’s future transportation ecosystem. The collaboration will deploy our autonomous driving technology through a multi-phase roll-out, starting with supervised Robotaxi trials in late 2025. Advancing operations to cover diverse environments. We have advanced our presence in South Korea by securing nationwide permits, enabling Robotaxi operations across the country. In Gangnam district, Seoul, we are navigating complex urban traffic and challenging conditions, including winter snowfall. In the second quarter, we further launched nighttime and early-morning operations. Ongoing positive regulatory and testing progress. Following the testing permit granted earlier this year in Luxembourg, we launched road testing in the city of Lenningen in the second quarter in partnership with Emile Weber, Luxembourg’s leading mobility and fleet service provider. 1 As of August 11, 2025, 213 Gen-7 Robotaxi vehicles had been produced. Unaudited Second Quarter 2025 Financial Results (in USD thousands)   Three Months Ended   Six Months Ended     June 30, 2024   June 30, 2025   June 30, 2024   June 30, 2025                   Revenues:                 Robotaxi services   592   1,526   1,168   3,256 Robotruck services   10,568   9,520   18,035   17,300 Licensing and applications   1,039   10,409   5,517   14,878 Total revenues   12,199   21,455   24,720   35,434                   Total revenues were US$21.5 million (RMB153.7 million) in the second quarter of 2025, representing an increase of 75.9% from US$12.2 million in the second quarter of 2024. The increase was mainly driven by robust growth in both Robotaxi services and Licensing and Applications revenues. Robotaxi services revenues were US$1.5 million (RMB10.9 million) in the second quarter of 2025, representing an increase of 157.8% from US$0.6 million in the second quarter of 2024. Revenues from both fare-charging and project-based engineering solution services demonstrated rapid growth, with fare-charging revenues surging by over 300% year-over-year. The strong growth was primarily driven by expanding user adoption, growing demand in tier-one cities and an increased fleet of deployed Robotaxi vehicles. We also continued to optimize our pricing and operation strategies across diverse user bases, leading to improved user engagement and service efficiency. Robotruck services revenues were US$9.5 million (RMB68.2 million) in the second quarter of 2025, representing a decrease of 9.9% from US$10.6 million in the second quarter of 2024. The decrease primarily reflected our proactive operation optimization to focus on high-margin revenues. Licensing and applications revenues were US$10.4 million (RMB74.6 million) in the second quarter of 2025, representing a significant increase of 901.8% from US$1.0 million in the second quarter of 2024. The growth was mainly driven by increased orders and deliveries of autonomous domain controller (“ADC”) products, supported by rising demand from both new and existing clients in the robot-delivery segment. Cost of Revenues Total cost of revenues was US$18.0 million (RMB128.9 million) in the second quarter of 2025, representing an increase of 47.0% from US$12.2 million in the second quarter of 2024. Gross Profit (Loss) and Gross Margin Gross profit was US$3.5 million (RMB24.8 million) in the second quarter of 2025, compared to gross loss of US$41 thousand in the second quarter of 2024. Gross margin was 16.1% in the second quarter of 2025, compared to negative 0.3% in the second quarter of 2024. The significant gross margin improvement was mainly driven by our focused strategy on prioritizing high-margin revenues sources within Robotaxi and Robotruck services to reduce gross margin variability. We also made solid progress in optimizing Robotaxi unit economics, particularly key cost items such as remote assistance and vehicle insurance. Operating Expenses Operating expenses were US$64.7 million (RMB463.7 million) in the second quarter of 2025, representing an increase of 75.1% from US$37.0 million in the second quarter of 2024. The increase in share-based compensation expenses reflected the normalization of expense recognition following our IPO in November 2024, as vesting is no longer contingent on IPO completion. Non-GAAP2 operating expenses were US$57.5 million (RMB412.1 million) in the second quarter of 2025, representing an increase of 58.5% from US$36.3 million in the second quarter of 2024. The increase in operating expenses was primarily driven by increased investments in mass production, alongside employee expenses aimed at strengthening R&D capacity for Gen-7 Robotaxi vehicles. Research and development expenses were US$49.0 million (RMB351.2 million) in the second quarter of 2025, representing an increase of 69.0% from US$29.0 million in the second quarter of 2024. Non-GAAP research and development expenses were US$44.1 million (RMB315.6 million), representing an increase of 53.3% from US$28.7 million in the second quarter of 2024. The increase was mainly due to i) investments in mass production for the Gen-7 vehicles and ii) increased employee compensation and benefits to strengthen technological capabilities. Selling, general and administrative expenses were US$15.7 million (RMB112.5 million) in the second quarter of 2025, representing an increase of 97.3% from US$8.0 million in the second quarter of 2024. Non-GAAP selling, general and administrative expenses were US$13.5 million (RMB96.5 million), representing an increase of 78.2% from US$7.6 million in the second quarter of 2024. The increase was primarily due to i) increased personnel expenses in preparation for large-scale commercial deployment and ii) increased professional service fees. Loss from Operations Loss from operations was US$61.3 million (RMB438.9 million) in the second quarter of 2025, compared to US$37.0 million in the second quarter of 2024. Non-GAAP loss from operations was US$54.1 million (RMB387.3 million), compared to US$36.3 million in the second quarter of 2024. Net Loss Net loss was US$53.3 million (RMB381.6 million) in the second quarter of 2025, compared to US$30.9 million in the second quarter of 2024. Non-GAAP net loss was US$46.1 million (RMB329.9 million) in the second quarter of 2025, compared to US$30.3 million in the second quarter of 2024. Basic and Diluted Net Loss per Ordinary Share Basic and diluted net loss per ordinary share was both US$0.14 (RMB1.00) in the second quarter of 2025, compared to US$0.92 in the second quarter of 2024. Non-GAAP basic and diluted net loss per ordinary share was both US$0.13 (RMB0.93) in the second quarter of 2025, compared to US$0.91 in the second quarter of 2024. Each American depositary shares (“ADS”) represents one Class A ordinary share. Balance Sheet and Cash Flow Cash and cash equivalents, short-term investments, restricted cash and long-term debt instruments for wealth management were US$747.7 million (RMB5,356.1 million) as of June 30, 2025. In the second quarter of 2025, financing activities provided cash of US$33.1 million, showing an increase compared to the second quarter of 2024. This was mainly due to employee share sales following the expiration of the lock-up period, resulting in funds collected on behalf of employees for future distribution. 2 Non-GAAP financial measures exclude share-based compensation expenses and changes in fair value of warrants liability, and such adjustment has no impact on income tax. For further details, see the “Unaudited Reconciliation of U.S. GAAP and Non-GAAP Results” set forth at the end of this earnings release. Conference Call Pony.ai will hold a conference call at 8:00 AM U.S. Eastern Time on Tuesday, August 12, 2025 (8:00 PM Beijing/Hong Kong Time on the same day) to discuss financial results and answer questions from investors and analysts. For participants who wish to join the call, please complete online registration using the link provided below prior to the scheduled call start time. Upon registration, participants will receive a confirmation email containing dial-in numbers, passcode, and a unique access PIN. Participant Online Registration: https://dpregister.com/sreg/10201767/ffa814a510 A replay of the conference call will be accessible through August 19, 2025, by dialing the following numbers: United States: 1-877-344-7529 International: 1-412-317-0088 Replay Access Code: 3152089     Additionally, a live and archived webcast of the conference call will be available on the Company’s investor relations website at https://ir.pony.ai. Exchange Rate This press release contains translations of certain RMB amounts into U.S. dollars (“USD”) at specified rates solely for the convenience of the reader. Unless otherwise stated, all translations from RMB to USD were made at the rate of RMB7.1636 to US$1.00, the noon buying rate in effect on June 30, 2025, in the H.10 statistical release of the Federal Reserve Board. The Company makes no representation that the RMB or USD amounts referred could be converted into USD or RMB, as the case may be, at any particular rate or at all. For analytical presentation, all percentages are calculated using the numbers presented in the financial statements contained in this earnings release. Non-GAAP Financial Measures The Company uses non-GAAP financial measures, such as non-GAAP research and development expenses, non-GAAP selling, general and administrative expenses, non-GAAP operating expenses, non-GAAP loss from operations, non-GAAP net loss, non-GAAP net loss attributable to Pony AI Inc., non-GAAP basic and diluted net loss per ordinary share, and non-GAAP free cash flows, in evaluating its operating results and for financial and operational decision-making purposes. By excluding the impact of share-based compensation expenses and changes in fair value of warrants liability, the Company believes that the non-GAAP financial measures help identify underlying trends in its business and enhance the overall understanding of the Company’s past performance and future prospects. The Company also believes that the non-GAAP financial measures allow for greater visibility with respect to key metrics used by the Company’s management in its financial and operational decision-making. The non-GAAP financial measures are not presented in accordance with U.S. GAAP and may be different from non-GAAP methods of accounting and reporting used by other companies. The non-GAAP financial measures have limitations as analytical tools and when assessing the Company’s operating performance, investors should not consider them in isolation, or as a substitute for financial information prepared in accordance with U.S. GAAP. The Company encourages investors and others to review its financial information in its entirety and not rely on a single financial measure. The Company mitigates these limitations by reconciling the non-GAAP financial measures to the most comparable U.S. GAAP performance measures, all of which should be considered when evaluating the Company’s performance. For more information on the non-GAAP financial measures, please see the table captioned “Unaudited Reconciliation of U.S. GAAP and Non-GAAP Results” set forth at the end of this earnings release. About Pony AI Inc. Pony AI Inc. is a global leader in achieving large-scale commercialization of autonomous mobility. Leveraging its vehicle-agnostic Virtual Driver technology, a full-stack autonomous driving technology that seamlessly integrates Pony.ai’s proprietary software, hardware, and services, Pony.ai is developing a commercially viable and sustainable business model that enables the mass production and deployment of vehicles across transportation use cases. Founded in 2016, Pony.ai has expanded its presence across China, Europe, East Asia, the Middle East and other regions, ensuring widespread accessibility to its advanced technology. For more information, please visit: https://ir.pony.ai. Safe Harbor Statement This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to,” and similar statements. Statements that are not historical facts, including statements about Pony.ai’s beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in Pony.ai’s filings with the SEC. All information provided in this press release is as of the date of this press release, and Pony.ai does not undertake any obligation to update any forward-looking statement, except as required under applicable law. For investor and media inquiries, please contact: Pony.ai Investor Relations Email: ir@pony.ai Christensen Advisory Email: pony@christensencomms.com   Pony AI Inc. Unaudited Condensed Consolidated Balance Sheets (All amounts in USD thousands)       As of   As of December 31, 2024   June 30, 2025           Assets         Current assets:         Cash and cash equivalents   535,976   318,533 Restricted cash, current   21   20 Short-term investments   209,035   289,493 Accounts receivable, net   28,555   27,084 Amounts due from related parties, current   8,322   7,443 Prepaid expenses and other current assets   52,713   59,228 Total current assets   834,622   701,801 Non-current assets:         Restricted cash, non-current   175   188 Property, equipment and software, net   17,241   29,443 Operating lease right-of-use assets   13,342   16,338 Long-term investments   130,799   214,142 Prepayment for long-term investments   52,823   25,000 Other non-current assets   1,819   4,134 Total non-current assets   216,199   289,245 Total assets   1,050,821   991,046 Liabilities and Shareholders’ Equity         Current liabilities:         Accounts payable and other current liabilities   66,548   107,804 Operating lease liabilities, current   3,438   4,825 Amounts due to related parties, current   900   744 Total current liabilities   70,886   113,373 Operating lease liabilities, non-current   9,835   11,928 Other non-current liabilities   1,389   1,480 Total liabilities   82,110   126,781 Total Pony AI Inc. shareholders’ equity   951,122   853,363 Non-controlling interests   17,589   10,902 Total shareholders’ equity   968,711   864,265 Total liabilities and shareholders’ equity   1,050,821   991,046           Pony AI Inc. Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (All amounts in USD thousands, except for share and per share data)       Three Months Ended   Six Months Ended     June 30, 2024   June 30, 2025   June 30, 2024   June 30, 2025                   Revenues   12,199     21,455     24,720     35,434   Cost of revenues   (12,240 )   (17,992 )   (22,134 )   (29,655 ) Gross (loss) profit   (41 )   3,463     2,586     5,779   Operating expenses:                 Research and development expenses   (29,011 )   (49,030 )   (58,725 )   (96,516 ) Selling, general and administrative expenses   (7,956 )   (15,701 )   (15,579 )   (26,574 ) Total operating expenses   (36,967 )   (64,731 )   (74,304 )   (123,090 ) Loss from operations   (37,008 )   (61,268 )   (71,718 )   (117,311 ) Investment income   5,173     6,513     11,350     28,687   Changes in fair value of warrants liability   -     -     5,617     -   Other income (expenses), net   891     1,493     2,978     (2,015 ) Loss before income tax   (30,944 )   (53,262 )   (51,773 )   (90,639 ) Income tax expenses   (2 )   (1 )   (2 )   (1 ) Net loss   (30,946 )   (53,263 )   (51,775 )   (90,640 ) Net (loss) income attributable to non-controlling interests   (227 )   (165 )   (458 )   5,446   Net loss attributable to Pony AI Inc.   (30,719 )   (53,098 )   (51,317 )   (96,086 ) Foreign currency translation adjustments   (741 )   10     (1,046 )   114   Unrealized gain (loss) on available-for-sale investments   5,185     (47 )   5,236     (13,771 ) Total other comprehensive income (loss)   4,444     (37 )   4,190     (13,657 ) Total comprehensive loss   (26,502 )   (53,300 )   (47,585 )   (104,297 ) Less: Comprehensive loss attributable to non-controlling interests   (268 )   (134 )   (529 )   (252 ) Total comprehensive loss attributable to Pony AI Inc.   (26,234 )   (53,166 )   (47,056 )   (104,045 ) Weighted average number of ordinary shares outstanding used in computing net loss per ordinary share, basic and diluted   91,777,215     366,831,015     91,557,008      359,375,886   Net loss per ordinary share, basic and diluted   (0.92 )   (0.14 )   (1.14 )   (0.27 )                           Pony AI Inc. Unaudited Condensed Consolidated Statements of Cash Flows (All amounts in USD thousands)       Three Months Ended   Six Months Ended     June 30, 2024   June 30, 2025   June 30, 2024   June 30, 2025                   Net cash used in operating activities   (18,046 )   (25,411 )   (59,122 )   (79,570 ) Net cash used in investing activities   (83,013 )   (67,145 )   (28,669 )   (160,416 ) Net cash (used in)/provided by financing activities   (357 )   33,086     (710 )   23,600   Effect of exchange rate changes on cash, cash equivalents and restricted cash 2,268     (1,167 )   (2,704 )   (1,045 ) Net change in cash, cash equivalents and restricted cash   (99,148 )   (60,637 )   (91,205 )   (217,431 ) Cash, cash equivalents and restricted cash at beginning of period   434,148     379,378     426,205     536,172   Cash, cash equivalents and restricted cash at end of period   335,000     318,741     335,000     318,741                     Pony AI Inc. Unaudited Reconciliation of U.S. GAAP and Non-GAAP Results (All amounts in USD thousands, except for share and per share data)       Three Months Ended   Six Months Ended     June 30, 2024   June 30, 2025   June 30, 2024   June 30, 2025                   Research and development expenses   (29,011 )   (49,030 )   (58,725 )   (96,516 ) Share-based compensation expenses   273     4,970     605     11,874   Non-GAAP research and development expenses   (28,738 )   (44,060 )   (58,120 )   (84,642 )                   Selling, general and administrative expenses   (7,956 )   (15,701 )   (15,579 )   (26,574 ) Share-based compensation expenses   398     2,235     855     4,343   Non-GAAP selling, general and administrative expenses   (7,558 )   (13,466 )   (14,724 )   (22,231 )                   Operating expenses   (36,967 )   (64,731 )   (74,304 )   (123,090 ) Share-based compensation expenses   671     7,205     1,460     16,217   Non-GAAP operating expenses   (36,296 )   (57,526 )   (72,844 )   (106,873 )                   Loss from operations   (37,008 )   (61,268 )   (71,718 )   (117,311 ) Share-based compensation expenses   671     7,205     1,460     16,217   Non-GAAP loss from operations3   (36,337 )   (54,063 )   (70,258 )   (101,094 )                   Net loss   (30,946 )   (53,263 )   (51,775 )   (90,640 ) Share-based compensation expenses   671     7,205     1,460     16,217   Changes in fair value of warrants liability   -     -     (5,617 )   -   Non-GAAP net loss   (30,275 )   (46,058 )   (55,932 )   (74,423 )                   Net loss attributable to Pony AI Inc.   (30,719 )   (53,098 )   (51,317 )   (96,086 ) Share-based compensation expenses   671     7,205     1,460     16,217   Changes in fair value of warrants liability   -     -     (5,617 )   -   Non-GAAP net loss attributable to Pony AI Inc.   (30,048 )   (45,893 )   (55,474 )   (79,869 )                   Weighted average number of ordinary shares outstanding used in computing net loss per ordinary share, basic and diluted   91,777,215     366,831,015     91,557,008     359,375,886   Non-GAAP net loss per ordinary share, basic and diluted   (0.91 )   (0.13 )   (1.19 )   (0.22 )                           3 Such adjustments have no impact on income tax for the three-month and six-month periods ended June 30, 2024 and 2025 due to i) the conditions on tax deduction for share-based compensation have not been met, and valuation allowance was provided for all deferred tax assets; and ii) warrants are issued by the Group’s Cayman entity, and its applicable income tax rate is nil.   Pony AI Inc. Unaudited Reconciliation of U.S. GAAP and Non-GAAP Results (All amounts in USD thousands, except for share and per share data)       Three Months Ended   Six Months Ended     June 30, 2024   June 30, 2025   June 30, 2024   June 30, 2025                   Net cash used in operating activities   (18,046 )   (25,411 )   (59,122 )   (79,570 ) Capital expenditures   (1,736 )   (9,576 )   (1,906 )   (14,464 ) Free cash flows4(Non-GAAP)   (19,782 )   (34,987 )   (61,028 )   (94,034 )                           4 Free Cash Flows are a non-GAAP measure, commonly defined as cash flows from operating activities as presented in the statement of cash flows, less capital expenditures. However, in the context of the Company, operating cash flows are a cash out (i.e., a cash outflow). Free Cash Flows represent the total of operating cash outflows plus capital expenditures. This metric reflects the Company's important cash outflows, as it combines the funds required to maintain operations and invest in growth. The post PONY AI Inc. Accelerates Gen-7 Robotaxi Production with over 200 Newly Produced, On Track to Scale Up 1,000-Vehicle Fleet by Year End appeared first on ForexTV.

TORONTO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Award-winning public affairs executive and former Google Policy Lead Saeed Selvam today announced the launch of Selvam Public Affairs (SelvamPA), a full-service, cross-border firm helping organizations secure funding, navigate crises, and secure regulatory wins across Canada and the U.S. With more than 20 years of experience advising global brands, heads of government, and senior executives, Selvam founded the firm to serve as a results-driven partner in a rapidly shifting political and economic landscape. The firm offers integrated services spanning government relations, strategic communications, cross-border advisory, executive search and training. “Today’s leaders don’t just want access, they want a roadmap, traction, and clear ROI,” said Saeed Selvam, Founder & President of Selvam Public Affairs. “We built SelvamPA for organizations that expect public affairs services to perform like any other high-impact business unit: strategically, efficiently, and with outcomes that justify the investment.” SelvamPA supports clients in Canada and the United States across sectors ranging from technology and education to energy, healthcare, and NGOs at the municipal, provincial, and federal levels. About Saeed Selvam Saeed Selvam is a nationally recognized public affairs strategist and trusted advisor to political leaders and global brands. Prior to a senior leadership role at one of Canada’s largest PR agencies, Saeed served as a Global Policy Lead with Google working on high-profile crises like COVID-19 and the Russian invasion of Ukraine. He also served as Managing Director (Ontario and Federal) of New West Public Affairs, scaled ApplyBoard’s marketing communications strategy and was an informal advisor to the Obama-Biden White House, a Premier of Ontario and two Toronto mayors. His work has influenced legislation, unlocked millions in public funding, and enhanced brand reputations across sectors. Saeed is a regular national media commentator, a Millennium Scholar (Government of Canada), recipient of the Lincoln Alexander Award (Government of Ontario), and a Massey Fellow at the University of Toronto. He holds a Master of Public Policy and an Honours Bachelor of Arts in Political Science, both from the University of Toronto. About Selvam Public Affairs Selvam Public Affairs is a government relations and strategic communications firm based in Toronto, Canada, serving clients across Canada and the United States. The firm brings together deep policy insight, multi-partisan networks, and compelling storytelling to help organizations influence policy, shape public opinion, and navigate reputational risk. Learn more at www.selvampa.com. CONTACT: Media Contact Selvam Public Affairs info@selvampa.com The post Selvam Public Affairs Launches to Drive Policy, Funding and Reputation Wins in Canada and the U.S. appeared first on ForexTV.

Highly desirable Jaguar D-Type will be one of the highlights of Broad Arrow Zürich Auction in partnership with Auto Zürich on 1 November 1956 Jaguar D-Type set to star at Broad Arrow's inaugural Zurich Auction Credit - Robin Möhl / Courtesy of Broad Arrow Auctions The unraced, highly original Jaguar D-Type set to star at Broad Arrow's inaugural Zurich Auction Credit - Robin Möhl / Courtesy of Broad Arrow Auctions LONDON, England, Aug. 12, 2025 (GLOBE NEWSWIRE) -- One of only 71 Jaguar D-Types produced Rare example that has never been used in competitive motorsport Matching engine and chassis numbers Meticulously cared for by current Swiss owner for past three decades Highly desirable Jaguar D-Type will be one of the highlights of Broad Arrow Zürich Auction in partnership with Auto Zürich on 1 November D-Type estimated to bring CHF 5’250’000 - 6’250’000 Broad Arrow Auctions, a Hagerty (NYSE: HGTY) company, is proud to offer one of the most pristine examples of the iconic Jaguar D-Type at its inaugural Zürich Auction this November. One of only 71 produced, Chassis XKD 551 is a rare short-nose version of the D-Type and one of the last to have been manufactured. Its desirability is undeniable and further enhanced by the fact that it has never been used in competition, which will undoubtedly generate intense interest among the international collector car community. The Jaguar D-Type will be a highlight of Broad Arrow’s Zürich Auction, which will be held in partnership with Auto Zürich at the world-famous Dolder Grand hotel on Saturday 1 November 2025. “We are extremely honoured to have been granted the opportunity to offer this incredible Jaguar D-Type at our first Zürich Auction,” says Yves Boitel, Car Specialist, EMEA, at Broad Arrow Auctions. “The fact that this car has never been used competitively and has been meticulously cared for throughout its life, makes it one of the most exceptional D-Types in existence and one that will surely create great excitement among collectors.” Manufactured in 1956, chassis XKD 551 was sold to its first private owner in October 1957, who rather than heading to the nearest racetrack as many D-Types did, carefully converted it to semi-XKSS specification, removing the central bulkhead, adding a passenger door, and fitting a full-width windscreen. In 1963, ownership moved to Hon. James Dawnay, who famously owned and raced the Aston Martin DBR1/1. Motorsport provenance continued when it was sold to Australian Formula 1 driver Paul Hawkins. The 1970s saw another owner remove the XKSS-style modifications to return this highly collectible D-Type to its original configuration, and it eventually landed with its current Swiss owner in 1994. Prior to this, the original XK inline-six engine (no. E 2070-9) had been removed to ensure its preservation, with a correct specification engine fitted in its place. The new owner invested in a significant rebuild of the original engine, which continued to be preserved in storage for the next two decades. Recently, XKD 551 was reunited with its original engine, still fresh from its 2005 rebuild, and this incredible D-Type was treated to a service by the renowned Swiss specialists Graber Sportgarage in preparation for the sale. This extremely rare, un-raced example of the iconic Jaguar D-Type, complete with matching chassis and engine numbers, represents a remarkable opportunity for any discerning collector. It is also accompanied by previous FIA Historical Identity Form (1992), FIA Passport (2009) and FIVA Identity Card (2012), and is eligible for the world's most celebrated historic racing events, including the Goodwood Revival, Silverstone Classic, Mille Miglia Storica, Le Mans Classic, Monaco Historic Grand Prix, and Spa Classic.  “The excitement is building ahead of our inaugural Zürich Auction,” says Paul Gaucher, Head of Consignments for Switzerland at Broad Arrow Auctions. “The addition of this truly superb example of the iconic Jaguar D-Type will undoubtedly add to that excitement among international car collectors. There is plenty more to come and we can’t wait to share additional news on the highly desirable models that will be joining the catalogue soon.” Additional information on The Zürich Auction is available at broadarrowauctions.com. Collectors interested in consigning to or attending the auction are invited to speak with a Broad Arrow car specialist about this very special addition to the international collector car calendar. Editor’s Notes About Broad Arrow AuctionsBroad Arrow Auctions, a Hagerty (NYSE: HGTY) company, is a leading global collector car auction house. Founded in 2021 by highly experienced industry veterans, Broad Arrow offers exceptional quality cars to collectors and enthusiasts around the world. As the fastest growing auction house in its segment, Broad Arrow’s flagship annual events include The Monterey Jet Center Auction, in conjunction with Motorlux in California, The Amelia Auction, as the official auction of The Amelia (Concours d’Elegance) in Florida, and The Porsche Auction, in conjunction with Air | Water by Luftgekühlt in California. Broad Arrow expanded its global footprint in 2023, with renowned car specialists joining the team in the UK and Europe. Broad Arrow launched its first auction in Europe in May 2025 as the new official auction house of the Concorso d’Eleganza Villa d’Este in Italy in partnership with BMW AG. Broad Arrow now expands its global auction footprint with three new auctions in 2025 to be held during Zoute Grand Prix, Concours at Wynn Las Vegas, and Auto Zürich. Learn more at broadarrowauctions.com and follow us on Instagram, Facebook, LinkedIn, and Twitter.  About Hagerty, Inc. (NYSE: HGTY) Hagerty is an automotive enthusiast brand committed to saving driving and to fueling car culture for future generations. The company is a leading provider of specialty vehicle insurance, expert car valuation data and insights, live and digital car auction services, immersive events and automotive entertainment custom made for the 67 million Americans who self-describe as car enthusiasts. Hagerty also operates in Canada and the U.K. and is home to Hagerty Drivers Club, a community of over 875,000 who can’t get enough of cars. For more information, please visit www.hagerty.com or connect with us on Facebook, Instagram, X and LinkedIn.  Forward-Looking Statements - This press release contains statements that constitute “forward-looking statements” within the meaning of the federal securities laws. All statements provided, other than statements of historical fact, are forward-looking statements, including those regarding Hagerty’s future operating results and financial position, Hagerty’s business strategy and plans, products, services, and technology implementations, market conditions, growth and trends, expansion plans and opportunities, and Hagerty’s objectives for future operations. The words “anticipate,” “believe,” “envision,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “target,” “potential,” “will,” “would,” “could,” “should,” “continue,” “ongoing,” “contemplate,” and similar expressions, and the negative of these expressions, are intended to identify forward-looking statements. Hagerty has based these forward-looking statements largely on current expectations about future events, which may not materialize. Actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. These factors include, among other things, Hagerty’s ability to: (i) compete effectively within our industry and attract and retain our insurance policyholders and paid Hagerty Drivers Club (“HDC”) subscribers; (ii) maintain key strategic relationships with our insurance distribution and underwriting carrier partners; (iii) prevent, monitor, and detect fraudulent activity; (iv) manage risks associated with disruptions, interruptions, outages or other issues with our technology platforms or our use of third-party services; (v) accelerate the adoption of our membership and marketplace products and services, as well as any new insurance programs and products we offer; (vi) manage the cyclical nature of the insurance business, including through any periods of recession, economic downturn or inflation; (vii) address unexpected increases in the frequency or severity of claims, and (viii) comply with the numerous laws and regulations applicable to our business, including state, federal and foreign laws relating to insurance and rate increases, privacy, the internet, and accounting matters. The forward-looking statements herein represent the judgment of Hagerty as of the date of this release and Hagerty disclaims any intent or obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, or otherwise. This press release should be read in conjunction with the information included in Hagerty’s other press releases, reports and other filings with the Securities and Exchange Commission. Understanding the information contained in these filings is important in order to fully understand Hagerty’s reported financial results and its business outlook for future periods. Attachments 1956 Jaguar D-Type set to star at Broad Arrow's inaugural Zurich Auction The unraced, highly original Jaguar D-Type set to star at Broad Arrow's inaugural Zurich Auction CONTACT: Ian Kelleher Broad Arrow Auctions 917-971-4008 ikelleher@hagerty.com Meghan McGrail Broad Arrow Auctions 519-365-8750 mmcgrail@hagerty.com The post BROAD ARROW PRESENTS STUNNING AND UN-RACED JAGUAR D-TYPE AT INAUGURAL ZÜRICH AUCTION appeared first on ForexTV.

L&G achieves a 54% increase in call-to-lead conversions, in addition to enhancing internal innovation to boost operational efficiency San Diego, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Legal & General (L&G), one of the UK’s leading financial services providers, has redefined customer engagement by integrating Tealium’s real-time Customer Data Platform (CDP) with Snowflake’s AI Data Cloud. With 12.8 million customers and a complex portfolio spanning life insurance, pensions, and retirement income, L&G has modernized its digital strategy to deliver faster, more personalized support across channels. Powered by Tealium’s integration with Snowflake’s Snowpipe Streaming API, L&G can better support its customers with application and call center requests by routing them to agents already aware of their specific pain points. This transformation led to a 54% increase in call-to-lead conversions and a 15% boost in application completions through personalized, zero-party data-driven guidance. Marketing teams also saw improved ROI by using a proprietary lifetime value model to optimize spend across paid and CRM channels. “Through Snowflake’s easy, trusted and connected platform combined with Tealium’s CDP, we are helping centralise data so that everyone in L&G who requires data, gets immediate access,” said Rinesh Patel, Global Head of Financial Services, Snowflake. “Business departments are now getting the insights they need to improve experiences for their customers, and boost business productivity.” Legal & General also leveraged the integration to drive internal innovation. The company has automated the analysis of experiments, enabling teams to receive real-time alerts when tests reach statistical significance. This has eliminated the need for manual reviews, allowing teams to make faster, data-driven decisions. As a result, L&G has accelerated its optimization efforts and improved the speed at which new ideas are tested, validated, and scaled across the organization. “On one side, we’ve got Tealium operating in real time. It's one of our highest velocity data platforms in the business,” said Josh Williams, from L&G’s MarTech Engineering team. “It has an incredible variety of data, taking information from an enormous number of sources and forwarding and orchestrating that data to a wide variety of places. Snowflake has deep capabilities in data science, data engineering operations…it holds models and can execute and call those models at a high pace.” Gareth Jones, Head of Engagement MarTech at L&G, continued, “As a product owner, my focus is on setting a clear vision for how this capability delivers value – for both the business and our customers. We demo Tealium at our key stakeholder meetings, sprint reviews, and internal conferences to keep the momentum going and ensure everyone understands its impact.” Looking ahead, L&G is expanding its use of the platform with the deployment of proprietary chatbot large language models (LLMs). By leveraging Tealium’s integration with Model Context Protocol (MCP), the company aims to deliver even more intelligent, context-aware customer experiences through conversational AI.  By uniting real-time data orchestration with advanced analytics, Legal & General is closing engagement gaps, improving ROI with a lifetime value model, and driving smarter financial decisions. Check out the full case study.  To keep up with the latest company news, visit Tealium’s Newsroom.  About Tealium Tealium helps companies collect, govern, and enrich their customer data in real-time to power AI initiatives and delight customers in the moments that matter. Tealium’s turnkey integration ecosystem supports more than 1,300 built-in connections from the world’s most prominent technology experts. Tealium’s solutions include a real-time customer data platform (CDP) with intelligent AI data streaming, tag management, and an API hub. Tealium’s data collection, management, and activation capabilities enable enterprises to accelerate operating performance, enhance customer experiences, drive better outcomes, and support global data compliance. More than 850 leading businesses globally trust Tealium to power their customer data strategies. For more information, visit www.tealium.com. CONTACT: Natalie Passarelli Tealium Inc. natalie.passarelli@tealium.com The post Legal & General taps Tealium & Snowflake to accelerate AI-powered CX and business growth appeared first on ForexTV.

Delray Beach, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The Pipe Insulation Market is estimated to grow from USD 5,265.4 million in 2024 to USD 7,195.9 million by 2030, at a CAGR of 5.4% between 2025 and 2030. , as per the recent study by MarketsandMarkets™. The pipe insulation market is on the rise due to the increasing need for energy efficiency, a rise in construction activities, and stricter environmental regulations. By insulating pipes, we can reduce energy loss, enhance system performance, and decrease operational costs across industrial, commercial, and residential settings. The demand for thermal and acoustic insulation is further driven by the expansion of district heating and cooling systems, oil and gas infrastructure, and the chemical industry. Additionally, as more people become aware of sustainability and the importance of reducing carbon footprints, there is a push for advanced insulation materials. Emerging economies are also investing in infrastructure development, which significantly boosts market growth in sectors such as building & construction, industrial, district energy systems, oil, gas, and others. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=263389325 Browse in-depth TOC on “Pipe Insulation Market” 222 - Market Data Tables 54 – Figures 246 - Pages List of Key Players in Pipe Insulation Market: Saint-Gobain S.A. (France) BASF SE (Germany) Johns Manville (US) Owens Corning (US) Kingspan Group PLC (UK) Rockwool A/S (Denmark) Covestro AG (Germany) Huntsman Corporation (US) Armacell (Luxembourg) Knauf Insulation (US) Drivers, Opportunities and Challenges in Pipe Insulation Market: Drivers: Growth in oil and gas demand Restraint: Volatile prices of plastic foams Opportunity: Availability of green insulation material Challenge: Corrosion under insulation leads to health and safety-related issues Get Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=263389325 Key Findings of the Study: In 2024, the rock wool material type accounted for the second-largest share in terms of value of the pipe insulation market. In 2024, the oil application segment was the third largest in the pipe insulation market in terms of value. Central & Western Europe was the fourth-largest pipe insulation market in terms of value in 2024. Based on material type, the pipe insulation market is segmented as rock wool, glass wool, PUR /PIR foam, phenolic foam, elastomeric foam, other plastic foam, and others. Among these types, rock wool is expected to register the second-highest CAGR in terms of value during the forecast period. Its high melting point makes it suitable for applications in high-temperature industries such as power plants, petrochemical plants, and district heating. Additionally, increased awareness of fire safety and energy efficiency in building codes and industrial standards is driving the demand for non-combustible insulation products like rock wool. The product is also waterproof yet vapor-permeable, reducing the chances of corrosion under insulation (CUI), a significant issue in metal piping systems. Rock wool is eco-friendly and recyclable, aligning with global initiatives toward green construction and industrial practices. The industrialization and rising energy-efficiency standards in emerging economies are further boosting the demand. The combination of performance, safety, and environmental compliance places rock wool at the forefront of the expanding pipe insulation industry. Based on application, the pipe insulation market is segmented into district energy systems, oil, gas, building & construction, industrial, and others. The industrial application segment is expected to report the second-lowest CAGR in the market for pipe insulation during 2025–2030, driven by rising demand for safety, energy efficiency, and operational reliability in industries such as oil & gas, chemicals, power generation, and food processing. In these sectors, extensive networks of hot and cold pipelines are used for process operations and fluid transport, making thermal insulation essential to reduce energy loss, maintain process temperatures, and avoid freezing or condensation. Increasing energy costs and environmental regulations are compelling industries to adopt advanced insulation systems to conserve more energy and reduce carbon emissions. Additionally, growing awareness of workplace safety and equipment longevity is encouraging businesses to invest in insulation materials that protect staff from hot surfaces and mitigate corrosion under insulation (CUI). Industrial expansions, particularly in developing economies in Asia-Pacific and the Middle East, are also driving demand for robust and effective insulation solutions. These factors collectively contribute to the strong growth of the industrial segment in the pipe insulation market throughout the forecast period. Get Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=263389325 Based on the region, North America is forecast to achieve the second-highest CAGR for the pipe insulation market during 2025 to 2030 based on robust regulatory environments, rising investments in infrastructure, and a strong focus on energy efficiency. The industrial base of the region, particularly in petrochemicals, oil & gas, and power generation, is well established and significantly depends on insulated piping systems to minimize heat loss, enhance safety, and adhere to environmental requirements. Moreover, increased retrofit and renovation activities in residential and commercial properties, fueled by energy conservation incentives and green building regulations, are helping to fuel the demand for pipe insulation. The key players profiled in the report include Saint-Gobain S.A. (France), BASF SE (Germany), Johns Manville (US), Owens Corning (US), Kingspan Group PLC (UK), Rockwool A/S (Denmark), Covestro AG (Germany), Huntsman Corporation (US), Armacell (Luxembourg), and Knauf Insulation (US), and among others. Saint-Gobain S.A., established in 1665 with its main office in Courbevoie, France, leads the world in light and sustainable construction. This company has a major impact on the pipe insulation market. With a history of over 360 years, Saint-Gobain creates, makes, and sells materials for building and industrial use. It works through various parts of the business, like construction products, which offer pipe insulation. Headquartered in Ludwigshafen, Germany, BASF SE is one of the world’s leading chemical companies, with a recognized presence in the insulation and construction sectors—particularly in advanced pipe insulation solutions. Through its Performance Materials division, BASF develops and markets innovative thermal insulation systems, leveraging deep expertise in polyurethane chemistry. Browse Adjacent Markets Foam and Insulation Market Research Reports & Consulting  Related Reports: Medical Device Packaging Market 1,4-Butanediol Market Milled Carbon Fiber Market Process Oil Market Cooling Tower Market CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445, USA: +1-888-600-6441 Email: sales@marketsandmarkets.com Visit Our Website: www.marketsandmarkets.com The post Pipe Insulation Market worth $7,195.9 million by 2030, at a CAGR of 5.4%, says MarketsandMarkets™ appeared first on ForexTV.

Delray Beach, FL, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The Steel Rebar Market was USD 212.9 billion in 2024, and it is projected to reach USD 268.4 billion in 2030, at a CAGR of 4.0%, registering a CAGR of 6.7% during the forecast period, as per the recent study by MarketsandMarkets™. Steel rebar, or reinforcing bar, is a steel rod used to strengthen concrete and masonry structures. It offers tensile strength, which concrete lacks, helping to prevent cracking and structural failure under tension. Rebar is usually made of carbon steel and comes in different grades, sizes, and surface finishes to enhance bonding with concrete. It is used in most building projects, bridges, and infrastructure to boost the durability, stability, and load-carrying capacity of reinforced concrete structures. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=176200687 Browse in-depth TOC on “Steel Rebar Market” 309 - Market Data Tables 61 – Figures 290 - Pages List of Key Players in Steel Rebar Market: Nippon Steel Corporation (Japan) ArcelorMittal (Luxemberg) Gerdau S/A (Brazil) Nucor Corporation (US) Commercial Metals Company (US) TATA Steel (India) Steel Authority of India Limited (India) Mechel PAO (Russia) Steel Dynamics, Inc.  (US) NLMK Group (Russia) JSW (India) Baosteel Group Co., Ltd. (China) Drivers, Opportunities and Challenges in Steel Rebar Market: Drivers: Expansion of urban mass transit systems across developing economies Restraint: Import tariffs and anti-dumping measures Opportunity: Green steel rebar from hydrogen-based DRI Challenge: Lack of recycling infrastructure in emerging economies Get Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=176200687 Key Findings of the Study: By end-use sector, the infrastructure segment accounted for the largest market share in 2024. By coating type, the plain carbon steel segment is projected to witness the highest CAGR during the forecast period. Asia Pacific accounted for the largest share of the market in 2024. The steel rebar market is divided by type, which includes deformed and mild. Deformed steel bars feature ribs, lugs, and horns on their surface to enhance the bond between concrete and the rebar, reducing the risk of concrete corrosion. They are widely used across various sectors, such as the construction industry, for building bridges and skyscrapers. Their superior tensile strength and durability have gained recognition worldwide for infrastructure and commercial construction. By contrast, mild steel rebar, which is smooth and has much lower tensile strength, is used for smaller projects like garden walls or reinforcing other types of temporary large structures. Although soft rebar is cheaper, its weak adhesion and tendency to slip have led to decreased use in recent years for new building materials. The steel rebar market is segmented by process into basic oxygen steelmaking (BOS) and electric arc furnace (EAF). The BOS process is the most commonly used method for steel production, primarily in regions with high steel demand and abundant virgin iron ore supplies. It is widely used by integrated steel plants for large-scale manufacturing. Meanwhile, the EAF route is quickly gaining popularity as a flexible, low-carbon option that recycles scrap steel. EAF is especially favored in sustainable steelmaking and circular economy applications. With strict environmental regulations and a plentiful supply of scrap, EAF is expected to grow faster in the steel rebar market. The steel rebar market is segmented by coating type into plain carbon steel rebar, galvanized steel rebar, and epoxy-coated steel rebar. Plain carbon steel rebar (ASTM A1044, available in ASTM A615, A706, A775, and A996) is made from unfinished-rolled steel and is the most common type of rebar. However, it lacks corrosion resistance, making it unsuitable for moist conditions. Galvanized steel rebar, which is zinc-coated, offers rust and corrosion resistance suitable for coastal or humid environments. Epoxy-coated steel reinforcement (ASTM A775) provides an effective solution for preventing corrosion of steel rebar and prolonging the lifespan of building structures. Increasing focus on infrastructure longevity and reducing maintenance costs is driving demand for coated rebar, especially zinc and epoxy-coated types. Get Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=176200687 The steel rebar market is also segmented by bar size, which includes #3, #4, #5, #8, and other sizes. #3 rebar, being smaller, is used in light-duty construction such as reinforcing patios, driveways, and residential slabs. #4 and #5 rebar sizes are commonly used for these applications, balancing strength with ease of concrete placement in foundations, walls, and columns in both residential and commercial buildings. Conversely, larger #8 rebar is generally used for heavy-duty projects like bridges, large industrial facilities, and multi-story buildings requiring substantial load-bearing capacity. The selection of bar size depends on structural design, service conditions, and building code requirements for different types of structures. The steel rebar market is segmented based on end-use sector, which includes infrastructure, housing & industrial. The infrastructure vertical is a major revenue contributor due to the huge amount of government spending on roads, bridges, railways, and airports in developing countries. Steel rebar is a must in order to maintain the structure and integrity of these heavy concrete projects. Another significant source of contribution is the housing sector, which is driven by urbanization, population increase, and the requirement for affordable as well as tall apartments. The industrial segment sells steel rebar that is included in the construction of manufacturing plants, warehouses, coal and battery plants, and other industrial facilities. The rising industrialization and the development of energy and logistics systems have been demanding more in this segment. Rebar specifications and quantity are also affected by the specific construction requirements of each sector. The steel rebar market is studied in five regions: Asia Pacific, Europe, North America, the Middle East & Africa, and South America. Of these, Asia Pacific is leading the market and is projected to experience the fastest CAGR during the forecast period. This is driven by the rapid pace of urbanization, the development of large-scale infrastructure, and the significant government spending on transportation, energy, and housing in countries such as China, India, Indonesia, and Vietnam. Projects such as India’s Smart Cities Mission and China’s Belt and Road Initiative are driving steel rebar demand in the region. North America is a market that is relatively mature, with demand through rehabilitation of aging infrastructure and modernization, particularly in the US and Canada. The U.S. Infrastructure Investment and Jobs Act has increased demand for rebar for bridges, highways, and public transit systems. The market is also witnessing a growing preference for epoxy-coated and corrosion-resistant rebars in light of stringent construction and safety standards. Europe also indicates firm demand, driven by residential renovation, energy-efficient building construction, and earthquake-resistant buildings in Southern and Eastern Europe. South America, led by Brazil and Argentina, is slowly growing, fueled by public infrastructure projects and an increased demand for housing. But economic disruptions could out turn consistent development. The Middle East & Africa coupler for hollow structures market is proving to be a promising market. Continuation of mega projects, including construction sites for Saudi Arabia’s NEOM city and UAE infrastructure development projects, rollout of Vision Plan 2021, and introduction of tourism and energy sources are expected to aid in the long-term demand for high-strength and durable steel rebar in the region. Browse Adjacent Markets Building and Construction Market Research Reports & Consulting Related Reports: Green Hydrogen Market Protective Packaging Market Building Thermal Insulation Market Silicone Elastomers Market Adhesives & Sealants Market CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445, USA: +1-888-600-6441 Email: sales@marketsandmarkets.com Visit Our Website: www.marketsandmarkets.com The post Steel Rebar Market worth $268.4 billion by 2030, at a CAGR of 4.0%, says MarketsandMarkets™ appeared first on ForexTV.

PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS) Strategic Investment and Partnership with KOPIN Corporation - Augmented Reality System Development Long-Term Supply Agreement with eMagin Corporation – OLED Displays Strategic Industrial Partnership with ALEREON – Wireless Communication Extending AR-MR-VR Capability via Investment in VARJO 11 August, 2025 – Theon International Plc (THEON) is proud to announce new strategic investments and strategic partnerships as part of its THEON NEXT initiative, building a platform to drive the development of next-generation soldier systems through targeted investments, collaborations, and co-development initiatives. With a focus on the creation of innovative Digital and Augmented Reality (AR) solutions THEON NEXT aims to onboard best-in-class partners in their field of expertise to help shaping the future of operational dominance in modern warfare environments. To this end, THEON is announcing four major investments / strategic cooperations in the United States and Europe, marking a significant milestone in its journey to continue being a global leader in man-portable electro-optics. These transactions reinforce THEON’s commitment to innovation, supply chain security, and transatlantic cooperation in defense technologies. Following the establishment of a leading position in night vision systems, THEON has successfully expanded into thermal and digital solutions with its new A.R.M.E.D. product family. Similarly to the approach adopted for traditional Night Vision systems, favoring vertical integration and long-term supply agreements, THEON is now proactively stepping further into the rapidly growing Digital and AR domain, which relies on three critical technologies: Augmented and Virtual Reality Software – the foundation of next-generation soldier systems, enabling immersive situational awareness, enhanced decision- making, and digital overlays in real-world environments. Micro-displays – essential for next generation visual augmentation systems, with a strategic focus on developing a US-European microLED technology. Near-Range Wireless Connectivity – enabling seamless, cable-free integration of soldier gear with real-time data transmission. To successfully face these challenges, THEON announces four major initiatives and agreements that not only constitute relevant milestones in its technological roadmap but also deepen the US-European industrial cooperation: First, THEON is investing a total of $15 million in Kopin Corporation (KOPIN, NASDAQ: KOPN), a US-based defense micro-display and sub-system specialist with operations in the US and Scotland, UK. This comprises a $7 million interest bearing loan, convertible in preferred stock of KOPIN at a share price range of $3 to $4.5 in THEON’s option, and $8 million capital increase for the acquisition of a 49% stake in KOPIN’s Scottish subsidiary, which will serve as the foundation for a new European joint venture acting as the global (non-US) conduit for the production and distribution of AR-enabled systems co-developed between KOPIN and THEON and microLED display production. The whole investment in KOPIN of $15 million, is geared towards the co-development of products and reflects the belief by THEON, that the already extensive R&D investments that KOPIN has undertaken have established the necessary foundation, for a cooperation that can promptly translate into cost efficient, AR-enabled products. This strategic partnership will also see THEON US subsidiary (T-Industries) moving their relevant industrial and product development operations at KOPIN’s facility in Reston, VA, which shall become the US manufacturing hub for THEON’s AR-enabled and future digital electro-optic products. As part of T-Industries’ normal course of business, THEON, over the next five years, will be investing $8 million to support its US operations, as well as the new KOPIN -THEON co-development efforts. This new cooperation will not affect THEON’s two existing partnerships in the night vision domain. Secondly, THEON has signed a renewable minimum two-year supply agreement with eMagin, a US-based manufacturer of OLED micro-displays and virtual imaging technologies. eMagin specializes in high-resolution displays for military aviation, night vision, AR/VR, and other near-eye imaging applications. eMagin is a strategic supplier to THEON, providing most OLED displays used in THEON’s products, including A.R.M.E.D. products, including foremost IRIS-C. Thirdly, THEON has entered into a strategic partnership with ALEREON, a U.S.-based leader in Ultra-Wide-Band (UWB) wireless technology. ALEREON provides battle- proven UWB solutions that form the established Intra-Soldier communication protocol for the U.S. Army, enabling secure, jam-resistant communication between devices such as between THEON’s THERMIS, THEA, IRIS-C, and ORION. Unlike conventional protocols like Wi-Fi or Bluetooth, ALEREON’s UWB technology delivers unparalleled security, low latency, and resilience in battlefield conditions. Through this partnership, THEON will fully integrate UWB into its A.R.M.E.D. product line, produce it in Greece and will promote this unique solution in Europe and the Middle East as ALEREON’s primary partner in the regions. Lastly, THEON announces a strategic minority investment in Varjo Technologies Oy (VARJO), a Finnish deep-tech company specializing in Virtual Reality (VR) and Mixed Reality (MR) headsets and applications, deepening THEON’s reach into the European innovation ecosystem. VARJO was founded in 2016 and supplies the most relevant aerospace and defense companies globally, delivering advanced military-grade VR/MR technology for training and simulation. The strategic collaboration between THEON and VARJO will combine THEON’s technological know-how with VARJO’S advanced virtual and mixed reality hardware and software, with the companies having agreed to collaborate closely on multiple product and business initiatives. The agreement envisages an investment in VARJO via a €5 million convertible loan, structured to be converted into VARJO share capital upon the occurrence of defined events. THEON also holds an option to invest an additional €5 million under the same terms. This investment will support VARJO’S continued development of immersive technologies and reinforce THEON’s digital expansion strategy under the THEON NEXT initiative, particularly on the development of high-tech products for defense applications. Christian Hadjiminas, CEO of THEON, stated: “Following the recent significant KAPPA acquisition, THEON has managed to sign such pioneering agreements, ensuring it retains its leading position in man-portable electro-optics. We are very proud that these arrangements bring the US and Europe closer together to develop the next generation of soldier-borne systems. The partnership initially involves operations in the United States, the United Kingdom, Finland as well as Greece and will be eventually enlarged into Germany and Belgium where our EU thermal/digital hub is being established. Together, we are pushing the frontier of Augmented Reality defense capabilities. These initiatives and investments will be further expanded upon during our announced Capital Markets Day to be held in Athens in November 2025 (details to be publicized). I am very proud of our commercial and R&D teams that have helped secure these agreements in a short time frame following a thorough review of essential technologies and potential partners over the past 12 months.” Dimitrios Mandridis, CTO of Theon Sensors stated: “THEON has managed to establish an advanced global technical cooperation framework combining all key technologies of the new inter-connected AR-capable-soldier era, as can be seen by the introduction of THEON’s A.R.M.E.D. product line and its ever-growing adoption by modern armies. Every piece of this cooperation ensures that THEON will be at the forefront of new developments in the digital and AR technology space which further evolve THEON’s A.R.M.E.D. product line for the benefit of our final customers. THEON’s R&D department has been expanded and restructured to enable the integration of all these partnerships.” Dimitris Parthenis, CFO of THEON, stated: “Obtaining key technologies—especially when these relate to large companies also operating in the civil sector—through such agreements represents a flexible and financially efficient investment and rapid outcome for all our stakeholders. THEON’s option to convert such development funds into equity positions would positively affect its future financial results. The current investment, totaling €25 million over two to five years, is expected to be paid back quickly, through enhancing the features and the price positioning of our current offer and also via the future growth of these companies that have some of the most promising civil and defense technologies. We are proud to be looking to the future with these compelling partners who share our leading entrepreneurial spirit.” Michael Murray, CEO of KOPIN, stated: “With defense investments accelerating globally, especially among European NATO allies, strategic partnerships have become critical to delivering next-generation, mission-ready technologies. We are proud to collaborate with THEON in a partnership that exemplifies innovation, agility, and shared purpose. By integrating KOPIN’s cutting-edge micro-displays and application-specific optical subassemblies with Theon’s advanced expertise in night vision, thermal imaging, and Electro-Optical ISR systems, we are not only meeting the evolving demands of modern defense operations, but we are also actively shaping the future of battlefield awareness and operational effectiveness.” Amal Ghosh, CEO of eMagin stated: “We are excited to partner with Theon, a leader in advanced optics and imaging systems, to integrate eMagin’s state-of-the-art OLED microdisplay technology into their next generation of products. This collaboration underscores our shared commitment to delivering unmatched image quality, performance, and reliability for mission-critical applications. By combining eMagin’s innovation in microdisplays with Theon’s expertise in precision optics, we are poised to create solutions that set a new standard in the field and deliver exceptional value to customers worldwide.” David Shoemaker, CEO of ALEREON, stated: “We’re excited to partner with THEON and be part of this forward-looking initiative. THEON’S proven expertise in electro-optics and extensive international business development network make them an ideal ally in expanding the reach and implementation of ALEREON’s UWB technology. With THEON as our key partner in Europe and the Middle East, we look forward to bringing our battle- proven communication solutions into the hands of many more allied soldiers.” Timo Toikkanen, CEO of VARJO, added: “We are proud to welcome THEON as a strategic investor in VARJO. Since our inception, VARJO has been creating the most advanced VR/XR military systems globally. THEON’s extensive experience and leadership in the defense sector make them an ideal partner as we expand our impact in mission-critical training and simulation, enabling unprecedented levels of realism, readiness, and operational effectiveness.” For inquiries, please contact: Investor RelationsNikos MalesiotisE-Mail: ir@theon.comTel: +30 210 6772290 Media ContactElli MichouE-Mail: press@theon.com Tel: +30 210 6728610 About THEON GROUPTHEON GROUP of companies develops and manufactures cutting-edge night vision and thermal Imaging systems for Defense and Security applications with a global footprint. THEON GROUP started its operations in 1997 from Greece and today occupies a leading role in the sector thanks to its international presence through subsidiaries and production facilities in Greece, Cyprus, Germany, the Baltics, the United States, the Gulf States, Switzerland, Denmark, Belgium, Singapore and South Korea. THEON GROUP has more than 220,000 systems in service with Armed and Special Forces in 71 countries around the world, 26 of which are NATO countries. ΤΗΕΟΝ ΙΝΤΕRNATIONAL PLC has been listed on Euronext Amsterdam (AMS: THEON) since February 2024.www.theon.com Attachment ΤHEON announces new strategic US and European investments and partnerships The post THEON announces new strategic US and European investments and partnerships to build global leadership in Digital and Augmented Reality defense optronics domain under the THEON NEXT initiative appeared first on ForexTV.

Strong operating results following a strategic transition to a pure-play industrial REIT TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Nexus Industrial REIT (the “REIT”) (TSX: NXR.UN) announced today its results for the second quarter ended June 30, 2025. “The second quarter marked our first as a pure-play industrial REIT, and our strong operating results continued. Compared to a year ago, our normalized FFO per unit grew 5.6%, and industrial SPNOI grew 2.8%” said Kelly Hanczyk, CEO of Nexus Industrial REIT. “Over the past 12 months we have simultaneously grown NOI by 1.7%, while also completing the strategic disposition of 33 legacy retail, office, and non-core industrial properties. And, we will soon begin to realize the next phase of growth: we are nearing completion of two developments ahead of plan, which will add $6.6 million of annual stabilized NOI, representing unlevered returns of 9.4% on costs. I am very pleased with the progress that we have made, and I am confident that our strategy will continue to be rewarding for our stakeholders” concluded Mr. Hanczyk. Second Quarter 2025 Highlights: Advanced construction on the 325,000 sq. ft. expansion project in St. Thomas, ON, and on the 115,000 sq. ft. new industrial small-bay complex in Calgary, AB. Combined, these projects will add annual stabilized NOI of $6.6 million when complete and stabilized. Completion of both projects is planned for the third quarter. Completed 395,412 sf of leasing at an average spread of 38% over expiring and in-place rents. Completed the sale of two non-core industrial properties for a total proceeds of $11.2 million. Net loss was $7.6 million driven by fair value losses on Class B LP units and on investment properties, partially offset by net operating income ("NOI")(1) of $32.2 million and by fair value gains on derivative instruments. NOI(1) increased 1.7% versus a year ago to $32.2 million from the acquisition of high-quality, tenanted income-producing industrial properties, and growth in industrial Same Property NOI(1), despite selling 33 legacy retail, office, and non-core industrial properties. Industrial Same Property NOI(1) increased 2.8% year over year to $28.5 million. Normalized FFO(1) per unit increased $0.009 versus a year ago to $0.188 and Normalized AFFO(1) per unit increased $0.011 versus a year ago to $0.160. Year-to-Date 2025 Highlights: Completed the transition to a pure-play industrial REIT by selling 15 legacy retail properties, one legacy office property and two non-core industrial properties for total proceeds of $62.1 million. Advanced construction on the 325,000 sq. ft. expansion project in St. Thomas, ON, and on the 115,000 sq. ft. new industrial small-bay complex in Calgary, AB. Combined, these projects will add annual stabilized NOI of $6.6 million when complete. Completion of both projects is planned for the third quarter. Completed 1,192,792 sf of leasing at an average spread of 82% over expiring and in-place rents. Net income was $25.5 million driven by NOI(1) of $64.2 million and by fair value gains on Class B LP units, partially offset by fair value losses on derivative instruments and investment properties. NOI(1) increased 5.0% versus a year ago to $64.2 million from the acquisition of high-quality, tenanted income-producing industrial properties, and growth in industrial Same Property NOI(1), despite selling 33 legacy retail, office, and non-core industrial properties. Industrial Same Property NOI(1) increased 4.3% year over year to $54.5 million. Normalized FFO(1) per unit increased $0.032 versus a year ago to $0.375 and Normalized AFFO(1) per unit increased $0.029 versus a year ago to $0.313. Unitholders' equity increased by $5.6 million to $1.1 billion or $15.01 per unit. NAV per unit(1) of $13.17 decreased $0.02 or (0.2)% versus Q4 2024. (1) This is a Non-IFRS Financial Measure. Subsequent events: On July 4, 2025, 2,764,464 Class B LP Units valued at $10.50 per unit were issued to 0768723 BC Ltd in settlement of the initial portion of the contractual construction obligations in respect of the construction of 52,000 additional square feet at the REIT's Richmond, BC property. The units are subject to trading restrictions until specific construction milestones are met. The restricted units will not accrue any distributions declared during the restriction period. On August 5, 2025, the REIT increased the Unsecured Credit Facilities by $160 million, from $625 million to $785 million, increasing the term loan facility from $175 million to $200 million and the revolving facility from $440 million to $575 million. The REIT also amended the maturity date of the Unsecured Credit Facilities by extending the term loan facility and the revolving facility from March 1, 2027 to August 5, 2027 and August 5, 2028, respectively. Summary of Results (In thousands of Canadian dollars, except per unit amounts) Three months ended June 30, Six months ended June 30,   2025  2024  2025  2024    $ $ $ $ FINANCIAL INFORMATION         Operating Results         Property revenues 42,022   43,910   86,776   85,507   NOI (1) 32,150   31,617   64,240   61,154   Net (loss) income and comprehensive (loss) income (7,625 ) 43,525   25,526   87,196   Adjusted EBITDA (LTM) (1) 121,859   112,688   121,859   112,688             FFO (1) 18,157   16,576   35,200   30,931   Normalized FFO (1) (2) 17,744   16,712   35,323   32,091   AFFO (1) 15,449   13,770   29,846   25,358   Normalized AFFO (1) (2) 15,033   13,906   29,511   26,518   Distributions declared (3) 15,076   14,970   30,149   29,910   Same Property NOI (1) 28,842   28,401   55,423   53,724   Industrial Same Property NOI (1) 28,520   27,741   54,537   52,276             Weighted average units outstanding (000s):         Basic (4) 94,233   93,541   94,218   93,441   Diluted (4) 94,513   93,717   94,498   93,617             Per unit amounts:         Distributions per unit – basic (3) (4) 0.160   0.160   0.320   0.320   Distributions per unit – diluted (3) (4) 0.160   0.160   0.320   0.320             Normalized FFO per unit – basic (1) (2) (4) 0.188   0.179   0.375   0.343   Normalized FFO per unit – diluted (1) (2) (4) 0.188   0.178   0.374   0.343             Normalized AFFO per unit – basic (1) (2) (4) 0.160   0.149   0.313   0.284   Normalized AFFO per unit – diluted (1) (2) (4) 0.159   0.148   0.312   0.283             AFFO payout ratio (1) (3) 97.6%   108.7%   101.0%   118.0%   Normalized AFFO payout ratio – basic (1) (2) (3) 100.3%   107.7%   102.2%   112.8%   Normalized AFFO payout ratio – diluted (1) (2) (3) 100.6%   108.1%   102.6%   113.1%             Same Property NOI Growth % (1) 1.6%   3.3%   3.2%   1.4%   Industrial Same Property NOI Growth % (1) 2.8%   3.5%   4.3%   2.3%   (1) This is a Non-IFRS Financial Measure. (2) Until Q1 2024, Normalized FFO and Normalized AFFO included adjustments for vendor rent obligation amounts due from the vendor of the REIT’s Richmond, BC property, until certain conditions were satisfied. During Q2 2024, these conditions were satisfied and the vendor settled all outstanding amounts. (3) Includes distributions payable to holders of Class B LP Units which are accounted for as finance expense in the consolidated financial statements. (4) Weighted average number of units includes Class B LP Units.   June 30,   December 31,     2025   2024   (In thousands of Canadian dollars, unless stated otherwise) $   $   PORTFOLIO INFORMATION     Total Portfolio     Number of Investment Properties (2) 88   106   Number of Properties Under Development 2   2   Investment Properties Fair Value (excludes assets held for sale) 2,480,540   2,458,174   Gross leasable area (“GLA”) (in millions of sq. ft.) (at the REIT's ownership interest) 11.7   12.5   Industrial occupancy rate – in-place and committed (period-end) (3) 94%   96%   Weighted average lease term (“WALT”) (years) 7.1   6.8   Industrial WALT (years) 7.1   7.0   Estimated spread between industrial portfolio market and in-place rents 18.5%   25.3%         FINANCING AND CAPITAL INFORMATION     Financing     Net debt (1) 1,258,770   1,279,538   Total Indebtedness Ratio (1) 48.9%   49.1%   Net Debt to Adjusted EBITDA (1) 10.3   10.9   Adjusted Net Debt to Adjusted EBITDA (1) 9.4   10.2   Debt service coverage ratio (times) 1.68   1.62   Secured Indebtedness Ratio 26.2%   27.4%   Unencumbered investment properties as a percentage of investment properties 40.6%   39.5%   Total assets 2,576,227   2,604,460   Cash 5,640   11,532   Capital     Total equity (per consolidated financial statements) 1,067,313   1,061,724   Total equity (including Class B LP Units) 1,240,836   1,241,747   Total number of Units (in thousands) (4) 94,233   94,159   NAV per Unit (1) 13.17   13.19   (1)   See Non-IFRS Financial Measures.(2)   Includes 2 properties (17 properties - December 31, 2024) classified as assets held for sale.(3)   Includes committed new leases for future occupancy.(4)   Includes Class B LP units. Net (Loss) Income Net loss for the three months ended June 30, 2025 was $7.6 million or $51.2 million lower than the prior year, primarily due to a decrease in the fair value adjustment of Class B LP units by $35.8 million, decrease in the fair value adjustment of investment properties by $24.7 million, partially offset by an increase in the fair value adjustment of derivative financial instruments by $7.7 million, a lower finance expense of $1.2 million and a higher NOI of $0.5 million. Net income for the six months ended June 30, 2025 was $25.5 million or $61.7 million lower than the prior year, primarily due to decrease in the fair value adjustment of investment properties by $31.0 million, a lower gain on the fair value adjustment of Class B LP units by $27.6 million, and by a decrease in the fair value adjustment of derivative financial instruments by $7.7 million partially offset by a higher NOI of $3.1 million, a lower finance expense of $1.2 million and a higher foreign exchange gain by $1.1 million. NOI NOI for the three months ended June 30, 2025 was $32.2 million or $0.5 million higher than the prior year, which was primarily due to $1.5 million from lease termination and tenant reimbursed capital improvements, increase in NOI of $0.6 million from acquisitions of industrial income producing properties completed subsequent to Q2 2024, an increase in Same Property NOI by $0.4 million, $0.2 million relating to development projects and $0.1 million relating to lower tenant incentives and leasing costs amortization, partially offset by lower NOI of $2.2 million relating to dispositions completed since Q2 2024. NOI for the six months ended June 30, 2025 was $64.2 million or $3.1 million higher than the prior year, which was primarily due to increased NOI of $2.8 million from acquisitions of industrial income producing properties completed subsequent to Q2 2024, $2.1 million from lease termination and tenant reimbursed capital improvements, an increase in Same Property NOI by $1.7 million and $0.4 million relating to development projects, partially offset by lower NOI of $3.7 million relating to dispositions completed since Q2 2024 and $0.2 million relating to lower straight-line rent adjustments. Fair value adjustment of investment properties The fair value loss on investment properties for the three months ended June 30, 2025, totaled $11.1 million. The REIT engaged external appraisers to value properties totaling $122.2 million in the quarter. Overall, fair value losses recorded for the REIT’s portfolio primarily consists of $13.1 million relating to changes in stabilized NOI and capitalization rates, $2.9 million of capital expenditures that were not deemed to increase the fair value of the properties and therefore fair valued to zero and $0.1 million relating to investment property sale price adjustments prior to disposition, partially offset by $5.0 million gain relating to properties held for development based on development progress relative to the as-completed value. The fair value loss on investment properties for the six months ended June 30, 2025, totaled $2.3 million. Overall, fair value losses recorded for the REIT’s portfolio primarily consists $6.0 million of capital expenditures net of adjustments that were not deemed to increase the fair value of the properties and therefore fair valued to zero, $3.0 million relating to changes in stabilized NOI and capitalization rates, and $2.8 million relating to investment property sale price adjustments prior to disposition, partially offset by $9.5 million gain relating to properties held for development based on development progress relative to the as-completed value. Outlook The REIT is focused on delivering total unitholder return through profitable long-term growth, and by pursuing its strategy as a Canada-focused pure-play industrial REIT. Overall, the REIT anticipates mid-single digit Same Property NOI growth in its industrial portfolio for the full year. The expected growth is primarily attributed to the lease-up of vacant space, and releasing space at market rents that exceed expiring rents, thereby continuing to benefit from positive spreads between market rental rates and the REIT's in-place rental rates. In 2025, the REIT expects to benefit from the completion of two significant development projects. Combined, these properties will add annual stabilized NOI of approximately $6.6 million when complete: The REIT expects to complete its 325,000 sq ft Dennis Rd. expansion project in St. Thomas, ON in the third quarter of 2025. This project is being constructed for an existing tenant. The REIT earns 7.8% on capital expenditures during the construction phase, and will earn a contractual going-in yield of 9.0% on the total development costs of $54.9 million upon completion. The REIT is constructing a 115,000 sq ft small-bay industrial building adjacent to an existing building that it owns in Calgary, AB. The project is expected to be completed in the third quarter of 2025 and to earn a going-in yield of approximately 11% on total development costs of $15.4 million. Notwithstanding that the normalized AFFO payout ratios for the three and six months ended June 30, 2025 are 100.3% and 102.2%, respectively, the REIT believes that current distributions are sustainable as disclosed in the FFO and AFFO section of the REIT's MD&A. Earnings Call Management of the REIT will host a conference call at 10:00 AM Eastern Standard Time on Tuesday August 12, 2025 to review the financial results and operations. To participate in the conference call, please dial 647-846-8414 or 1-833-752-3601 (toll free in Canada and the US) at least five minutes prior to the start time and ask to join the Nexus Industrial REIT conference call. A recording of the conference call will be available until September 12, 2025. To access the recording, please dial 1-412-317-0088 or 1-855-669-9658 (toll free in Canada and the US) and enter access code 2608098. September and October Distributions The REIT will make a cash distribution in the amount of $0.05333 per unit, representing $0.64 per unit on an annualized basis, payable October 15, 2025, to unitholders of record as of September 30, 2025. The REIT will also make a cash distribution in the amount of $0.05333 per unit, representing $0.64 per unit on an annualized basis, payable November 14, 2025, to unitholders of record as of October 31, 2025. About Nexus Industrial REIT Nexus is a growth-oriented real estate investment trust focused on increasing unitholder value through the acquisition of industrial properties located in primary and secondary markets in Canada, and the ownership and management of its portfolio of properties. The REIT currently owns a portfolio of 88 properties (including one property held for development in which the REIT has an 80% interest) comprising approximately 11.7 million square feet of gross leasable area. The REIT has approximately 97,019,000 voting units issued and outstanding, including approximately 71,301,000 REIT Units and approximately 25,718,000 Class B LP Units of subsidiary limited partnerships of Nexus, which are convertible to REIT Units on a one-to-one basis. Non-IFRS Measures Information in this news release is a select summary of results. This news release should be read in conjunction with the MD&A and the Trust's consolidated financial statements and the accompanying notes for the three months ended June 30, 2025 and 2024 (the “Financial Statements”). The Financial Statements are prepared in accordance with IFRS accounting standards as issued by the IASB, however, included in the tables above and elsewhere in this news release are non-IFRS financial measures or non-IFRS ratios which do not have a standardized meaning prescribed under generally accepted accounting principles (“GAAP”) in accordance with IFRS and that should not be construed as an alternative to net income / loss or other measures of financial performance calculated in accordance with IFRS and may not be comparable to similar measures as reported by other issuers. A definition of each non-IFRS financial measure or ratio used herein and an explanation of management's reasons as to why it believes the measure is useful to investors are incorporated by reference and can be found on page 3 in the REIT’s Management’s Discussion and Analysis for the three and six months ended June 30, 2025, available on SEDAR+ at www.sedarplus.ca and on the REIT’s website under Investor Relations. See Appendix A of this earnings release for a reconciliation of the non-IFRS financial measures to the primary financial statement measures. Forward Looking Statements Certain statements contained in this news release constitute forward-looking statements which reflect the REIT’s current expectations and projections about future results, including statements under the heading "Outlook" and regarding the REIT's expectations relating to growth in NOI, benefits from developments and the sustainability of its distributions. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the REIT to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this news release. Such forward-looking statements are based on a number of assumptions that may prove to be incorrect. While the REIT anticipates that subsequent events and developments may cause its views to change, the REIT specifically disclaims any obligation to update these forward-looking statements except as required by applicable law. These forward-looking statements should not be relied upon as representing the REIT’s views as of any date subsequent to the date of this news release. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The factors identified above are not intended to represent a complete list of the factors that could affect the REIT. For further information please contact:Kelly C. Hanczyk, CEO at (416) 906-2379 orMike Rawle, CFO at (647) 823-1381 APPENDIX A – NON-IFRS FINANCIAL MEASURES (In thousands of Canadian dollars, except per unit amounts) Three months ended June 30,   Six months ended June 30,   2025    2024    Change     2025    2024    Change   FFO $   $   $     $   $   $                   Net (loss) income and comprehensive (loss) income (7,625 ) 43,525   (51,150 )   25,526   87,196   (61,670 ) Adjustments:               Loss on disposal of investment properties 196   251   (55 )   281   251   30   Fair value adjustments 21,285   (31,713 ) 52,998     1,558   (65,224 ) 66,782   Adjustments for equity accounted joint venture (1) 8   113   (105 )   84   71   13   Distributions on Class B LP Units expensed 3,697   3,849   (152 )   7,410   7,787   (377 ) Amortization of tenant incentives and leasing costs 277   384   (107 )   643   657   (14 ) Lease principal payments (24 ) (16 ) (8 )   (50 ) (20 ) (30 ) Amortization of right-of-use assets 30   30   -     60   60   -   Net effect of unrealized foreign exchange on USD debt and related hedges 313   153   160     (312 ) 153   (465 ) Funds from operations (FFO) 18,157   16,576   1,581     35,200   30,931   4,269   Weighted average units outstanding (000s) Basic (4) 94,233   93,541   692     94,218   93,441   777   FFO per unit – basic 0.193   0.177   0.016     0.374   0.331   0.043                   FFO 18,157   16,576   1,581     35,200   30,931   4,269   Add: Vendor rent obligation (2) -   -   -     -   628   (628 ) Add: Non-recurring personnel transition costs -   66   (66 )   107   326   (219 ) Add: Non-recurring adjustments from asset dispositions (5) 34   -   34     505   -   505   Add: Other non-cash items (6) (447 ) 70   (517 )   (489 ) 206   (695 ) Normalized FFO 17,744   16,712   1,032     35,323   32,091   3,232   Weighted average units outstanding (000s) Basic (4) 94,233   93,541   692     94,218   93,441   777   Normalized FFO per unit – basic 0.188   0.179   0.009     0.375   0.343   0.032                                   (In thousands of Canadian dollars, except per unit amounts) Three months ended June 30,   Six months ended June 30,   2025    2024    Change     2025    2024    Change   AFFO $   $   $     $   $   $                   FFO 18,157   16,576   1,581     35,200   30,931   4,269   Adjustments:     -         -   Straight-line adjustments ground lease and rent (1,108 ) (1,206 ) 98     (2,154 ) (2,373 ) 219   Capital reserve (3) (1,600 ) (1,600 ) -     (3,200 ) (3,200 ) -   Adjusted funds from operations (AFFO) 15,449   13,770   1,679     29,846   25,358   4,488   Weighted average units outstanding (000s) Basic (4) 94,233   93,541   692     94,218   93,441   777   AFFO per unit – basic 0.164   0.147   0.017     0.317   0.271   0.046   Distributions declared 15,076   14,970   106     30,149   29,910   239   AFFO payout ratio - basic 97.6%   108.7%   -11.1%     101.0%   118.0%   -16.9%                                   AFFO 15,449   13,770   1,679     29,846   25,358   4,488   Add: Vendor rent obligation (2) -   -   -     -   628   (628 ) Add: Non-recurring personnel transition costs -   66   (66 )   107   326   (219 ) Add: Non-recurring adjustments from asset dispositions (5) 31   -   31     47   -   47   Add: Other non-cash items (6) (447 ) 70   (517 )   (489 ) 206   (695 ) Normalized AFFO 15,033   13,906   1,127     29,511   26,518   2,993   Weighted average units outstanding (000s) Basic (4) 94,233   93,541   692     94,218   93,441   777   Normalized AFFO per unit – basic 0.160   0.149   0.011     0.313   0.284   0.029   Distributions declared 15,076   14,970   106     30,149   29,910   239   Normalized AFFO payout ratio - basic 100.3%   107.7%   -7.4%     102.2%   112.8%   -10.6%   (1) Adjustment for equity accounted joint venture relates to a fair value adjustment of swaps in place at the joint venture to swap floating rate bankers’ acceptance rates to a fixed rate and a fair value adjustment of the joint venture investment property. (2) Until Q1 2024, Normalized FFO and Normalized AFFO included adjustments for vendor rent obligation amounts due from the vendor of the REIT’s Richmond, BC property, until certain conditions were satisfied. During Q2 2024, these conditions were satisfied and the vendor settled all outstanding amounts. (3) Capital reserve includes maintenance capital expenditures, tenant incentives and leasing costs. Reserve amounts are established with reference to building condition reports, appraisals, and internal estimates of tenant renewal, tenant incentives and leasing costs. The REIT believes that a reserve is more appropriate given the fluctuating nature of these capital expenditures. (4) Weighted average number of units includes the Class B LP Units. (5) These adjustments represent one-time balance sheet write-offs, early mortgage repayment charges, and other costs associated with the disposals made during the period. (6) This adjustment is predominantly unrealized foreign exchange losses (gains) on transactions relating to deferred purchase consideration. Note that the comparative periods for 2024 have been updated to conform with the current period presentation. SAME PROPERTY RESULTS (In thousands of Canadian dollars)                 Three months ended June 30,   Six months ended June 30,   2025   2024   Change     2025   2024   Change     $   $   $     $   $   $                   Property revenues 42,022   43,910   (1,888 )   86,776   85,507   1,269   Property expenses (9,872 ) (12,293 ) 2,421     (22,536 ) (24,353 ) 1,817   NOI 32,150   31,617   533     64,240   61,154   3,086   Add/(Deduct):               Amortization of tenant incentives and leasing costs 267   384   (117 )   627   653   (26 ) Straight-line adjustments of rent (1,107 ) (1,203 ) 96     (2,152 ) (2,367 ) 215   Development and expansion (125 ) 45   (170 )   (402 ) (26 ) (376 ) Acquisitions (881 ) (314 ) (567 )   (4,331 ) (1,578 ) (2,753 ) Disposals 152   (2,026 ) 2,178     (274 ) (3,975 ) 3,701   Termination fees and tenant reimbursed capital improvements (1,614 ) (102 ) (1,512 )   (2,285 ) (137 ) (2,148 ) Same Property NOI 28,842   28,401   441     55,423   53,724   1,699                   Industrial same property NOI 28,520   27,741   779     54,537   52,276   2,261   ADJUSTED EBITDA (In thousands of Canadian dollars) Trailing twelve months ended June 30,       2025   2024   Change       $   $   $               Net income 29,212   166,287   (137,075 )   Add (deduct):         Net interest expense 54,009   50,315   3,694     Distributions on Class B LP Units 14,901   15,152   (251 )   Fair value adjustments (1) 22,300   (118,684 ) 140,984     Amortization expense (1)(2) (3,151 ) (3,633 ) 482     Loss on disposal of investment properties 1,485   251   1,234     Unrealized foreign exchange loss (gain) (211 ) 394   (605 )   Income from development property 2,981   661   2,320     Non-recurring personnel transition costs 125   1,945   (1,820 )   Non-recurring costs related to asset dispositions 208   -   208     Adjusted EBITDA 121,859   112,688   9,171     (1)   Includes equity accounted investments adjustments.(2)   Includes amortization of straight line rent, tenant improvement, and leasing commissions. ADJUSTED NET DEBT       (In thousands of Canadian dollars) June 30,   December 31,     2025   2024     $   $   Current and non-current:     Mortgages payable 583,037   590,292   Credit facilities 665,368   649,836   Lease liabilities 10,665   10,715   Liabilities associated with assets held for sale 5,340   40,227   Total indebtedness 1,264,410   1,291,070   Less: Unrestricted cash (5,640 ) (11,532 ) Less: Additions to properties under development (114,241 ) (79,811 ) Adjusted net debt 1,144,529   1,199,727   The post Nexus Industrial REIT Announces Second Quarter 2025 Financial Results appeared first on ForexTV.

Ike Shehadeh at the Hollywood Ike's Love & Sandwiches From sports legends to music icons to Iron Chefs, Ike has been teaming up with his favorite humans to create bold, crave-worthy sandwiches that are just as unforgettable as the stars behind them. Hey Now, You’re An All Star (#1999) A worldwide hit, this sandwich features a melody of spicy and savory with halal chicken, bacon, red pesto, sriracha, wasabi mayo, and pepper jack cheese. Los Angeles, CA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- This August, Ike’s Love & Sandwiches is turning up the flavor, the star power, and the Dirty Sauce to declare what we’ve always known: Ike’s deserves its own holiday. So, we’re making one. All month long, Ike’s is celebrating “National Ike’s Month” with new special offers and promos every week, just for Ike’s Rewards members. All of them leading up to a brand-new juicy Ike-conic collab sandwich reveal.   From sports legends to music icons to Iron Chefs, Ike has been teaming up with his favorite humans to create bold, crave-worthy sandwiches that are just as unforgettable as the stars behind them. These aren’t just sandwiches, they’re full-on flavor quests.  “There are a lot of famous people out there, but these are some of the coolest friends I’ve got, and they’ve got incredible taste,” said Ike Shehadeh, founder of Ike’s Love & Sandwiches. “I love every one of these sandwiches and every one of these people. National Ike’s Month is my way of saying: These hits were made with love. Come taste what we created together.” Featured Ike-conic Collabs include: Michael Clifford’s SIDEQUEST (#1337): A fried chicken banger loaded with BBQ, Voodoo Chips, and Dirty Sauce, straight from the popstar. Hey Now, You’re An All Star (#1999): A worldwide hit, this sandwich features a melody of spicy and savory with halal chicken, bacon, red pesto, sriracha, wasabi mayo, and pepper jack cheese. Howie Eat It (#562): Howie Mandel’s sandwich is no joke with Tuna, Godfather Sauce, Dirty Sauce and Pepperjack Cheese. Howie personally recommends it on Ike’s French bread. Rockin’ Roenick (#2797): Pro hockey icon Jeremy Roenick delivers a flavor slapshot of turkey, chicken, bacon, red pesto, and more. Mitch the Rock Richmond (#2802): An all-vegan slam dunk with meatballs, mushrooms, and major BBQ vibes. Mr. Irrelevant by Cat Cora (#9999): Iron Chef meets Dirty Sauce in this chip-loaded, ham and bacon-packed flavor bomb. Every Monday, Ike’s Reward Members will get a notification about new special offers for that week. And to close out National Ike’s Month, Ike will drop a brand-new celebrity collab sandwich. Follow @ikessandwiches on Instagram and TikTok so you don’t miss the big reveal. With over 1,000 sandwiches and more than 100 celebrity collabs, Ike’s isn’t just the most creative sandwich shop in the game, it’s a flavor playground with something for everyone, whether you’re meat-loving, vegan, or just Dirty Sauce-obsessed. All sandwiches come on Ike’s signature Dutch Crunch bread, toasted with Dirty Sauce baked right in. Ready to celebrate National Ike’s Month? Order online at ikessandwiches.com or through the Ike’s app to celebrate in the most delicious way possible. Unlock the $10 Ike-conic Collabs pricing. Follow @ikessandwiches for surprise giveaways, celeb shoutouts, and more ways to celebrate Ike’s all month long. # # # # # About Ike’s Love & Sandwiches In 2007, a rebel with a dream opened a small sandwich shop in San Francisco’s Castro District. Lines around the block, craveable secret ingredients and inventive flavor combinations sparked a phenomenon spreading love and sandwiches across the country. Whether you’re a meat lover, vegetarian, vegan, halal, or gluten-free, your first Ike’s sandwich sets you on an epic quest to try all the endless combinations and over 999 signature sandwiches. Our Dutch Crunch bread paired with Ike’s exclusive “Dirty Sauce,” a creamy garlic aioli toasted right into the bread, is as iconic as Ike Shehadeh himself. Ike’s cartoon caricature can be seen as guests explore the menu of eclectically named sandwiches including tributes to local celebrities and athletes. Get your Ike’s creation and earn rewards today at ikessandwich.com.  Help Ike’s share the love and sandwiches on Instagram, Facebook and TikTok. Attachments Ike Shehadeh at the Hollywood Ike's Love & Sandwiches Hey Now, You’re An All Star (#1999) CONTACT: Brian Rosman DOG AND A DUCK 323.443.7780 brian@dogandaduck.com The post August Is for The Icons: Ike’s Celebrates National Ike’s Month with Ike-Conic Collabs All Month Long appeared first on ForexTV.

Wichita, KS , Aug. 11, 2025 (GLOBE NEWSWIRE) -- The Grounds Guys of Wichita announces a significant milestone in customer satisfaction, surpassing 200 Google reviews with an outstanding 4.8-star rating. This achievement reflects the company's commitment to excellence in landscaping and outdoor services throughout the greater Wichita area since its founding in 2009. Baker Family, Owners of The Grounds Guys of Wichita "Reaching this milestone is truly humbling and represents the incredible dedication of our team and the trust our community has placed in us," said Jeff Baker, owner of The Grounds Guys of Wichita. "I want to thank our hardworking team who brings professionalism and expertise to every project, and our loyal customers throughout Wichita who have supported us for over 15 years. This achievement belongs to all of them." Since opening in 2009, The Grounds Guys of Wichita has established itself as a premier provider of comprehensive landscaping solutions across Wichita and surrounding communities. The company specializes in lawn sprinkler systems, irrigation installation and repair, sod installation, and commercial irrigation services, while also offering full-service landscaping, including ongoing maintenance programs and lawn drainage. The company's extensive service area includes Andale, Andover, Augusta, Bel Aire, Benton, Burns, Cassoday, Cheney, Colwich, Derby, Douglass, El Dorado, Eureka, Goddard, Haysville, Kechi, Leon, Maize, McConnell AFB, Mulvane, Potwin, Rosalia, Rose Hill, Sedgwick, Towanda, Valley Center, and Wichita. "We strive to be the best landscapers Wichita has to offer, and our local team understands that yards can be very different depending on where you live in Wichita," Baker explained. "That's why we cover everything, from lawn drainage to installing complete irrigation systems in Wichita and surrounding areas. We create customized plans for each homeowner because no two properties are exactly alike." The Grounds Guys of Wichita distinguishes itself through superior technical expertise and professional credentials. The company employs backflow-certified and licensed irrigation technicians, with the lead technician having received specialized training at Hunter Industries Headquarters in San Marcos, California. The team holds a master irrigator's license for Kansas and maintains a business commercial applicator's license with licensed applicators. This technical excellence, combined with their comprehensive approach to landscaping in Wichita, has earned The Grounds Guys recognition as a trusted partner for both residential and commercial properties throughout the region. "Each of these 200-plus reviews represents a family or business that trusted us with their outdoor space," said Baker. "We're grateful for every opportunity to serve our community and proud that our commitment to quality and professionalism continues to earn recognition from our clients." The company's vision centers on being recognized as the customer's preferred choice for premium grounds care services, building a reputation for professionalism and excellence that inspires complete confidence in their landscaping and irrigation services in Wichita and nearby. Homeowners and businesses interested in experiencing The Grounds Guys' award-winning service can visit https://www.groundsguys.com/east-wichita/ or call (316) 854-1443 to request service, or follow The Grounds Guys of Wichita on social media for the latest information and homeowner tips. The Grounds Guys of Wichita Award-winning Landscaping & Irrigation Service Team About The Grounds Guys of Wichita The Grounds Guys of Wichita is a locally owned and operated business providing professional landscaping and outdoor services since 2009. The company combines technical expertise with comprehensive service offerings to create and maintain beautiful, functional outdoor spaces for residential and commercial clients throughout the greater Wichita area. With specialized focus on irrigation systems, sod installation, and commercial irrigation alongside full-service landscaping, The Grounds Guys continues to earn its reputation for consistent excellence and professional service.  Press inquiries The Grounds Guys of Wichita https://www.groundsguys.com/east-wichita/ Desirae Benington eastwichita@groundsguys.com (316) 854-1443 1816 N Wabash AveWichita, KS 67214 The post The Grounds Guys of Wichita Celebrates Customer Service Excellence with 200+ Google Reviews and 4.8-Star Rating appeared first on ForexTV.

Consolidated revenue for Q2 2025 grew 3.5% year-over-year, to $119.1 million, driven by strength in the Logistics segment. Logistics revenue increased 16.8% year-over-year, fueled by 19% increase in US volume, highlighting growth of new customers and the scalability of Titanium’s asset-light model. Enhanced financial flexibility with $12.4 million in debt reduction, $16.4 million cash on hand. BOLTON, Ontario, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Titanium Transportation Group Inc. ("Titanium" or the "Company") (TSX:TTNM, OTCQX:TTNMF), a leading provider of transportation and logistics services throughout North America, is pleased to report its financial results for the three and six-month period ended June 30, 2025. All amounts are in Canadian currency. Q2 2025 Financial and Business Highlights Compared with Q2 2024 Consolidated revenue of $119.1 million, a 3.5% increase, compared to $115.1 million in Q2 2024 Consolidated EBITDA1 of $10.0 million, compared to $10.2 million in Q2 2024, with consolidated EBITDA Margin1 of 9.3% Cash flow from operating activities increased to $10.9 million, compared to $9.4 million in Q2 2024 Truck Transportation segment revenue of $54.4 million, down 8.5% compared to $59.4 million in Q2 2024, reflective of the strategic rationalization of fleet operations in latter half of 2024 to eliminate unprofitable service offerings. Logistics segment revenue of $65.6 million, up 16.8% compared to $56.2 million in Q2 2024 Fully diluted adjusted net income per share from continuing operations of $0.02, compared to fully diluted adjusted net loss per share from continuing operations of $0.00 in Q2 2024. Cash was $16.4 million on June 30, 2025. Repaid $10.1 million in loans and finance leases. “Titanium continued to show resiliency in Q2 2025, achieving 3.5% year-over-year revenue growth amidst persistent macroeconomic challenges,” said Ted Daniel, Chief Executive Officer, Titanium Transportation Group. “Our Logistics segment continued to be the primary growth driver, with revenue up nearly 17% fueled by 19% increase in US volume, a testament to our strong customer wins and the scalability of our asset-light model. In Truck Transportation, we executed a disciplined pricing strategy returning the segment to positive operating income despite a 15% decline in volumes due to our proactive exit from non-core service lines.” “In the current operating environment, financial discipline remains paramount. We reduced loans and lease liabilities by $10.1 million in the quarter, strengthened our net debt-to-equity ratio, and ended with a solid cash position of $16.4 million. These actions enhance our financial flexibility and position us to capitalize on strategic opportunities as market dynamics improve. Our continued investments in technology and operational efficiency are critical levers to protect margins and drive long-term, profitable growth,” added Mr. Daniel. Q2 YTD 2025 Financial Highlights Compared with Q2 YTD 2024 Consolidated revenue of $240.5 million, compared to $228.0 million in Q2 2024. EBITDA of $18.8 million, compared to $19.9 million and EBITDA Margin1 of 8.7%. Logistics segment revenue of $131.7 million, up 17.2% compared to $112.4 million. EBITDA of $6.5 million and EBITDA Margin of 5.5%. Truck Transportation segment revenue of $110.5 million. EBITDA of $14.2 million with an EBITDA Margin of 14.5%. Summary of Q2 2025 Financial Results (in thousands $CAD)   Q2 2025 Q2 2024 % Change   YTD 2025 YTD 2024 % Change Consolidated Results Revenue 119,123   115,085   3.5 %   240,528   228,006   5.5 % EBITDA1 9,965   10,218   (2.5 %)   18,761   19,902   (5.7 %) EBITDA margin1 9.3 % 10.1 %     8.7 % 9.9 %   Net Income 1,019   (2,329 ) 143.8 %   (2,368 ) (1,649 ) (43.6 %) Net Income per share 0.02   (0.05 )     ($0.05 ) ($0.04 )   Net income (loss) from continuing operations 1,019   (113 ) 1,001.8 %   (2,368 ) (1,689 ) (40.2 %) Net income (loss) per share from continuing operations 0.02   (0.00 )     (0.05 ) (0.04 )                   Truck Transportation               Revenue 54,405   59,450   (8.5 %)   110,492   116,801   (5.4 %) EBITDA1 7,646   7,961   (4.0 %)   14,208   15,676   (9.4 %) EBITDA margin1 15.7 % 15.5 %     14.5 % 15.6 %                   Logistics               Revenue 65,619   56,167   16.8 %   131,720   112,390   17.2 % EBITDA1 3,180   3,135   1.4 %   6,496   6,204   4.7 % EBITDA margin1 5.4 % 6.2 %     5.5 % 6.1 %   EBITDA to Net Income (in thousands $CAD)   Q2 2025 Q2 2024 Net Income 1,019   (2,329 ) Add(deduct)     Gain on sale of equipment (10 ) (1,499 ) Finance costs 2,583   3,223   Finance income (84 ) (97 ) Foreign exchange (633 ) 511   Income taxes 763   (650 ) Discontinued operations -   2,216   Operating Income 3,638   1,375   Depreciation 6,327   8,395   Amortization of intangible assets -   448   EBITDA 9,965   10,218   2025 Outlook Ted Daniel, Chief Executive Officer, Titanium Transportation Group, noted, “As we head into the second half of 2025, freight markets remain challenging, but we are encouraged by sequential improvements and early signs of stabilization in certain regions. While broader market recovery is likely to be gradual and uneven, Titanium’s strategic focus remains clear: Protect margins, maintain balance sheet strength, and leverage our people, technology, and scalable logistics network to navigate this cycle with discipline and agility.” “Our asset-light logistics model, prudent capital allocation, and strong operational execution continue to differentiate us. We remain committed to reducing debt and selectively investing in high-return growth opportunities that strengthen our competitive position. As industry fundamentals stabilize, we are confident that Titanium is positioned to emerge as a stronger, more efficient operator, delivering sustainable growth and long-term value for shareholders,” added Mr. Daniel. 2025 Guidance Amid ongoing macroeconomic uncertainty, freight market volatility, and unpredictable tariff backdrop, Titanium Transportation estimates Revenue of $115 million to $120 million, and EBITDA % of 8.5% - 9.5% for the next quarter. The Company remains confident in the fundamentals of the business and is focused on operational execution, margin preservation and cash generation. Conference Call The Company will also hold a conference call for analysts and investors with Ted Daniel, President and Chief Executive Officer, Tuesday, August 12, 2025 at 8:00 a.m. Eastern Time, to discuss these results. Details of the conference call: Date: Tuesday, August 12, 2025 Time: 8:00 a.m. ETNorth America dial-in number: 1-800-717-1738International dial-in number: 1-289-514-5100 A replay of the conference call can be accessed until midnight on August 26, 2025. Details of the replay: North America dial-in number: 1-888-660-6264International dial-in number: 1-289-819-1325Conference ID: 40251Passcode: 40251# For more details, or visit Titanium’s investor relations website at https://www.ttgi.com/investors About Titanium Titanium is a leading North American transportation company with asset-based trucking operations and logistics brokerages servicing Canada and the United States, with approximately 850 power units, 3,000 trailers and 1,300 employees and independent owner operators. Titanium provides truckload, dedicated, and cross-border trucking services, logistics, and warehousing and distribution to over 1,000 customers. Titanium has established both asset-based and brokerage operations in Canada and the U.S. with eighteen (18) locations. Titanium is a recognized purchaser of asset-based trucking companies, having completed thirteen (13) transactions since 2011. Titanium ranked among top 500 companies in the inaugural Financial Times Americas’ Fastest Growing Companies in 2020. The Company was ranked by Canadian Business as one of Canada's Fastest Growing Companies for eleven (11) consecutive years. For four (4) consecutive years, Titanium has also been ranked one of Canada’s Top Growing Companies by the Globe and Mail’s Report on Business of Canada. Titanium is listed on the Toronto Stock Exchange under the symbol “TTNM" and “TTNMF” on the OTCQX. NON-IFRS FINANCIAL MEASURES The following financial measures do not have any standardized meaning under IFRS and may not be comparable to similar measures employed by other companies: "Earnings before interest, income taxes, depreciation and amortization" ("EBITDA") is calculated as net income before depreciation, amortization, asset impairments, gains or losses on the sale of equipment, finance income and costs, gains or losses on foreign exchange, income tax expense, transaction costs, accelerated customer list amortization and goodwill impairment. "EBITDA margin" is calculated as EBITDA as a percentage of revenue before fuel surcharge. “Free cash flow” is calculated as cash flow from operations plus proceeds from finance lease receivables and proceeds from disposition, less capital expenditures. Management of the Company believes that these financial measures are useful for investors and other readers, when used in conjunction with other IFRS financial measures, as they are measurers used internally by management to evaluate performance. However, these financial measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of financial performance prepared in accordance with IFRS. CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS Certain statements contained in this press release constitute forward-looking information within the meaning of Canadian securities laws. Forward-looking statements are provided for the purposes of assisting the reader in understanding Titanium's current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. Forward-looking information may relate to Titanium's future outlook and anticipated events, and may include statements regarding the financial position, business strategy, budgets, litigation, projected costs, capital expenditures, financial results, taxes and plans and objectives of or involving Titanium. Particularly, statements regarding future acquisitions, the availability of credit, performance, achievements, prospects or opportunities for Titanium or the industry in which it operates are forward-looking statements. In some cases, forward-looking information can be identified by terms such as "may", "might", "will", "could", "should", "would", "occur", "expect", "plan", "anticipate", "believe", "intend", "seek", "aim", "estimate", "target", "project", "predict", "forecast", "potential", "continue", "likely", "schedule", or the negative thereof or other similar expressions concerning matters that are not historical facts. Information contained in forward-looking statements is based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including management's perceptions of historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances. While management considers these assumptions to be reasonable based on currently available information, they may prove to be incorrect. The forward-looking statements made in this press release are dated, and relate only to events or information, as of the date of this press release. Except as specifically required by law, Titanium undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release. Contact Information Titanium Transportation Group Inc.Ted Daniel, CPA, CAChief Executive Officer(905) 266-3011ted.daniel@ttgi.comwww.ttgi.com For Investors James Bowen416-519-9442James.Bowen@loderockadvisors.com The post Titanium Reports Q2 2025 with 16.8% Logistics Revenue Increase; Further Debt Reduction Strengthens Balance Sheet appeared first on ForexTV.

CALGARY, Alberta, Aug. 11, 2025 (GLOBE NEWSWIRE) -- TSX-V: CWV: Crown Point Energy Inc. (“Crown Point”, the “Company” or "we") today announced its financial and operating results for the three and six months ended June 30, 2025. Selected information is outlined below and should be read in conjunction with the Company’s June 30, 2025 unaudited condensed interim consolidated financial statements and management’s discussion and analysis (“MD&A”) that are being filed with Canadian securities regulatory authorities and will be made available under the Company’s profile at www.sedarplus.ca and on the Company’s website at www.crownpointenergy.com. All dollar figures are expressed in United States dollars ("USD") unless otherwise stated. In the following discussion, the three months ended June 30, 2025 may be referred to as “Q2 2025”. The comparative three months ended June 30, 2024, may be referred to as “Q2 2024”. Q2 2025 SUMMARY During Q2 2025, the Company: Reported net cash provided by operating activities and funds flow used in operating activities of $5.6 million and $5.0 million, respectively, as compared to Q2 2024 when the Company reported net cash and funds flow used in operating activities of $1.5 million and $1.4 million, respectively; Earned $22.2 million of oil and natural gas sales revenue on total average daily sales volumes of 4,083 BOE per day, which was higher than the $5.6 million of oil and natural gas sales revenue earned on total average daily sales volumes of 1,340 BOE per day in Q2 2024 due to the oil sales from the Santa Cruz Concessions that were acquired on October 31, 2024; Received an average of $3.45 per mcf for natural gas and $67.26 per bbl for oil compared to $3.71 per mcf for natural gas and $65.50 per bbl for oil received in Q2 2024; Reported an operating netback of $(7.50) per BOE¹ down from $(4.22) per BOE in Q2 2024; Obtained $13.1 million of working capital and overdraft loans, and repaid $5.5 million of notes payable and $8.8 million of working capital and overdraft loans; Reported loss before taxes of $9.1 million, tax recovery of $3.4 million and net loss of $5.7 million as compared to Q2 2024 when the Company reported loss before taxes of $4.3 million, tax recovery of $1.3 million and net loss of $3.1 million; Reported a working capital deficit² of $50.7 million and current liabilities of $74.5 million. SUBSEQUENT EVENTS Subsequent to June 30, 2025 the Company: Repaid $5.62 million of working capital loans and overdraft loans. Repaid $3.4 million principal amount of Series IV Notes and $2.1 million principal amount of Series III Notes. Issued a total of $25 million principal amount of unsecured fixed-rate Series VII Notes, denominated in USD and payable in ARS in two equal installments on January 11, 2027 and July 11, 2027. Series VII Notes accrue interest at a fixed rate of 13% per annum, payable every six months in arrears from the issue date. UPDATE ON CHUBUT ACQUISITION In June 2025, Crown Point entered into agreements with Tecpetrol S.A., YPF S.A. and Pampa Energía S.A. (collectively the “Sellers”), to acquire the Sellers’ aggregate 95% operated interest in the El Tordillo, La Tapera and Puesto Quiroga hydrocarbons exploitation concessions (the "Chubut Concessions") and certain related infrastructure. The aggregate base purchase price payable by the Company to the Sellers is approximately $57.9 million in cash, subject to customary closing adjustments, plus contingent consideration of up to $3.5 million in cash. During the six months ended June 30, 2025, the Company made a $643,998 acquisition deposit related to Pampa's working interest in the Chubut Concessions and the stamp tax on the transactions. In July 2025, the Company made $8.06 million and $1.3 million of acquisition deposits to Tecpetrol and YPF, respectively, related to their working interests in the Chubut Concessions. The acquisition of each Seller’s working interest is expected to close in the third quarter of 2025. Completion of the acquisitions is subject to, among other things, the receipt of all necessary regulatory and Provincial approvals, including the approval of the TSX Venture Exchange, and other customary closing conditions. For further details on the proposed acquisition, see the Company's press release issued on June 9, 2025, a copy of which is available at www.sedarplus.ca. APPOINTMENT OF NEW DIRECTOR The Company is pleased to announce that, effective today, Mr. Juan Llado has been appointed as a director of the Company by Crown Point's board of directors. Juan is an attorney and has held various positions during his career in the financial services, insurance and energy sectors, including as: CEO of Life Seguros de Personas y Patrimoniales S.A. (formerly MetLife Argentina); CEO of Life Group Seguros S.A. (formerly Prudential Argentina); Legal & Compliance Director at Grupo ST S.A.; Legal Affairs Manager and Trust Banking Manager at Banco de Servicios y Transacciones S.A.; Legal Affairs Manager at Orígenes Seguros; and Legal Affairs Manager at Credilogros Compañía Financiera S.A. Juan is currently a member of the Executive Committee of Grupo ST S.A. and serves on the Board of Directors of the following companies: Grupo ST S.A.; Banco de Servicios y Transacciones S.A.; ST Securities S.A.; Best Leasing S.A.; Life Seguros S.A.; Liminar Energía S.A. (which is the Company's controlling shareholder); and Crown Point Energía S.A. (a wholly-owned subsidiary of the Company). Juan has a Bachelor of Laws degree from the University of Buenos Aires and a Master's Degree in Finance from the Universidad del CEMA. OPERATIONAL UPDATE Santa Cruz Concessions During Q2 2025, Piedra Clavada Concession oil production averaged 1,902 bbls of oil per day and Koluel Kaike Concession oil production averaged 1,060 bbls of oil per day. During Q2 2025, the Company performed workovers on twelve oil producing wells. Tierra del Fuego Concession ("TDF" or "TDF Concessions") During Q2 2025, San Martin oil production averaged 398 (net 192) bbls of oil per day; Las Violetas concession natural gas production averaged 8,028 (net 3,880) mcf per day and associated oil production averaged 198 (net 96) bbls of oil per day. Mendoza Concessions ("Mendoza Concessions") Oil production for Q2 2025 averaged 766 (net 383) bbls of oil per day from the Chanares Herrados Concession ("CH Concession") and 170 (net 85) bbls of oil per day from the Puesto Pozo Cercado Oriental Concession. During Q2 2025, the Company performed workovers on five oil producing wells in the CH Concession. OUTLOOK The Company’s capital spending for fiscal 2025 is budgeted at approximately $12.3 million, of which $10.4 million is allocated to the Santa Cruz Concessions for well workovers, facilities improvements and a drilling campaign comprised of 2 wells; $1.1 million is for well workovers, facilities improvements and optimization in the Mendoza Concessions, and $0.8 million is for testing of the gas bearing sandstone layers of the Neuquen Group at Cerro de Los Leones. During the June 2025 period, the Company incurred $0.9 million of capital expenditures in the Mendoza Concessions and $3.3 million of capital expenditures in the Santa Cruz Concessions. RESULTS OF OPERATIONS Sales Volumes     Three months ended Six months ended     June 30 June 30     2025 2024 2025 2024   Total sales volumes (BOE) 371,484   121,897   756,738   240,377     Oil bbls per day 3,422   727   3,511   813     NGL bbls per day 16   13   12   19     Natural gas mcf per day 3,867   3,597   3,947   2,933     Total BOE per day 4,083   1,340   4,181   1,321   Operating Netback (1)     Three months ended Six months ended     June 30 June 30     2025 2024 2025 2024         Per BOE     Per BOE     Per BOE     Per BOE   Oil and natural gas sales revenue ($) 22,208,934   59.78   5,584,314   45.81   45,717,428   60.41   11,685,400   48.61     Export tax ($) (101,251 ) (0.27 ) (80,779 ) (0.66 ) (193,755 ) (0.26 ) (232,795 ) (0.97 )   Royalties and turnover tax ($) (3,963,657 ) (10.67 ) (1,028,669 ) (8.44 ) (8,163,142 ) (10.79 ) (2,045,091 ) (8.51 )   Operating costs ($) (20,927,925 ) (56.34 ) (4,988,866 ) (40.93 ) (39,180,510 ) (51.78 ) (9,241,577 ) (38.45 )   Operating netback (1) ($) (2,783,899 ) (7.50 ) (514,000 ) (4.22 ) (1,819,979 ) (2.42 ) 165,937   0.68   (1) "Operating netback" is a non-IFRS measure. “Operating netback per BOE” is a non-IFRS ratio. See "Non-IFRS and Other Financial Measures". About Crown Point Crown Point Energy Inc. is an international oil and gas exploration and development company headquartered in Buenos Aires, Argentina, incorporated in Canada, trading on the TSX Venture Exchange and operating in Argentina. Crown Point’s exploration and development activities are focused in four producing basins in Argentina, the Golfo San Jorge basin in the Province of Santa Cruz, the Austral basin in the province of Tierra del Fuego, and the Neuquén and Cuyo (or Cuyana) basins in the province of Mendoza. Crown Point has a strategy that focuses on establishing a portfolio of producing properties, plus production enhancement and exploration opportunities to provide a basis for future growth. Advisory Non-IFRS and Other Financial Measures: Throughout this press release and in other materials disclosed by the Company, we employ certain measures to analyze financial performance, financial position, and cash flow. These non-IFRS and other financial measures do not have any standardized meaning prescribed by IFRS and therefore may not be comparable to similar measures provided by other issuers. The non-IFRS and other financial measures should not be considered to be more meaningful than financial measures which are determined in accordance with IFRS, such as net income (loss), oil and natural gas sales revenue and net cash (used) provided by operating activities as indicators of our performance. "Operating Netback" is a non-IFRS measure. Operating netback is comprised of oil and natural gas sales revenue less export tax, royalties and turnover tax and operating costs. Management believes this measure is a useful supplemental measure of the Company’s profitability relative to commodity prices. See “Operating Netback” for a reconciliation of operating netback to oil and natural gas sales revenue, being our nearest measure prescribed by IFRS. "Operating netback per BOE" is a non-IFRS ratio. Operating netback per BOE is comprised of operating netback divided by total BOE sales volumes in the period. Management believes this measure is a useful supplemental measure of the Company’s profitability relative to commodity prices. In addition, management believes that operating netback per BOE is a key industry performance measure of operational efficiency and provide investors with information that is also commonly presented by other crude oil and natural gas producers. Operating netback is a non-IFRS measure. See "Operating Netback" for the calculation of operating netback per BOE. "Working capital" is a capital management measure. Working capital is comprised of current assets less current liabilities. Management believes that working capital is a useful measure to assess the Company's capital position and its ability to execute its existing exploration commitments and its share of any development programs. See “Summary of Financial Information” for a reconciliation of working capital to current assets and current liabilities, being our nearest measures prescribed by IFRS. Abbreviations and BOE Presentation: "bbl" means barrel; "bbls" means barrels; "BOE" means barrels of oil equivalent; "mcf” means thousand cubic feet; "mmcf" means million cubic feet, "NGL" means natural gas liquids; "UTE" means Union Transitoria de Empresas, which is a registered joint venture contract established under the laws of Argentina and "WI" means working interest. All BOE conversions in this press release are derived by converting natural gas to oil in the ratio of six mcf of gas to one bbl of oil. BOE may be misleading, particularly if used in isolation. A BOE conversion ratio of six mcf of gas to one bbl of oil (6 mcf: 1 bbl) is based on an energy equivalency conversion method primarily applicable at the burner tip and does not represent a value equivalency at the wellhead. Given that the value ratio based on the price of crude oil as compared to natural gas in Argentina from time to time may be different from the energy equivalency conversion ratio of 6:1, utilizing a conversion on a 6:1 basis may be misleading as an indication of value. Forward-looking Information: This document contains forward-looking information. This information relates to future events and the Company’s future performance. All information and statements contained herein that are not clearly historical in nature constitute forward-looking information. Such information represents the Company’s internal projections, estimates, expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance. This information involves known or unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. In addition, this document may contain forward-looking information attributed to third party industry sources. Crown Point believes that the expectations reflected in this forward-looking information are reasonable; however, undue reliance should not be placed on this forward-looking information, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. This press release contains forward-looking information concerning, among other things, the following: under "Update on Chubut Acquisition", our expectations regarding the terms, conditions and timing for closing the proposed acquisition of the Chubut Concessions; under “Outlook”, our estimated capital expenditure budget for fiscal 2025, and the capital expenditures that we intend to make in our concessions during the balance of 2025; and under “About Crown Point”, all elements of the Company’s business strategy and focus. The reader is cautioned that such information, although considered reasonable by the Company, may prove to be incorrect. Actual results achieved during the forecast period will vary from the information provided in this document as a result of numerous known and unknown risks and uncertainties and other factors. A number of risks and other factors could cause actual results to differ materially from those expressed in the forward-looking information contained in this document including, but not limited to, the following: the risk that the tariffs imposed or threatened to be imposed by the U.S. on other countries, and retaliatory tariffs imposed or threatened to be imposed by other countries on the U.S., will trigger a broader global trade war which could have a material adverse effect on global economies, and by extension the Argentine oil and natural gas industry and the Company, including by decreasing demand for (and the price of) oil and natural gas, disrupting supply chains, increasing costs, causing volatility in global financial markets, and limiting access to (and/or increasing the cost of) financing; that the Company is unable to truck oil to the Enap refinery and/or the Rio Cullen marine terminal and/or that the cost to do so rises and/or becomes uneconomic; that the price received by the Company for its oil is at a substantial discount to the Brent oil price; that the Company is not able to meet its obligations as they become due and continue as a going concern; that the Company is unable to complete the proposed acquisition of the Chubut Concessions on the terms described herein or at all, whether due to the inability of the Company to obtain financing to fund the purchase price, obtain requisite regulatory approvals, satisfy applicable conditions precedent, or otherwise; risks associated with the insolvency and/or bankruptcy of our joint venture partners and/or the operators of the concessions in which we have an interest, including the risk that any such insolvency and/or bankruptcy has an adverse effect on one of our UTEs, one of our concessions and/or the Company; and the risks and other factors described under “Business Risks and Uncertainties” in our MD&A and under “Risk Factors” in the Company’s most recently filed Annual Information Form, which is available for viewing on SEDAR+ at www.sedarplus.ca. With respect to forward-looking information contained in this document, the Company has made assumptions regarding, among other things: that the Company will complete the proposed acquisition of the Chubut Concessions on the terms described herein on a timely basis, including the ability of the Company to obtain the requisite financing to fund the purchase price on acceptable terms, obtain all requisite regulatory approvals and satisfy all applicable conditions precedent; the ability and willingness of OPEC+ nations and other major producers of crude oil to balance crude oil production levels and thereby sustain higher global crude oil prices; that our joint venture partners and the operators of our concessions that we do not operate will honour their contractual commitments in a timely fashion and will not become insolvent or bankrupt; the impact of inflation rates in Argentina and the devaluation of the Argentine peso against the USD on the Company; the impact of increasing competition; the general stability of the economic and political environment in which the Company operates, including operating under a consistent regulatory and legal framework in Argentina; future oil, natural gas and NGL prices (including the effects of governmental incentive programs and government price controls thereon); the timely receipt of any required regulatory approvals; the ability of the Company to obtain qualified staff, equipment and services in a timely and cost efficient manner; drilling results; the costs of obtaining equipment and personnel to complete the Company’s capital expenditure program; the ability to operate the projects in which the Company has an interest in a safe, efficient and effective manner; that the Company will not pay dividends for the foreseeable future; the ability of the Company to obtain financing on acceptable terms when and if needed and continue as a going concern; the ability of the Company to service its debt repayments when required; field production rates and decline rates; the ability to replace and expand oil and natural gas reserves through acquisition, development and exploration activities; the timing and costs of pipeline, storage and facility construction and expansion and the ability of the Company to secure adequate product transportation; currency, exchange, inflation and interest rates; the regulatory framework regarding royalties, taxes and environmental matters in Argentina; and the ability of the Company to successfully market its oil and natural gas products. Management of Crown Point has included the above summary of assumptions and risks related to forward-looking information included in this document in order to provide investors with a more complete perspective on the Company’s future operations. Readers are cautioned that this information may not be appropriate for other purposes. Readers are cautioned that the foregoing lists of factors are not exhaustive. The forward-looking information contained in this document are expressly qualified by this cautionary statement. The forward-looking information contained herein is made as of the date of this document and the Company disclaims any intent or obligation to update publicly any such forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable Canadian securities laws. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. _____________________________________¹ Non-IFRS financial ratio. See "Non-IFRS and Other Financial Measures".² Capital management measure. See "Non-IFRS and Other Financial Measures". CONTACT: For inquiries please contact: Marisa Tormakh Vice-President, Finance & CFO Ph: (403) 232-1150 Crown Point Energy Inc. mtormakh@crownpointenergy.com The post Crown Point Announces Operating and Financial Results for the Three and Six Months Ended June 30, 2025 and Appointment of New Director appeared first on ForexTV.

FORT WORTH, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tandy Leather Factory, Inc. (Nasdaq: TLF) today announced the Company’s financial results for the second fiscal quarter of 2025. Highlights from second quarter 2025: Revenues were $17.8 million, up 2.8% from 2024 Generated operating income of $0.1 million Net loss of $0.2 million versus income of $0.1 million in 2024 Gross margins of 59.5%, up from 58.0% in 2024 Operating expenses $10.5 million, up 5.5% from 2024 Adjusted EBITDA* (from operations) of $0.3 million Ended quarter with $16.4 million of cash and cash equivalents Tandy Leather Factory’s second quarter sales were $17.8 million in 2025, up from $17.3 million in 2024. Second quarter 2025 gross profit was $10.6 million, up from $10.0 million in 2024. As of June 30, 2025, the Company held $16.4 million of cash and cash equivalents, up from $13.3 million a year earlier; this increase reflects the net proceeds from the sale of the Company’s corporate headquarters in January 2025 (the “HQ Sale”), offset by the payment of a special dividend to stockholders in the first quarter of approximately $12.7 million. The Company held inventory of $36.2 million, up from $35.6 million as of December 31, 2024. The Company had basic and diluted net losses in the quarter of $0.02 per share, versus $0.01 basic and diluted net income per share in the prior year. Johan Hedberg, Chief Executive Officer of the Company, said, “We were pleased to have grown our sales and margin dollars in the second quarter, despite the challenging environment and economic uncertainty.   These gains were driven primarily by increased sales productivity in our U.S. retail stores. Our operating expenses increased as expected, driven largely by the shift to leasing our headquarters and distribution center spaces (which we owned during 2024) and other costs related to our now-in-progress move of those facilities in the third quarter; we still expect those costs to lead to operating losses for full year 2025. We hope to continue our sales momentum through the third quarter, while noting that newly-announced tariffs—which did not meaningfully affect our product costs in the second quarter—may impact our sales and profits going forward.” Investors are encouraged to send their questions to the Company’s investor relations hotline at investorrelations@tandyleather.com. * Adjusted EBITDA is a non-GAAP financial measure that the Company believes helps investors to compare its operating performance to that of other companies. The following is a reconciliation of the Company’s net income to Adjusted EBITDA (in millions):   Quarter endedJune 30, 2025 Net income ($0.2 ) Adjustment to net income (1) 0.4   Adjusted net income (2) 0.2   Add back:   Depreciation and amortization 0.2   Interest income (0.2 ) Income tax provision -   Stock-based compensation 0.1   Adjusted EBITDA (from operations) $0.3       (1) This adjustment to net income removes the net proceeds from the sale of our corporate headquarters, related one-time relocation expenses, and tax related tax provision due to the sale. (2) Adjusted net income represents income from operations plus interest income.     Tandy Leather Factory, Inc., (http://www.tandyleather.com), headquartered in Fort Worth, Texas, is a specialty retailer of a broad product line, including leather, leatherworking tools, buckles and adornments for belts, leather dyes and finishes, saddle and tack hardware, and do-it-yourself kits. The Company distributes its products through its 101 stores located in 40 US states and six Canadian provinces, including one store located in Spain.  Its common stock trades on the Nasdaq Capital Market under the symbol “TLF”. To be included on Tandy Leather Factory's email distribution list, go to: http://www.b2i.us/irpass.asp?BzID=1625&to=ea&s=0. Contact:  Johan Hedberg, Tandy Leather Factory, Inc.,  (817) 872-3200 or johan.hedberg@tandyleather.com This news release may contain statements regarding future events, occurrences, circumstances, activities, performance, outcomes and results that are considered "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Actual results and events may differ from those projected as a result of certain risks and uncertainties. These risks and uncertainties include but are not limited to: changes in general economic conditions, negative trends in general consumer-spending levels, failure to realize the anticipated benefits of opening retail stores; availability of hides and leathers and resultant price fluctuations; change in customer preferences for our product, and other factors disclosed in our filings with the Securities and Exchange Commission.  These forward-looking statements are made only as of the date hereof, and except as required by law, we do not intend to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The post Tandy Leather Factory Reports Second Quarter 2025 Results appeared first on ForexTV.

Posts Positive Organic Growth and Adjusted EBITDA‎1 of 23.5% of Revenue CINCINNATI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fiscal third quarter 2025 financial results and operational highlights. These results pertain to the three and nine months ended June 30, 2025, and are reported in United States dollars. Conference Call Quipt will host its Earnings Conference Call on Tuesday, August 12, 2025 at 10:00 a.m. (ET). Interested parties may participate in the call by dialing 1 (833) 752-3722 or 1 (647) 846-8549. A live webcast of the call will be accessible via the investor section of the Company’s website through the following link: www.quipthomemedical.com, and a replay will be available on the investor section of the Company’s website for at least the first year following the event. Financial Highlights: Revenue for Q3 2025 was $58.3 million compared to $60.8 million for Q3 2024, representing a 4.1% decrease. This compares to revenue of $57.4 million in Q2 2025, reflecting a return to positive quarter-over-quarter organic growth of 1.6%. Revenue for the nine months ended June 30, 2025 decreased to $177.0 million, compared to $184.6 million for the nine months ended June 30, 2024, representing a decrease of 4.1%. Recurring Revenue‎1 for Q3 2025 continues to be strong at 81% of total revenue. Adjusted EBITDA1 for Q3 2025 was $13.7 million (23.5% of revenue) compared to $14.2 million (23.4% of revenue) for Q3 2024, representing a 3.6% decrease. Adjusted EBITDA1 of $41 million (23.2% of revenue) for the nine months ended June 30, 2025, compared to $44.4 million (24.1% of revenue) for the nine months ended June 30, 2024, a decrease of 7.7%. Net income (loss) for Q3 2025 was ($3.0) million, or ($0.07) per diluted share, compared to ($1.6) million, or ($0.04) per diluted share, for Q3 2024. Cash flow from operations was $27.9 million for the nine months ended June 30, 2025, compared to $25.4 million for the nine months ended June 30, 2024. The Company reported $11.3 million of cash on hand as of June 30, 2025 as compared to $17.1 million of cash on hand as of March 31, 2025. Total credit availability of $35.3 million as of June 30, 2025, with $14.3 million available on a revolving credit facility and $21.0 million available pursuant to a delayed-draw term loan facility. The Company maintains a conservative balance sheet with Net Debt to Adjusted EBITDA Leverage Ratio1 of 1.5x. Operational Highlights: The Company’s customer base decreased 1.3% year-over-year, serving 151,000 unique patients as of June 30, 2025, compared to 153,000 unique patients as of June 30, 2024. This compares to 146,000 in Q2 2025, reflecting a positive quarter-over-quarter growth of 3.4%. Completed 210,000 unique set-ups/deliveries in Q3 2025, a 2.8% decrease from 216,000 set-ups/deliveries in Q3 2024. This compares to 203,000 in Q2 2025, reflecting a positive quarter-over-quarter growth of 3.5%. Respiratory resupply set-ups/deliveries were 119,000 in Q3 2025, compared to 120,000 in Q3 2024. This compares to 111,000 in Q2 2025, reflecting a positive quarter-over-quarter growth of 7.2%. Subsequent Highlights: On July 7th, 2025, Quipt announced the acquisition of 100% of a full-service durable medical equipment (DME) provider, which was wholly-owned by Ballad Health, a major integrated health system serving the Appalachian Highlands region. The acquiree reported unaudited revenue of $6.6 million for the fiscal year ended June 30, 2025. The acquisition expanded Quipt's reach to over 12,500 patients annually across four branch locations in East Tennessee and Southwest Virginia. Quipt also signed a Preferred Provider Agreement (PPA) with Ballad Health embedding the Company directly into the health system's hospital discharge planning process and providing access to patient referrals from 20 hospitals across Tennessee, Virginia, North Carolina, and Kentucky. The transaction was funded entirely with cash on hand and at a highly attractive valuation, preserving balance sheet flexibility. Management expects the acquired operation's Adjusted EBITDA margins to align with Quipt's historical range within two quarters, driven by operational efficiencies and clinical workflow integration. Management Commentary: “Our third quarter results reflect important progress, as we returned to positive organic growth and achieved clear revenue stabilization across the overall business. These results highlight the dedication of our team and the structural improvements we’ve made over the past several quarters, which position us for sustainable long-term growth,” said Greg Crawford, Chief Executive Officer and Chairman of Quipt. “The subsequent completion of the Ballad Health acquisition marks a meaningful milestone for Quipt. This transaction embeds us directly into the discharge pathway of a prominent integrated health system and reinforces our broader strategy of expanding through healthcare system partnerships. We believe this scalable model will be powerful in advancing our growth platform. As we move through the remainder of 2025 and into 2026, our focus remains on maximizing long-term shareholder value. The Board and management team continue to evaluate opportunities supporting this objective and we are confident the actions we are taking today will lay a strong foundation for future value creation.” “We are extremely pleased with the stability we saw in our fiscal third quarter results. Our Adjusted EBITDA margin remained strong and consistent, even as we have navigated a transitioning revenue environment. This underscores the scalability and resiliency of our operating platform,” said Hardik Mehta, Chief Financial Officer of Quipt. “We are thrilled to have executed the Ballad-owned durable medical equipment acquisition after quarter end while maintaining a conservative balance sheet and strong financial flexibility. This transaction enhances our geographic footprint, deepens our health system relationships, and aligns with our playbook for growth. As we continue to scale, the combination of our recurring revenue base, financial strength, and proven execution gives us confidence in delivering consistent performance.” 1 Non-GAAP financial measure or ratio. See “Non-GAAP Financial Measures” below for additional information. ABOUT QUIPT HOME MEDICAL CORP. The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services, and making life easier for the patient. Reader AdvisoriesReaders are cautioned that the financial information regarding the acquiree disclosed herein is unaudited and derived as a result of the Company’s due diligence, including a review of the acquisition’s bank statements and tax returns. Forward-Looking Statements Certain statements contained in this press release constitute “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 or “forward-looking information” as such term is ‎‎‎‎‎‎defined in applicable Canadian securities legislation (collectively, “forward-looking statements”). The words “may”, “would”, “could”, “should”, "potential”, ‎‎‎‎‎‎‎"will”, "seek”, "intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect”, “outlook”, or the negatives thereof or variations of such words, and similar expressions ‎‎‎‎‎as ‎they relate to the Company are intended to ‎identify forward-looking statements, including: the Company anticipating strong margin performance throughout the year and a return to historical organic growth levels in calendar 2025; the Company’s expectations regarding the impact of the acquisition of the DME provider and the PPA; management’s expectations regarding the acquiree’s Adjusted EBITDA margin and the timing of such results; and opportunities to increase long-term shareholder value. All statements ‎other ‎than ‎statements of ‎‎historical fact, including those that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-‎looking statements and may involve estimates, assumptions and uncertainties that could cause actual results or outcomes to differ materially from those expressed in the forward-looking statements. Such statements reflect the ‎Company's ‎current ‎views and ‎‎intentions with respect to future ‎events, and current information available to the ‎Company, and ‎are ‎subject to ‎‎certain risks, uncertainties and ‎assumptions, including, without limitation: the ‎Company successfully identifying, ‎‎‎negotiating and ‎completing additional acquisitions; operating and other financial metrics maintaining their ‎‎current trajectories, the Company not being impacted by any further external and unique events like the Medicare ‎‎75/25 rate cut and the Change Healthcare cybersecurity incident for the remainder of 2025; and the ‎Company not being subject to a material change to it cost structure. Many ‎factors could cause the actual ‎results, ‎‎performance or achievements that may be ‎expressed ‎or implied by such ‎forward-looking statements to ‎vary from ‎‎those described herein should one or more ‎of these ‎risks or ‎uncertainties materialize. Examples of such ‎risk ‎factors ‎include, without limitation: risks related ‎to credit, market ‎‎‎(including equity, commodity, foreign exchange ‎and interest ‎rate), ‎liquidity, operational ‎‎(including technology ‎and ‎infrastructure), reputational, insurance, ‎strategic, ‎regulatory, legal, ‎environmental, and ‎capital adequacy; the ‎‎general business and economic conditions in ‎the regions ‎in which the ‎Company operates; ‎the ability of the ‎‎Company to execute on key priorities, including the ‎successful ‎completion of ‎acquisitions, ‎business retention, and ‎‎strategic plans and to attract, develop and retain ‎key ‎executives; difficulty ‎integrating ‎newly acquired businesses; ‎‎the ability to implement business strategies and ‎‎pursue business opportunities; low ‎profit ‎market segments; ‎‎disruptions in or attacks (including cyber-attacks) on ‎‎the Company's information ‎technology, ‎internet, network ‎‎access or other voice or data communications systems or ‎‎services; the evolution of ‎various types ‎of fraud or other ‎‎criminal behavior to which the Company is exposed; the ‎‎failure of third parties to ‎comply with ‎their obligations to ‎‎the Company or its affiliates; the impact of new and ‎‎changes to, or application of, ‎current ‎laws and regulations; ‎‎decline of reimbursement rates; dependence on few ‎‎payors; possible new drug ‎discoveries; a ‎novel business ‎model; ‎dependence on key suppliers; granting of permits ‎‎and licenses in a highly ‎regulated ‎business; legal proceedings and litigation, including as it relates to the civil ‎‎investigative demand (“CID”) ‎received from the Department of Justice; ‎increased competition; ‎changes in ‎foreign currency rates; ‎the imposition of trade restrictions such as tariffs and retaliatory counter measures; increased ‎‎funding costs and market volatility due to ‎market illiquidity and ‎competition for ‎funding; the ‎availability of funds ‎‎and resources to pursue operations; ‎critical accounting ‎estimates and changes ‎to accounting ‎standards, policies, ‎‎and methods used by the Company; the Company’s status as an emerging growth company and a smaller reporting company; the occurrence of ‎natural and unnatural ‎catastrophic ‎events or health epidemics or concerns; as well as those risk factors ‎discussed or ‎‎referred to ‎in the Company’s disclosure ‎documents filed with ‎United States Securities and Exchange ‎Commission ‎ and ‎available at www.sec.gov, including the Company’s most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, and with ‎the securities ‎regulatory authorities in certain provinces of ‎Canada and ‎‎‎available at www.sedarplus.com. Should any ‎factor affect ‎the Company in an unexpected manner, or ‎should ‎‎‎assumptions underlying the forward-looking ‎statement prove ‎incorrect, the actual results or events may ‎differ ‎‎‎materially from the results or events predicted. ‎Any such forward-‎looking statements are expressly qualified ‎in their ‎‎‎entirety by this cautionary statement. Moreover, ‎the Company ‎does not assume responsibility for the ‎accuracy or ‎‎‎completeness of such forward-looking ‎statements. The ‎forward-looking statements included in this ‎press release are made as of the date of this press ‎release and the ‎Company undertakes no obligation to publicly ‎update or revise ‎‎‎any forward-looking statements, ‎other than as ‎required by applicable law‎.‎ Non-GAAP Financial Measures This press release refers to “Adjusted EBITDA”, “Recurring Revenue”, and “Net Debt to Adjusted EBITDA Leverage Ratio”, which are non-GAAP financial measures that do not have standardized meanings prescribed by generally accepted accounting principles in the United States (“GAAP”). The ‎Company’s presentation of these financial measures may not be comparable to similarly titled measures used by ‎other companies. These financial measures are intended to provide additional information to investors concerning ‎the Company’s performance.‎ Adjusted EBITDA is calculated as net loss, and adding back depreciation and amortization, right-of-use operating lease amortization and interest, interest expense, net, provision for income taxes, certain professional fees, including those related to the CID, the loss of private issuer status, and proxy contests and other actions of activist shareholders, stock-based compensation, acquisition-related costs, change in fair value of derivative liability – interest rate swaps, gain on disposals of property and equipment, loss (gain) on foreign currency transactions, and share of loss in equity method investment. The following table shows our non-GAAP measure, Adjusted EBITDA, reconciled to our GAAP net loss for the ‎following indicated periods‎ (in $millions)‎:‎                           Three   Three   Nine   Nine   months   months   months   months   ended June   ended June   ended June   ended June   30, 2025   30, 2024   30, 2025   30, 2024 Net loss $ (3.0 )   $ (1.6 )   $ (7.2 )   $ (3.8 ) Add back:                       Depreciation and amortization   11.2       11.1       33.6       33.0   Interest expense, net   1.5       1.6       4.6       4.9   Right-of-use operating lease amortization and interest   1.6       1.7       4.8       4.6   Provision for income taxes   —       —       0.1       0.5   Professional fees   1.3       0.7       3.1       2.2   Stock-based compensation   2.1       0.5       2.6       2.2   Acquisition-related costs   0.1       0.2       0.2       0.4   Change in fair value of derivative liability - interest rate swaps   0.2       (0.1 )     (0.4 )     0.2   Gain on disposals of property and equipment   (0.8 )     (0.1 )     (0.9 )     (0.1 ) Loss (gain) on foreign currency transactions   (0.6 )     0.1       0.2       0.1   Share of loss in equity method investment   0.1       0.1       0.2       0.2   Adjusted EBITDA $ 13.7     $ 14.2     $ 41.0     $ 44.4                                   Recurring Revenue for Q3 2025 is calculated as rentals of medical equipment of $23.2 million plus sales of respiratory resupplies of $23.8 million for a total of $47.0 million, divided by total revenues of $58.3 million, or 81%. Net Debt to Adjusted EBITDA Leverage Ratio is calculated as Net Debt, divided by (Adjusted EBITDA for Q3 times four), and is reconciled as follows (in $millions):         As of and for thethree monthsended June 30,2025 Senior credit facility, principal $ 66.0 Equipment loans   10.5 Lease liabilities   16.9 Cash   (11.3) Net Debt $ 82.1 Adjusted EBITDA for Q3 times four $ 54.8 Net Debt to Adjusted EBITDA Leverage Ratio   1.5x For further information please visit our website at www.Quipthomemedical.com, or contact: Cole StevensVP of Corporate DevelopmentQuipt Home Medical Corp.859-300-6455cole.stevens@myquipt.com Gregory CrawfordChief Executive OfficerQuipt Home Medical Corp.859-300-6455investorinfo@myquipt.com The post Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results appeared first on ForexTV.

TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules for the AI and data center markets, today reported its unaudited condensed consolidated financial results for the second quarter ended June 30, 2025. The Company’s financial results as well as the Management Discussion and Analysis have been filed on SEDAR+. All financial figures are in United States dollars (“USD”) unless otherwise indicated. Management Commentary: “The second quarter of 2025 marked a major step forward in preparing for volume production of optical engines at Globetronics, with all equipment now installed and operational,” said Dr. Suresh Venkatesan, Chairman & CEO of POET Technologies. “In addition, we expanded our manufacturing capabilities by engaging with NationGate Solutions (M) Sdn. Bhd in Malaysia to build our light source products. Customers have been visiting Malaysia as we qualify both facilities for production. “Our customer engagements are intensifying and expanding. We added Lessengers as a new customer based in Korea, which has committed to a module development using POET’s 800G optical engines. “In May, we closed a $30 million private placement—the largest single financing in our history—providing us with the capital needed to support near-term growth. Together, the manufacturing expansion, customer engagements, and financings reinforce our confidence that we can meet our growth objectives.” Notable Business Highlights: Partnered with Lessengers, an innovative optical solution provider based in South Korea, to offer a differentiated 800G DR8 transceiver. Expanded production capacity by signing a Master Agreement, Module Purchase Agreement and a Deed of Consignment with NationGate Solutions (M) Sdn. Bhd, to manufacture optical engine assemblies for POET in Penang, Malaysia. Successfully completed another round of equity financing at $5.00 per share for gross proceeds of $30,000,000. Selected as the winner of the “AI Hardware Innovation Award” in the 8th annual AI Breakthrough Awards. This was the sixth notable award the Company has won in the past 12 months. Non-IFRS Financial SummaryThe Company reported non-recurring engineering (“NRE”) and product revenue of $268,469 in the second quarter of 2025 compared to nil for the same period in 2024 and $166,760 in the first quarter of 2025. Historically the Company provided NRE services to multiple customers for unique projects that are being addressed utilizing the capabilities of the POET Optical Interposer™. The Company only had small product revenue in Q2 2025. The Company reported a net loss of $17.3 million, or $0.21 per share, in the second quarter of 2025 compared with a net loss of $8.0 million, or ($0.14) per share, for the same period in 2024 and a net income of $6.3 million, or 0.08 per share, in the first quarter of 2025. The net loss in the second quarter of 2025 included research and development costs of $3.2 million compared to $2.1 million for the same period in 2024 and $4.4 million in the first quarter of 2025. Fluctuations in R&D for a Company of this size and this stage of growth is expected on a period-over-period basis as the Company transitions from technology development to product development. The largest component of the Company’s loss was from the non-cash loss in the fair value adjustment to derivative warrant liability of $7.5 million in the second quarter of 2025, compared to a loss of $1.4 million in the same period in 2024 and a non-cash gain of $15.4 million in the first quarter of 2025. This non-cash item relates to warrants issued in a foreign currency and is periodically remeasured. Other non-cash expenses in the second quarter of 2025 included stock-based compensation of $1.2 million and depreciation and amortization of $0.8 million. Non-cash stock-based compensation and depreciation and amortization in the same period of 2024 were $1.6 million and $0.5 million, respectively. First quarter 2025 stock-based compensation and depreciation and amortization were $0.8 million and $0.7 million, respectively. The Company had non-cash finance costs of $31,000 in the second quarter of 2025 compared to non-cash finance costs of $21,000 in the second quarter of 2024 and non-cash costs of $33,000 in the first quarter of 2025. The Company recognized other income, including interest of $533,000 in the second quarter of 2025, compared to $175,000 in the same period in 2024 and $528,000 in the first quarter of 2025. Cash flow from operating activities in the second quarter of 2025 was ($7.7) million compared to ($4.5) million in the second quarter of 2024 and ($8.9) million in the first quarter of 2025. Summary of Financial PerformanceThe following is a summary of the Company’s operations over the five quarters ending June 30, 2025. This information should be read in conjunction with the Company’s financial statements filed on Sedar + on August 11, 2025.   POET TECHNOLOGIES INC.PROFORMA – NON-IFRS AND IFRS PRESENTATION OF OPERATIONS(All figures are in U.S. Dollars)   For the Quarter ended:     30-Jun-25   31-Mar-25   31-Dec-24   30-Sep-24   30-Jun-24                                   Revenue     268,469   166,760   29,032   3,685   -   Research and development     (3,150,044)   (4,360,192)   (3,437,683)   (1,765,481)   (2,117,828)   Depreciation and amortization     (792,814)   (726,868)   (475,281)   (525,955)   (509,699)   Professional fees     (562,583)   (276,184)   (679,156)   (480,871)   (366,839)   Wages and benefits     (1,042,380)   (2,123,274)   (758,883)   (667,963)   (780,146)   Loss on acquisition of 24.8% of SPX     -   -   (6,852,687)   -   -   Stock-based compensation     (1,165,482)   (841,793)   (1,404,995)   (1,525,131)   (1,591,741)   General expenses and rent     (1,009,778)   (898,056)   (474,937)   (465,448)   (448,357)   Finance advisory fees     (1,302,464)   (476,802)   (4,239,831)   (1,319,392)   (942,576)   Derivative liability adjustment     (7,559,991)   15,382,971   (12,444,661)   (6,179,836)   (1,376,761)   Interest expense     (30,925)   (32,786)   (31,605)   (30,482)   (20,833)   Other (income), including interest     533,308   527,782   511,448   216,337   174,911   Unrealized foreign exchange loss     (1,448,691)           Net loss     (17,263,375)   6,341,558   (30,259,239)   (12,740,537)   (7,979,869)                   Net income (loss) per share - Basic     (0.21)   0.08   (0.50)   (0.20)   (0.14)   Net income (loss) per share - Diluted     -   -   (0.50)   (0.20)   (0.14)                             Restricted Stock Unit (“RSU”) GrantOn August 7, 2025, the board of directors of the Company approved the grant of 2,121,771 RSUs at a price of $5.42, being the closing price of the Company’s shares on the Nasdaq on August 6, 2025. The RSUs were granted to officers of the Company. The RSUs will vest 33.33% on the first, second and third anniversaries of the grant. Should an officer resign prior to being fully vested, the RSUs will be vested pro-rata based on the time served from the date of grant to the date of resignation or termination. The RSUs were granted subject to provisions of the Company’s 2025 Omnibus Incentive Plan and are subject to the TSX Venture Exchange policies and applicable securities laws. About POET Technologies Inc.POET is a design and development company offering high-speed optical modules, optical engines and light source products to the artificial intelligence systems market and to hyperscale data centers.  POET’s photonic integration solutions are based on the POET Optical Interposer™, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using advanced wafer-level semiconductor manufacturing techniques. POET's Optical Interposer-based products are lower cost, consume less power than comparable products, are smaller in size and are readily scalable to high production volumes. In addition to providing high-speed (800G, 1.6T and above) optical engines and optical modules for AI clusters and hyperscale data centers, POET has designed and produced novel light source products for chip-to-chip data communication within and between AI servers, the next frontier for solving bandwidth and latency problems in AI systems.  POET’s Optical Interposer platform also solves device integration challenges in 5G networks, machine-to-machine communication, self-contained "Edge" computing applications and sensing applications, such as LIDAR systems for autonomous vehicles.  POET is headquartered in Toronto, Canada, with operations in Allentown, PA, Shenzhen, China, and Singapore.  More information about POET is available on our website at www.poet-technologies.com.     Media Relations Contact: Company Contact: Adrian Brijbassi Thomas R. Mika, EVP & CFO Adrian.brijbassi@poet.tech  tm@poet.tech      Forward-Looking StatementsThis news release contains “forward-looking information” (within the meaning of applicable Canadian securities laws) and “forward-looking statements” (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995). Such statements or information are identified with words such as “anticipate”, “believe”, “expect”, “plan”, “intend”, “potential”, “estimate”, “propose”, “project”, “outlook”, “foresee” or similar words suggesting future outcomes or statements regarding any potential outcome. Such statements include the Company’s expectations with respect to the success of the Company’s product development efforts, the performance of its products, the expected results of its operations, meeting revenue targets, and the expectation of continued success in the financing efforts, the capability, functionality, performance and cost of the Company’s technology as well as the market acceptance, inclusion and timing of the Company’s technology in current and future products and expectations for approval of proposals at the Company’s annual meeting of shareholders. Such forward-looking information or statements are based on a number of risks, uncertainties and assumptions which may cause actual results or other expectations to differ materially from those anticipated and which may prove to be incorrect. Assumptions have been made regarding, among other things, management’s expectations regarding the success and timing for completion of its development efforts, the introduction of new products, financing activities, future growth, recruitment of personnel, opening of offices, the form and potential of its joint venture, plans for and completion of projects by the Company’s consultants, contractors and partners, availability of capital, and the necessity to incur capital and other expenditures. Actual results could differ materially due to a number of factors, including, without limitation, the failure of its products to meet performance requirements, lack of sales in its products, once released, operational risks in the completion of the Company’s anticipated projects, lack of performance of its joint venture, risks affecting the Company’s ability to execute projects, the ability of the Company to generate sales for its products, the ability to attract key personnel, the ability to raise additional capital and the agreement by shareholders to approve proposals put forth by the Company at shareholders’ meetings. Although the Company believes that the expectations reflected in the forward-looking information or statements are reasonable, prospective investors in the Company’s securities should not place undue reliance on forward-looking statements because the Company can provide no assurance that such expectations will prove to be correct. Forward-looking information and statements contained in this news release are as of the date of this news release and the Company assumes no obligation to update or revise this forward-looking information and statements except as required by law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.120 Eglinton Avenue, East, Suite 1107, Toronto, ON, M4P 1E2- Tel: 416-368-9411 - Fax: 416-322-5075 The post POET Technologies Reports Second Quarter 2025 Financial Results appeared first on ForexTV.